data_1q7x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q7x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.924 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.744 ' O ' HD21 ' A' ' 15' ' ' LEU . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.624 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.767 ' HA ' HG23 ' A' ' 46' ' ' VAL . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 3.7 p . . . . . 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.188 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.859 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.756 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.852 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.825 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.651 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.651 ' H ' HG21 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.807 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.694 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.915 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.678 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.859 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.935 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.053 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.766 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.775 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' THR . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.591 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.737 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.52 0.364 0 CA-C-O 120.005 -0.331 . . . . 0.0 113.148 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.504 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.935 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.551 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.5 mt-10 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.996 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 15' ' ' LEU . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.599 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.659 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.928 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.838 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' H ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.847 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG13 ' CE2' ' A' ' 30' ' ' PHE . 5.6 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.759 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.27 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.908 HG21 HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.847 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.838 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.928 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.869 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.797 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.734 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 5.2 m-70 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.678 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.846 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.923 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.032 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.618 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 32.7 t-20 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 70' ' ' VAL . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.759 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 7.0 t60 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.79 ' N ' ' O ' ' A' ' 79' ' ' THR . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' THR . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.832 -0.427 . . . . 0.0 113.449 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 7.6 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.744 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.032 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.923 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.922 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.723 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.649 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.621 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.772 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.664 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 3.3 p . . . . . 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.861 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.753 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.85 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.664 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.822 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.901 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.651 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.651 ' H ' HG21 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.621 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.809 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.709 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.922 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.678 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.674 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.861 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.951 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' CD2' HD12 ' A' ' 10' ' ' ILE . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.057 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.777 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 70' ' ' VAL . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.774 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 79' ' ' THR . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.057 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.951 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.985 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.687 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.667 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.804 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.648 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.84 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' H ' HG23 ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.671 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.6 p . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.659 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.84 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.737 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.919 ' HA ' HG23 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.456 ' HG2' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.648 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.422 ' O ' HD23 ' A' ' 15' ' ' LEU . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.668 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.776 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.79 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.659 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.777 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.943 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.056 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.742 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.7 t60 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' THR . 7.7 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.565 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 CA-C-O 119.936 -0.369 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.744 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.056 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.943 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 66' ' ' ARG . 2.0 mt-10 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.999 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.894 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.817 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.602 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.922 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.455 HG22 HG22 ' A' ' 26' ' ' VAL . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' H ' HG21 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.4 p . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.792 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.841 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.841 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.922 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.63 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.902 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.717 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.894 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.669 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.637 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.832 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.042 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.721 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.597 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 28.6 t-20 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.705 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.2 t60 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 79' ' ' THR . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 79' ' ' THR . 10.5 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.876 -0.402 . . . . 0.0 113.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.749 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.925 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.3 mt-10 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 59' ' ' GLY . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.807 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.653 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.661 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' H ' HG21 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.406 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.61 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.62 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.3 p . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.703 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.488 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.816 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.806 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.701 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.837 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.734 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.907 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.877 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.565 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.669 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.629 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.048 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.602 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 17.3 t-20 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 70' ' ' VAL . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.703 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.769 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.8 t60 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 79' ' ' THR . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.932 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.3 mt-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 1.031 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.803 ' O ' HD21 ' A' ' 15' ' ' LEU . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.865 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.654 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.9 p . . . . . 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.753 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.779 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.866 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.751 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.927 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.866 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.672 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.707 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.899 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.664 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.753 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.046 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.768 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.58 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 70' ' ' VAL . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.774 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.9 t60 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' THR . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.742 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.886 -0.396 . . . . 0.0 113.504 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.726 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.046 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.893 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.951 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.897 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.742 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.716 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.635 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' HG13 ' A' ' 28' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.726 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 26' ' ' VAL . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.663 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.709 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.424 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.642 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.1 p . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.794 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.709 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.859 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.663 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.859 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.833 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' HD23 ' A' ' 15' ' ' LEU . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.897 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.644 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.653 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.788 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.928 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.053 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.766 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' VAL . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.5 t60 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 79' ' ' THR . 7.5 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.333 0 CA-C-O 119.942 -0.366 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.742 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.574 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.469 ' HD2' HD22 ' A' ' 98' ' ' LEU . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 1.004 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.775 ' O ' HD21 ' A' ' 15' ' ' LEU . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.543 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.67 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.91 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.655 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.0 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.839 ' H ' HG21 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.706 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.91 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.854 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.695 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.747 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.858 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.668 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.625 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.658 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.944 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.039 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.715 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.607 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 27.3 t-20 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 70' ' ' VAL . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.773 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' THR . 10.4 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.365 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.722 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 97' ' ' LEU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.944 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.631 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 1.01 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.895 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.79 ' O ' HD21 ' A' ' 15' ' ' LEU . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.79 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 31' ' ' ASP . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.662 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 27' ' ' THR . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.0 p . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.705 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.662 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.736 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.918 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.863 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.697 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.895 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.668 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.63 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.695 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.768 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.051 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.77 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.5 t60 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.77 ' N ' ' O ' ' A' ' 79' ' ' THR . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' THR . 10.0 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.888 -0.396 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.725 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.932 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.624 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.973 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.902 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.824 ' O ' HD21 ' A' ' 15' ' ' LEU . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.633 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.923 HG23 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.884 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.872 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 4.6 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.267 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.874 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.754 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.872 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.884 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.742 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.749 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.902 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.663 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.648 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.706 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.874 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.895 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.401 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.05 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.727 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t-20 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.773 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 8.0 t60 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 79' ' ' THR . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.758 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.854 -0.414 . . . . 0.0 113.455 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.74 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.528 ' O ' ' O ' ' A' ' 66' ' ' ARG . 7.0 mt-10 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.962 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.75 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.677 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.616 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.683 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.859 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 47' ' ' LYS . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.41 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.495 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.745 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.662 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.0 p . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.783 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.85 HG12 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.85 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.859 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' N ' HG21 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.824 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.622 ' HB3' ' HA2' ' A' ' 53' ' ' GLY . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' O ' HD23 ' A' ' 15' ' ' LEU . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.667 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.777 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.784 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.727 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.604 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 32.4 m-70 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.644 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.023 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.757 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.593 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.766 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 79' ' ' THR . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 79' ' ' THR . 8.5 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.75 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.938 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.592 ' O ' ' O ' ' A' ' 66' ' ' ARG . 2.0 mm-40 . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 12' ' ' GLU . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.936 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.804 ' O ' HD21 ' A' ' 15' ' ' LEU . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.628 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.922 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.74 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.657 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' H ' HG21 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.637 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG13 ' CE2' ' A' ' 30' ' ' PHE . 4.3 p . . . . . 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.789 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.874 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.922 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.848 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.744 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.791 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.691 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 26.4 m-70 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.632 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' CD2' ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.037 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.731 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.615 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 29.9 t-20 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.466 ' CG1' ' NE2' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.684 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.788 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' NE2' ' CG1' ' A' ' 73' ' ' VAL . 11.2 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.754 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.628 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 119.809 -0.44 . . . . 0.0 113.423 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.037 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 67' ' ' VAL . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.98 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.61 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.74 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.627 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.667 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.527 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.661 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.624 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.2 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.413 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.912 HG21 HG21 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.985 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.985 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.896 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.824 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.45 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.884 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.684 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' CA ' ' HB2' ' A' ' 48' ' ' ALA . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.813 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.051 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.714 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.581 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 70' ' ' VAL . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.7 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.329 0 CA-C-O 119.893 -0.393 . . . . 0.0 113.268 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.74 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.913 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.894 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.792 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.661 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.725 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.73 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.4 p . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.805 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 30' ' ' PHE . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.919 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.661 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.844 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.402 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.691 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.894 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.56 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.049 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.6 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 24.7 t-20 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.455 ' CG1' ' NE2' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.5 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.758 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.294 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.413 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.756 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.938 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.934 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.811 ' O ' HD21 ' A' ' 15' ' ' LEU . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.667 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.819 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HG13 ' A' ' 28' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.736 ' HA ' HG23 ' A' ' 46' ' ' VAL . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 31' ' ' ASP . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.656 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.5 p . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.838 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.789 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.696 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.845 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.656 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG2' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.884 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.676 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.891 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.707 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.648 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 31.3 m-70 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.656 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.838 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.954 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 10' ' ' ILE . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.044 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.778 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.574 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.683 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.777 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' A' ' 79' ' ' THR . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 79' ' ' THR . 7.3 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.124 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.554 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 67' ' ' VAL . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.954 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.214 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.941 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 59' ' ' GLY . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.813 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.813 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.635 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.903 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.792 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 31' ' ' ASP . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.647 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.9 p . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.843 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.818 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.652 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.903 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.643 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.626 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.825 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.671 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.85 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.661 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.935 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 99' ' ' GLU . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.074 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.745 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.564 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' VAL . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.674 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.783 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.6 t60 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 79' ' ' THR . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 119.945 -0.364 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.798 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.074 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' VAL . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.935 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 1.087 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' O ' ' A' ' 59' ' ' GLY . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.827 ' O ' HD21 ' A' ' 15' ' ' LEU . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.64 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.618 ' HA3' ' HB2' ' A' ' 54' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.716 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 26' ' ' VAL . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.625 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 6.2 p . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.79 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.873 ' H ' HG21 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.858 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.916 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.643 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.643 ' H ' HG21 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.819 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.703 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.911 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.673 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.619 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.646 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.79 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.066 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.727 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.595 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 14.4 t-20 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' VAL . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.738 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.75 ' C ' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.721 ' O ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 79' ' ' THR . 8.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.75 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.533 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.728 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.087 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.899 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.27 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.779 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.729 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.618 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.885 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.735 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.649 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.836 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.625 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 3.3 p . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.835 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.971 HG21 HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.836 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.845 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.649 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' N ' HG21 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.625 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.815 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.638 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.665 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.779 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.692 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.666 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.835 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 99' ' ' GLU . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.043 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.771 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.775 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.4 t60 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.0 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.729 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.043 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.553 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.916 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.788 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.824 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.673 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 26' ' ' VAL . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.657 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.625 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.443 ' CE ' ' HB3' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.2 p . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.371 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.829 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.65 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.966 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.966 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.896 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.825 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.702 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.786 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.788 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.661 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 46' ' ' VAL . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.941 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 10' ' ' ILE . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 1.052 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.765 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.582 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' VAL . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.781 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 79' ' ' THR . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' CG2' ' A' ' 79' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.673 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.963 -0.354 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.824 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 1.052 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.539 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.941 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.548 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -163.84 178.78 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 149.16 51.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 110.83 2.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.58 2.186 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.48 113.89 3.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.464 2.109 . . . . 0.0 112.491 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.67 160.68 55.6 Favored Pre-proline 0 CA--C 1.504 -0.814 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.63 168.3 7.03 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.624 1.549 . . . . 0.0 112.69 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.51 22.85 8.73 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.652 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.924 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.915 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.744 ' O ' HD21 ' A' ' 15' ' ' LEU . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.624 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.566 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.767 ' HA ' HG23 ' A' ' 46' ' ' VAL . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.607 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.81 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 3.7 p 160.35 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.81 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 4.8 p30 -144.6 22.8 1.63 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.494 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 9.0 t -1.71 -54.68 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.794 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.6 m 178.02 54.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.39 0.614 . . . . 0.0 110.324 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.29 -176.95 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.477 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.28 29.93 7.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.671 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 61.4 m-70 -138.83 -31.45 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.394 0.616 . . . . 0.0 111.323 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 147.68 -107.1 0.37 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.979 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.859 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.756 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.852 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.825 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.651 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.651 ' H ' HG21 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.807 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.694 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.915 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.678 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.859 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.935 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 41' ' ' HIS . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.053 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.766 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.734 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.508 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.775 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.076 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.538 ' O ' HG22 ' A' ' 86' ' ' THR . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 86' ' ' THR . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.737 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.51 -40.94 90.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.076 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.3 tt0 -60.83 -36.68 79.71 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.157 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.734 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -68.18 -36.23 79.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.953 -177.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 1.3 mt -58.71 -43.59 90.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -30.98 56.22 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.572 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -99.39 -11.25 21.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.7 OUTLIER -40.03 158.15 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.687 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 108.59 -62.82 0.29 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.148 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.504 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.738 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.935 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.551 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.5 mt-10 -124.32 109.3 13.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.652 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -67.04 109.85 3.16 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.188 -178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.19 35.97 1.13 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.648 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -57.58 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.141 -0.529 . . . . 0.0 111.175 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 1.3 m -136.94 -69.23 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.295 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 50.9 Cg_endo -68.23 169.97 15.64 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 122.249 1.966 . . . . 0.0 112.865 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -170.23 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.403 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -77.39 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 -46.44 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.722 0.296 . . . . 0.0 110.984 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.886 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t 62.78 120.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -60.01 142.49 89.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.77 109.94 2.84 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.602 2.202 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.72 -176.69 2.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.234 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -132.74 156.72 79.76 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-O 121.327 0.584 . . . . 0.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.07 176.81 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.811 1.674 . . . . 0.0 112.602 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.11 24.17 8.14 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.64 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.996 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.797 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 15' ' ' LEU . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.754 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.599 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.659 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.928 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.838 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.641 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' H ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.847 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.833 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 5.6 p 160.6 -154.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.833 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 9.7 p-10 -141.7 23.52 2.1 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER 1.4 -55.06 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.039 -2.346 . . . . 0.0 113.961 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.1 m -176.49 37.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 7.1 p -132.39 -150.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 3.7 tmm_? -130.15 -2.7 4.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 49.6 m-70 -106.99 -25.28 11.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.283 0.564 . . . . 0.0 110.849 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.759 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.31 -108.17 0.71 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.786 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.908 HG21 HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.847 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.838 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.641 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.928 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.659 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.869 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.797 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.734 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 5.2 m-70 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.678 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.846 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.923 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.032 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.618 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 32.7 t-20 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 70' ' ' VAL . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.759 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 7.0 t60 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.799 ' O ' ' HB ' ' A' ' 86' ' ' THR . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.89 -45.86 97.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.793 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 32.7 tt0 -63.6 -33.79 76.4 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.975 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -73.78 -38.91 64.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.043 -175.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 1.5 mt -59.68 -38.02 80.38 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -76.35 -30.96 57.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.572 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -97.66 -3.95 38.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 87' ' ' LEU . 3.1 p -46.21 176.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.969 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.92 -66.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.449 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 7.6 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.744 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.032 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.923 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.56 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -127.5 115.26 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.64 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -65.29 112.33 3.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.899 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.18 35.04 1.17 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.091 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -93.61 28.99 2.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.44 . . . . 0.0 111.4 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.96 109.58 1.99 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.32 173.83 8.08 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 C-N-CA 122.455 2.104 . . . . 0.0 112.743 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m -57.11 -27.51 61.86 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.518 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.4 29.77 18.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -139.62 -59.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.88 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 60.48 96.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -168.27 151.46 5.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.76 105.85 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.395 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.68 -52.95 7.89 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.496 2.13 . . . . 0.0 112.276 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 161.09 37.25 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-O 121.435 0.636 . . . . 0.0 111.273 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.74 176.41 0.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.91 1.74 . . . . 0.0 112.538 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.86 26.93 4.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.644 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.922 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.723 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.649 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.621 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.558 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.772 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.664 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.839 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 3.3 p 157.93 -147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.839 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -137.99 20.76 2.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 175.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' H ' ' CG1' ' A' ' 35' ' ' VAL . 9.3 t 1.42 -55.17 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 112.028 -2.351 . . . . 0.0 113.863 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.7 m 178.73 55.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.465 0.65 . . . . 0.0 110.508 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.72 -177.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.516 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.46 29.93 7.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.92 0.39 . . . . 0.0 111.697 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 54.8 m-70 -139.96 -28.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 111.465 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 145.01 -107.51 0.44 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.861 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.753 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.85 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.664 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.822 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.901 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.651 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD2' HG21 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.651 ' H ' HG21 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.621 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.809 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.709 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.922 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.678 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.674 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.861 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.951 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' HIS . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.057 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.777 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.69 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 70' ' ' VAL . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.591 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.774 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.068 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.511 ' O ' ' CG2' ' A' ' 86' ' ' THR . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' O ' HG22 ' A' ' 86' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.84 -40.55 89.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.068 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 15.8 tt0 -61.44 -37.28 82.96 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.69 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -68.9 -38.8 79.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.661 -176.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 26' ' ' VAL . 2.2 mt -61.11 -38.95 88.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -77.04 -31.19 56.06 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.089 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 -8.41 20.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -38.12 156.91 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.715 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.44 -59.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.546 -1.311 . . . . 0.0 113.016 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.057 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.951 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 -127.17 110.63 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.644 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.73 112.13 4.05 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.78 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.51 38.76 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.253 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -66.0 -175.07 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.909 0.385 . . . . 0.0 111.179 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -177.77 86.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.87 168.81 1.58 Allowed 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 122.677 2.251 . . . . 0.0 112.811 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -69.66 0.21 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.418 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -169.27 58.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.41 85.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -103.11 88.87 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -176.66 88.82 0.26 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.44 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.651 2.234 . . . . 0.0 112.428 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.9 59.24 6.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -126.34 158.0 68.39 Favored Pre-proline 0 CA--C 1.504 -0.79 0 CA-C-O 121.343 0.592 . . . . 0.0 111.297 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.05 -171.53 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.79 1.66 . . . . 0.0 112.687 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 101.27 24.09 9.17 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.682 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.985 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.744 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.687 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.667 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.804 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.648 ' HA3' ' HB1' ' A' ' 54' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.84 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.658 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' H ' HG23 ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB2' ' CE ' ' A' ' 32' ' ' LYS . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.671 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.748 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 7.6 p 155.23 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.748 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.2 25.97 1.69 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 175.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.511 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.7 t -8.3 -53.8 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.453 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' ASN . 5.2 m -162.38 67.33 0.24 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 8.1 p -167.41 -175.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.686 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 10.2 ttt-85 -114.54 24.46 11.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -136.31 -26.06 1.15 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.296 0.569 . . . . 0.0 111.786 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.71 -108.92 1.04 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.659 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.84 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.737 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.919 ' HA ' HG23 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.635 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.456 ' HG2' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.648 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.856 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.422 ' O ' HD23 ' A' ' 15' ' ' LEU . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.668 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.776 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.79 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.659 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.777 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.943 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.056 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.742 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.653 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.509 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.7 t60 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.055 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 86' ' ' THR . 7.7 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.617 ' O ' HG21 ' A' ' 86' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.9 -41.1 91.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.055 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.6 tt0 -61.49 -37.04 82.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.506 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -66.56 -39.09 88.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.431 -176.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.508 HD13 HG22 ' A' ' 26' ' ' VAL . 3.6 mt -62.26 -39.47 93.02 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.329 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -103.52 -10.66 18.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.7 OUTLIER -38.04 156.43 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.723 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 111.87 -63.93 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.151 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.744 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.056 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.943 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' A' ' 66' ' ' ARG . 2.0 mt-10 -120.1 110.12 16.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.682 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.84 109.21 2.82 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.365 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.51 34.49 1.37 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 6.5 mt-30 -61.08 -19.54 61.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.529 . . . . 0.0 111.241 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.405 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 1.1 m 64.63 53.97 1.28 Allowed Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 103' ' ' SER . 72.7 Cg_endo -73.46 67.21 4.51 Favored 'Trans proline' 0 CA--C 1.501 -1.158 0 C-N-CA 122.799 2.332 . . . . 0.0 112.795 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -174.71 37.6 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.186 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m -141.61 -47.29 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -106.27 -35.89 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.92 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -86.58 -67.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -134.77 72.15 69.23 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.79 110.2 2.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.91 177.96 5.8 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.444 2.096 . . . . 0.0 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 mtmt -150.22 162.2 28.48 Favored Pre-proline 0 CA--C 1.504 -0.795 0 CA-C-O 121.327 0.584 . . . . 0.0 111.266 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.6 -173.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.892 1.728 . . . . 0.0 112.606 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.06 25.07 7.67 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.658 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.999 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.894 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.817 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.602 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.922 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.455 HG22 HG22 ' A' ' 26' ' ' VAL . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' H ' HG21 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.767 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.4 p 156.94 -162.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.767 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 16.9 p-10 -139.64 23.72 2.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.1 t -6.38 -53.45 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.008 -2.36 . . . . 0.0 114.182 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.7 m -158.86 35.87 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.2 p -141.87 -155.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 44.4 ttm-85 -126.23 -16.89 5.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -89.2 -26.11 21.42 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.556 0.693 . . . . 0.0 110.566 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.03 -108.7 0.75 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.484 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.792 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.728 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.841 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.841 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.922 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.63 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.902 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.717 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.894 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.669 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.637 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.675 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.832 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.042 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.721 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.597 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 28.6 t-20 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 70' ' ' VAL . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.705 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.2 t60 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.79 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.5 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.726 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.7 -46.66 94.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.808 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 26.7 tt0 -61.94 -33.26 73.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.916 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.34 -34.43 61.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.221 -175.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 8.3 mt -62.33 -40.36 96.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -75.56 -30.69 59.78 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.49 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.1 m120 -96.56 -4.74 40.73 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.473 HG23 ' HA ' ' A' ' 87' ' ' LEU . 2.6 p -45.71 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.785 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.2 -65.39 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.45 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.749 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.925 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.3 mt-10 -123.56 109.47 13.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.658 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.75 110.03 3.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.144 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.9 37.61 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.788 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.5 mt-30 -54.78 -79.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.176 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -178.17 56.74 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.86 171.65 14.18 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.605 2.203 . . . . 0.0 112.745 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.3 p -60.06 -31.51 70.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.339 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 23.16 10.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 tpmp? 179.91 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 t -108.46 31.58 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.36 75.96 11.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.58 111.82 3.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.306 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 132.47 47.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.459 2.106 . . . . 0.0 112.272 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.74 162.98 35.68 Favored Pre-proline 0 CA--C 1.504 -0.817 0 CA-C-O 121.41 0.624 . . . . 0.0 111.314 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.15 -174.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.88 1.72 . . . . 0.0 112.526 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.49 26.86 5.48 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.668 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.877 HG11 ' O ' ' A' ' 59' ' ' GLY . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.807 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.653 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.907 HG23 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.661 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 ' H ' HG21 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.406 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.61 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.62 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.753 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 7.3 p 156.82 -163.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.753 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 33.2 p-10 -140.07 23.97 2.37 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 35' ' ' VAL . 1.7 t -5.42 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 112.122 -2.308 . . . . 0.0 114.176 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.6 m -158.72 35.66 0.22 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.17 -155.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 19.2 ttm180 -126.72 -16.14 5.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -89.86 -27.94 19.58 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.614 0.721 . . . . 0.0 110.58 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.703 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.91 -108.35 0.7 Allowed Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.515 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.816 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.806 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.701 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.837 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.734 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.907 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.653 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.877 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.565 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.669 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.629 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.048 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.602 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 17.3 t-20 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 70' ' ' VAL . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.703 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.769 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.8 t60 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.77 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.757 ' O ' ' HB ' ' A' ' 86' ' ' THR . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.36 -44.92 99.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.77 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.3 tt0 -65.54 -33.19 75.35 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.14 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.757 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.23 -41.59 27.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.272 -175.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HA ' HG23 ' A' ' 90' ' ' THR . 3.9 pp -59.99 -36.4 77.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.0 -31.15 56.28 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.447 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.39 -2.01 46.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.48 ' CG2' HG21 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -40.72 166.5 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.825 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.67 -64.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.474 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.932 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.3 mt-10 -124.28 110.62 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.668 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.69 109.93 3.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.221 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.95 37.41 0.66 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.793 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.3 mt-30 -56.04 -40.94 74.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.146 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.91 127.8 5.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.84 170.52 0.61 Allowed 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 122.52 2.146 . . . . 0.0 112.786 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -174.3 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.388 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.98 30.88 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -176.75 -54.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.921 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m -151.4 146.95 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.24 163.94 1.45 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.47 110.57 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.244 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.52 59.32 6.15 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.479 2.119 . . . . 0.0 112.438 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 140.13 21.18 Favored Pre-proline 0 CA--C 1.503 -0.841 0 CA-C-O 121.59 0.71 . . . . 0.0 111.304 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.1 178.38 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.157 1.904 . . . . 0.0 112.799 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 97.66 23.57 13.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.686 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 1.031 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.803 ' O ' HD21 ' A' ' 15' ' ' LEU . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.927 HG23 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.865 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.654 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.782 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.59 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.782 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 11.1 t-20 -144.75 25.48 1.46 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 ' N ' HG21 ' A' ' 35' ' ' VAL . 1.2 t -12.98 -52.67 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 111.947 -2.388 . . . . 0.0 113.975 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -166.14 36.28 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 6.0 p -134.1 -154.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.955 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.528 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 41.3 ttm-85 -132.17 0.18 3.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 50.4 m-70 -110.54 -23.22 11.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . 139.39 -108.83 0.61 Allowed Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.753 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.779 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.866 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.751 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.927 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.866 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.672 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.707 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.899 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.664 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.753 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.046 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.768 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.715 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 70' ' ' VAL . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.516 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.774 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.9 t60 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' A' ' 86' ' ' THR . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.629 ' O ' HG21 ' A' ' 86' ' ' THR . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.742 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.15 -40.79 90.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.059 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 19.2 tt0 -61.57 -36.63 81.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.526 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.715 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -67.95 -39.69 83.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.411 -176.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 84' ' ' VAL . 6.3 mt -61.54 -38.33 87.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -76.93 -30.98 56.32 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.187 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.34 -10.41 17.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -37.18 155.72 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.964 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.45 -63.1 0.31 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.504 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.726 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.046 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.893 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -111.97 110.02 20.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.686 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.87 107.94 2.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.446 -178.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.46 31.58 2.23 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.372 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -61.74 -171.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.954 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.9 p -104.17 89.94 2.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.877 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.15 137.45 34.34 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 122.831 2.354 . . . . 0.0 112.937 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 49.54 34.83 7.39 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.603 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -82.97 -29.51 28.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.769 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -40.93 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.92 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.49 -46.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.407 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 2.0 t -178.05 -61.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 45.0 Cg_endo -67.96 173.93 8.55 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.445 2.097 . . . . 0.0 112.271 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.16 90.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -129.89 161.28 60.62 Favored Pre-proline 0 CA--C 1.504 -0.793 0 CA-C-O 121.425 0.631 . . . . 0.0 111.284 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.49 171.88 1.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.912 1.742 . . . . 0.0 112.643 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.613 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 118.84 29.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.676 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.951 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.897 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.742 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.716 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.635 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.904 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.519 ' HB3' HG13 ' A' ' 28' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.726 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 26' ' ' VAL . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.663 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.709 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.424 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.775 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.1 p 156.08 -162.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.775 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 21.0 p-10 -141.18 24.31 2.14 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.487 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -2.72 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 112.189 -2.278 . . . . 0.0 114.098 -175.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -170.64 41.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 40' ' ' ARG . 2.6 p -131.11 -154.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.425 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 2.5 ttt-85 -133.5 32.71 3.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 111.194 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -148.45 -27.63 0.32 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.033 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.76 -109.77 0.83 Allowed Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.794 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.709 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.859 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.663 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.859 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.833 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' HD23 ' A' ' 15' ' ' LEU . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.897 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.682 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.644 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.653 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.788 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.928 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.053 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.766 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.758 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' VAL . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.492 ' N ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.5 t60 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.108 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.52 ' O ' HG21 ' A' ' 86' ' ' THR . 7.5 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' HG21 ' A' ' 86' ' ' THR . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.12 -39.07 84.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.108 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.5 tt0 -61.61 -36.61 81.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.001 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.758 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -71.74 -42.94 66.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.02 -176.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 84' ' ' VAL . 3.1 pp -62.09 -35.91 80.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.662 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -77.3 -31.33 54.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.405 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.7 m-80 -106.79 -6.27 17.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.7 OUTLIER -35.49 155.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.884 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.81 -62.48 0.33 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.803 -1.189 . . . . 0.0 113.234 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.742 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.928 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.574 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -125.76 115.74 20.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.676 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.81 122.96 18.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.264 -179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.43 33.97 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.802 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 16.6 mt-30 -51.71 128.35 23.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.657 -0.772 . . . . 0.0 111.26 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.406 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -63.53 -61.45 7.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 58.8 Cg_endo -71.31 169.92 19.58 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.596 2.198 . . . . 0.0 112.853 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -69.22 0.26 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.342 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 t -134.77 -44.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -128.96 -67.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.853 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -128.96 -75.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.13 65.41 2.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.976 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 31.9 Cg_exo -57.31 -47.15 23.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.566 2.178 . . . . 0.0 112.583 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 4' ' ' PRO . 93.5 Cg_endo -80.65 95.23 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.346 2.031 . . . . 0.0 112.499 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -127.59 158.99 68.26 Favored Pre-proline 0 CA--C 1.505 -0.781 0 CA-C-O 121.421 0.629 . . . . 0.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.21 149.23 81.85 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.79 1.66 . . . . 0.0 112.643 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.581 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.66 26.44 6.81 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.691 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.469 ' HD2' HD22 ' A' ' 98' ' ' LEU . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 1.004 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.775 ' O ' HD21 ' A' ' 15' ' ' LEU . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.543 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.67 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.91 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.655 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.788 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.0 p 159.4 -160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.788 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 12.9 t30 -143.52 26.03 1.63 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.3 t -9.86 -53.55 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.003 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.6 m -165.07 46.32 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 7.6 p -143.55 -151.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.52 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 42.0 ttt-85 -129.28 -6.41 4.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -106.72 -24.66 12.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 111.137 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.08 -107.87 0.72 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.839 ' H ' HG21 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.706 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.91 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.854 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.695 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.747 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.858 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.668 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.625 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.658 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.944 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.039 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.715 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.607 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 27.3 t-20 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 70' ' ' VAL . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.718 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.773 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.798 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.782 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.4 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.57 -45.94 96.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.798 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.1 tt0 -63.33 -33.23 75.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.083 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.782 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.41 -37.46 60.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.572 -0.851 . . . . 0.0 112.269 -175.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 5.1 mt -62.07 -38.38 88.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -30.78 58.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.556 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -97.93 -3.91 37.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 87' ' ' LEU . 2.8 p -45.27 175.16 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.913 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.38 -64.78 0.38 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.985 -1.103 . . . . 0.0 113.365 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.722 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 97' ' ' LEU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.944 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -120.65 114.68 22.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.691 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.76 109.95 3.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.238 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.35 36.06 0.81 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.936 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 5.2 mm100 -69.43 -75.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.371 -0.414 . . . . 0.0 111.161 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t -92.98 149.09 37.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.78 67.31 3.09 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.709 2.273 . . . . 0.0 112.75 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -174.87 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.359 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 t 63.06 37.52 11.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.748 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -167.7 -41.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.5 m -119.06 111.05 17.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.72 86.96 0.26 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.41 148.59 25.74 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.513 2.142 . . . . 0.0 112.311 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.24 157.19 11.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.492 2.128 . . . . 0.0 112.288 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.92 161.47 57.97 Favored Pre-proline 0 CA--C 1.505 -0.779 0 CA-C-O 121.338 0.59 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.15 179.68 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.745 1.63 . . . . 0.0 112.543 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 106.51 23.27 7.31 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.719 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.631 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 1.01 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.895 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.79 ' O ' HD21 ' A' ' 15' ' ' LEU . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.79 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 31' ' ' ASP . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.662 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 27' ' ' THR . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.791 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.35 -161.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.791 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 20.0 t-20 -143.9 25.96 1.57 Allowed 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 36' ' ' ASN . 1.4 t -9.95 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 112.095 -2.32 . . . . 0.0 113.195 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 9.0 m -165.48 69.96 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.178 0.514 . . . . 0.0 111.865 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.582 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 8.0 p -165.07 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.826 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.582 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -128.15 0.56 5.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -115.54 -26.16 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.254 0.549 . . . . 0.0 111.642 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 132.98 -108.04 0.73 Allowed Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.782 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.705 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.861 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.736 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.918 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.863 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.697 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.895 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.668 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.63 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.695 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.768 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.051 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.73 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' VAL . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.424 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.77 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.5 t60 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.809 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.743 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.0 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.51 -46.45 95.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.809 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.6 tt0 -62.5 -33.25 74.51 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.022 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.743 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -76.22 -36.95 58.33 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.461 -175.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 1.9 mt -61.05 -38.29 85.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -30.84 58.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.752 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -98.35 -4.73 34.27 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 87' ' ' LEU . 3.1 p -44.81 174.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.37 -64.89 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.372 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.471 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.725 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.932 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -116.71 121.23 41.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.719 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -78.04 110.78 13.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.579 -177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.02 35.56 0.84 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.696 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 10.9 mt-30 -53.47 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.306 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -90.97 -51.83 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 103' ' ' SER . 49.2 Cg_exo -54.14 166.18 1.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 122.507 2.138 . . . . 0.0 112.97 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.3 m -71.62 77.47 0.82 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.297 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.26 -60.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -167.5 33.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.921 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -138.2 31.48 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 152.99 38.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 32.0 Cg_exo -57.06 -47.1 24.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.521 2.147 . . . . 0.0 112.629 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 4' ' ' PRO . 96.8 Cg_endo -80.63 92.04 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.322 2.014 . . . . 0.0 112.371 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 157.41 42.76 Favored Pre-proline 0 CA--C 1.502 -0.867 0 CA-C-O 121.367 0.604 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -86.94 178.73 3.52 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 C-N-CA 121.752 1.635 . . . . 0.0 112.965 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.42 24.85 6.28 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.711 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.624 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.973 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.902 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.824 ' O ' HD21 ' A' ' 15' ' ' LEU . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.824 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.633 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.923 HG23 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.496 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.884 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.872 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.597 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.846 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 4.6 p 160.64 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.846 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 10.0 p-10 -141.76 22.45 2.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 36' ' ' ASN . 13.0 t 1.43 -53.78 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.217 -2.265 . . . . 0.0 114.052 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.0 m 178.17 39.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.191 0.519 . . . . 0.0 110.808 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 3.3 p -131.89 -153.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.116 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.448 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -134.32 32.13 3.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.178 0.513 . . . . 0.0 111.022 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 52.0 m-70 -143.03 -34.54 0.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.845 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 149.36 -107.91 0.38 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.659 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.874 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.754 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.872 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.884 HG23 ' HA ' ' A' ' 26' ' ' VAL . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.742 ' H ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.923 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.749 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.902 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.663 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.648 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.706 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.874 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.895 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 41' ' ' HIS . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.05 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.727 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t-20 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.773 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 8.0 t60 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.777 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.831 ' O ' ' HB ' ' A' ' 86' ' ' THR . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.758 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.72 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.777 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.4 tt0 -64.72 -33.52 76.17 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.99 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.831 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.4 -39.51 62.61 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.014 -175.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -60.39 -37.46 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -30.92 57.6 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.702 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m-20 -98.56 -5.11 32.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 87' ' ' LEU . 2.8 p -45.9 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.968 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.89 -65.13 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.455 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.74 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.528 ' O ' ' O ' ' A' ' 66' ' ' ARG . 7.0 mt-10 -119.57 116.18 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -73.39 111.12 8.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.622 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.57 35.72 1.02 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.805 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 8.1 mt-30 -58.22 -173.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.367 -0.417 . . . . 0.0 111.164 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.429 ' CB ' ' HD3' ' A' ' 104' ' ' PRO . 0.5 OUTLIER 179.2 -55.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 103' ' ' SER . 72.8 Cg_exo -49.78 132.76 32.15 Favored 'Trans proline' 0 CA--C 1.502 -1.092 0 C-N-CA 122.662 2.241 . . . . 0.0 113.134 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.5 m 43.71 31.46 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.752 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -36.24 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -118.37 33.69 5.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.05 -31.38 15.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m 60.89 70.51 0.94 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.4 170.84 16.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.581 2.187 . . . . 0.0 112.333 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.37 124.39 11.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.533 2.155 . . . . 0.0 112.208 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 162.54 39.85 Favored Pre-proline 0 CA--C 1.505 -0.765 0 CA-C-O 121.428 0.632 . . . . 0.0 111.34 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.37 171.23 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.972 1.781 . . . . 0.0 112.415 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.91 24.3 5.83 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.626 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.962 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.75 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.677 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.616 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.683 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.859 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 47' ' ' LYS . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.41 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.67 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.495 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.745 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.662 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.801 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.04 -160.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.801 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 13.6 t30 -144.62 26.41 1.42 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' C ' ' O ' ' A' ' 36' ' ' ASN . 1.2 t -10.58 -55.28 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.139 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 19.3 m -171.13 70.27 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.6 p -158.81 -154.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.857 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.51 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 2.6 tpt180 -130.68 30.1 4.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.4 ' H ' HG11 ' A' ' 39' ' ' VAL . 33.4 m-70 -148.64 -30.33 0.27 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 111.719 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.71 -108.59 0.62 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.783 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.745 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.85 HG12 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.85 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.859 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' N ' HG21 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.824 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.622 ' HB3' ' HA2' ' A' ' 53' ' ' GLY . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' O ' HD23 ' A' ' 15' ' ' LEU . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.667 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.777 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.784 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.727 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.604 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 32.4 m-70 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.644 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.023 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.757 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.672 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.766 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.054 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.538 ' O ' ' CG2' ' A' ' 86' ' ' THR . 8.5 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' O ' HG22 ' A' ' 86' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.87 -41.35 92.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.054 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.9 tt0 -61.31 -35.97 78.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.672 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -66.5 -38.71 87.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.2 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.435 HD11 HG23 ' A' ' 26' ' ' VAL . 6.6 mt -62.23 -38.96 91.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -76.87 -31.02 56.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.983 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 -9.51 19.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -38.86 157.58 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.704 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 109.47 -63.8 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.092 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.75 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.023 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.938 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.592 ' O ' ' O ' ' A' ' 66' ' ' ARG . 2.0 mm-40 -128.94 117.15 20.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.619 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.7 110.48 3.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.117 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.09 36.61 1.03 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.878 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -89.64 -176.73 5.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.158 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.95 86.65 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.83 172.22 11.01 Favored 'Trans proline' 0 CA--C 1.502 -1.118 0 C-N-CA 122.627 2.218 . . . . 0.0 112.755 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 p -58.03 -35.43 71.27 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.528 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -45.02 93.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -90.95 -66.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.827 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -164.06 35.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.8 -53.1 2.53 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.88 105.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.548 2.165 . . . . 0.0 112.407 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -176.5 2.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.537 2.158 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.81 161.8 60.28 Favored Pre-proline 0 CA--C 1.505 -0.786 0 CA-C-O 121.345 0.593 . . . . 0.0 111.223 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 26.7 Cg_exo -61.33 160.47 27.01 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.738 1.625 . . . . 0.0 112.491 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.59 26.34 6.21 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.683 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 12' ' ' GLU . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.936 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.804 ' O ' HD21 ' A' ' 15' ' ' LEU . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.628 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.922 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG12 ' A' ' 28' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.74 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.657 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' H ' HG21 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.637 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.839 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 4.3 p 160.69 -147.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.839 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 11.1 t30 -144.98 23.58 1.52 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -10.59 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.134 -176.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER 172.65 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.502 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 11.6 p -113.04 -2.25 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 112.346 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 61.98 19.3 10.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.069 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 78.1 m-70 -139.67 -25.9 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 35' ' ' VAL . . . 146.78 -107.05 0.39 Allowed Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.789 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.874 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.922 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.848 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.744 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.791 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.691 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 26.4 m-70 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.632 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' CD2' ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.037 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.731 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.615 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 29.9 t-20 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 ' CG1' ' NE2' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.684 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' CA ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.788 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.796 ' O ' ' HB ' ' A' ' 86' ' ' THR . 11.2 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.754 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.15 -45.62 98.07 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.791 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 21.6 tt0 -63.96 -33.59 76.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.796 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.45 -38.39 62.98 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.107 -175.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 1.2 mt -60.57 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -76.46 -30.93 57.51 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.695 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.2 m120 -97.95 -3.91 37.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 87' ' ' LEU . 2.8 p -45.4 174.76 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.953 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.628 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.47 -67.13 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.423 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.037 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 67' ' ' VAL . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.98 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.61 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -129.77 119.04 22.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.683 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -65.99 112.06 3.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.063 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.55 33.26 0.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.969 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -77.38 81.76 3.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.196 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -125.48 75.58 69.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.1 170.83 0.97 Allowed 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.661 2.241 . . . . 0.0 112.711 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 m -56.28 -49.72 73.42 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.58 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -166.85 38.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.13 31.35 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.919 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -69.27 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -178.2 80.11 0.23 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.11 110.75 2.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.614 2.209 . . . . 0.0 112.275 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.37 -169.88 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.496 2.131 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.99 93.46 Favored Pre-proline 0 CA--C 1.503 -0.833 0 CA-C-O 121.637 0.732 . . . . 0.0 111.211 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.41 171.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.763 2.309 . . . . 0.0 112.838 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.84 26.12 6.23 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.664 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.74 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.627 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.667 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.527 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.661 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.624 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.762 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.2 p 157.17 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.762 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -142.09 25.05 1.95 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 175.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.49 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.8 t -5.47 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 111.972 -2.376 . . . . 0.0 114.137 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.624 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.8 m -159.38 37.97 0.2 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.25 -155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 22.9 ttt85 -126.64 -16.48 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -89.88 -26.91 20.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 110.522 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 129.83 -108.51 0.87 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.435 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.912 HG21 HG21 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.985 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.985 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.896 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.824 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.45 ' O ' HD23 ' A' ' 15' ' ' LEU . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.884 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.684 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' CA ' ' HB2' ' A' ' 48' ' ' ALA . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.813 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.051 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.714 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.581 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 70' ' ' VAL . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.794 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.778 ' O ' ' HB ' ' A' ' 86' ' ' THR . 9.7 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.13 -44.88 97.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.794 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.7 tt0 -64.94 -32.97 74.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.948 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.778 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.05 -42.61 26.02 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.315 -175.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.552 ' HA ' HG23 ' A' ' 90' ' ' THR . 3.8 pp -58.66 -37.58 76.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 1.3 tpt180 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.786 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m120 -97.1 -2.56 42.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 87' ' ' LEU . 4.0 p -44.23 175.43 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.096 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.07 -64.69 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.268 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.476 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.74 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.913 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-10 -126.47 110.52 13.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.664 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.64 111.3 3.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.876 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.15 36.96 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.831 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -80.08 -49.41 11.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.333 -0.433 . . . . 0.0 111.217 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -59.96 -52.17 75.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 103' ' ' SER . 35.5 Cg_exo -41.9 95.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 123.109 2.54 . . . . 0.0 113.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.63 -174.24 0.11 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.052 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -88.92 53.69 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt 59.7 32.82 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.917 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -49.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -178.36 -61.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 60.1 Cg_endo -72.41 169.74 20.98 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.93 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.595 2.196 . . . . 0.0 112.205 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 6.9 tttp -179.23 139.99 0.35 Allowed Pre-proline 0 CA--C 1.504 -0.809 0 CA-C-O 121.542 0.687 . . . . 0.0 111.065 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 6' ' ' LYS . 10.4 Cg_endo -53.47 168.62 0.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.209 1.939 . . . . 0.0 112.49 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 104.91 28.2 5.69 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.69 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.894 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.792 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.661 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.919 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.725 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.637 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.73 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.716 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.741 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 7.4 p 156.65 -161.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.741 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 16.1 t-20 -142.33 25.23 1.89 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 36' ' ' ASN . 1.7 t -4.86 -56.05 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.11 -2.314 . . . . 0.0 113.315 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 36' ' ' ASN . 18.1 m -171.19 66.6 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.164 0.506 . . . . 0.0 111.828 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.4 p -156.61 -155.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.026 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.522 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 17.0 ttt180 -131.09 30.07 4.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -147.42 -31.03 0.32 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.428 0.633 . . . . 0.0 111.587 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 140.75 -108.31 0.55 Allowed Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.805 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 30' ' ' PHE . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.919 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.661 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB3' ' HA3' ' A' ' 23' ' ' GLY . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.844 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.402 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.691 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.894 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.56 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.049 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.724 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.6 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 24.7 t-20 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.455 ' CG1' ' NE2' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.479 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.554 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.774 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.616 ' O ' ' HB ' ' A' ' 86' ' ' THR . 9.5 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.758 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.41 -45.37 98.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.774 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.4 tt0 -65.56 -33.62 76.33 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.129 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 1.9 t -79.38 -38.78 34.13 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.608 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' HG21 ' A' ' 90' ' ' THR . 3.9 pp -61.84 -37.26 83.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -76.94 -31.02 56.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.695 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.64 -2.54 44.51 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 87' ' ' LEU . 2.7 p -43.84 173.86 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.031 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 106.86 -65.82 0.25 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.413 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.465 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.756 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.551 ' O ' HG13 ' A' ' 67' ' ' VAL . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.938 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -132.94 121.86 23.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.69 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -66.02 119.87 12.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.704 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 66' ' ' ARG . . . -158.05 34.8 0.52 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.598 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -90.18 -27.58 19.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.356 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.4 -53.95 50.74 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.206 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.07 133.19 14.83 Favored 'Trans proline' 0 CA--C 1.493 -1.529 0 C-N-CA 122.792 2.328 . . . . 0.0 113.308 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 108' ' ' GLU . 1.6 t -107.81 56.63 0.63 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.338 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m 63.23 49.44 3.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.37 70.62 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' CG ' ' CG2' ' A' ' 105' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -95.0 169.91 9.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 145.21 49.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.37 170.13 20.92 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.571 2.181 . . . . 0.0 112.307 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -167.94 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.646 2.23 . . . . 0.0 112.305 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -103.49 142.1 23.88 Favored Pre-proline 0 CA--C 1.504 -0.804 0 CA-C-O 121.643 0.735 . . . . 0.0 111.268 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.33 173.14 0.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.284 1.989 . . . . 0.0 112.758 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.84 24.04 5.95 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.626 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.934 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.811 ' O ' HD21 ' A' ' 15' ' ' LEU . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.667 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.819 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' HG13 ' A' ' 28' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.736 ' HA ' HG23 ' A' ' 46' ' ' VAL . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 31' ' ' ASP . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.656 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.745 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 7.5 p 156.56 -161.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.745 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 12.2 t30 -143.06 25.8 1.73 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 175.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 ' N ' HG21 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -8.94 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 111.817 -2.447 . . . . 0.0 114.149 -175.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.5 m -165.12 44.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 7.9 p -141.25 -151.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.534 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -129.81 -3.97 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -109.19 -26.87 9.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.43 0.633 . . . . 0.0 111.066 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.19 -108.41 0.62 Allowed Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.838 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.789 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.696 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.845 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.656 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.441 ' HG2' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.884 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.676 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.891 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.707 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.648 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 31.3 m-70 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.656 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.838 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.954 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' CD2' HD11 ' A' ' 10' ' ' ILE . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.044 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.778 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.688 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.683 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.567 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.777 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.096 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 86' ' ' THR . 7.3 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 86' ' ' THR . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.02 -39.36 85.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.096 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.9 tt0 -61.59 -36.33 80.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.044 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.688 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -70.02 -39.79 75.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.729 -0.788 . . . . 0.0 112.214 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 84' ' ' VAL . 3.6 pp -64.0 -36.23 83.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.463 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.33 -31.31 54.47 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.276 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.7 m-20 -104.64 -9.38 18.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -34.66 151.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 112.94 -58.37 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.639 -1.267 . . . . 0.0 113.124 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 67' ' ' VAL . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.954 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 -128.71 116.43 19.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.626 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 111.25 3.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.256 -179.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.78 34.78 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.741 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -88.28 -31.98 18.72 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.187 -0.507 . . . . 0.0 111.228 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.406 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -57.97 -51.82 78.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.372 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 103' ' ' SER . 27.5 Cg_exo -60.65 158.35 32.96 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 122.635 2.223 . . . . 0.0 112.725 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -42.8 65.66 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.325 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.0 m 66.09 20.45 11.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.178 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttt 176.69 -48.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.96 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -176.68 134.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.65 142.78 91.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.63 110.17 2.9 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.582 2.188 . . . . 0.0 112.443 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.27 179.8 5.12 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.407 2.071 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -121.61 150.31 54.79 Favored Pre-proline 0 CA--C 1.501 -0.94 0 CA-C-O 121.513 0.673 . . . . 0.0 111.324 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 70.7 Cg_endo -87.87 148.06 7.0 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 C-N-CA 121.886 1.724 . . . . 0.0 113.018 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.63 12.07 3.85 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.65 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.941 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 59' ' ' GLY . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.813 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.635 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.903 HG23 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.792 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 31' ' ' ASP . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.647 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.652 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.794 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.13 -161.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.794 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 14.3 t30 -144.11 26.34 1.51 Allowed 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 36' ' ' ASN . 7.4 t -10.25 -54.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 112.141 -2.3 . . . . 0.0 113.361 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASN . 24.1 m -169.63 64.64 0.05 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 4.6 p -154.09 -155.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.947 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -130.17 29.82 4.86 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 122.096 -0.377 . . . . 0.0 111.512 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.424 ' H ' HG12 ' A' ' 39' ' ' VAL . 33.1 m-70 -148.97 -28.41 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.62 -108.85 0.66 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.843 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.818 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.652 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.647 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.903 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.643 ' N ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.626 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.825 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.671 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.85 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.661 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.935 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 99' ' ' GLU . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.074 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.745 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.654 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' VAL . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.674 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.585 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.783 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.6 t60 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.087 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.569 ' O ' HG22 ' A' ' 86' ' ' THR . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.97 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.087 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 20.5 tt0 -60.94 -36.27 78.91 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.993 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.654 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -68.3 -38.85 82.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.605 -176.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 84' ' ' VAL . 1.4 pp -59.33 -43.19 92.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.511 0.672 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -76.55 -31.11 57.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.595 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.9 m-20 -100.44 -11.48 20.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -38.19 155.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.775 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.635 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.3 -62.36 0.29 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.056 -1.068 . . . . 0.0 113.017 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.798 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.074 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' VAL . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.935 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -127.26 114.4 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.46 112.17 3.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.766 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.27 36.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.067 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -72.48 -174.7 1.42 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.399 . . . . 0.0 111.27 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -156.43 117.01 2.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.79 169.88 9.49 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.536 2.157 . . . . 0.0 112.857 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -28.78 66.38 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.05 30.94 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -145.96 -52.04 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.883 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.94 76.63 1.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m 61.78 152.31 0.11 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.21 121.25 7.63 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.66 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.396 2.064 . . . . 0.0 112.268 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' CG ' ' HD2' ' A' ' 7' ' ' PRO . 8.8 ttmt -113.83 140.12 24.35 Favored Pre-proline 0 CA--C 1.504 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.0 111.201 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 6' ' ' LYS . 10.2 Cg_endo -53.91 -169.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.364 2.042 . . . . 0.0 112.851 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.78 26.18 6.89 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.685 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.503 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 1.087 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' O ' ' A' ' 59' ' ' GLY . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.827 ' O ' HD21 ' A' ' 15' ' ' LEU . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.64 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.618 ' HA3' ' HB2' ' A' ' 54' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.716 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 26' ' ' VAL . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.625 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.784 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 6.2 p 156.59 -162.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.784 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 11.9 t30 -145.46 26.98 1.27 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.504 ' H ' HG22 ' A' ' 35' ' ' VAL . 8.0 t -9.77 -54.79 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 112.247 -2.251 . . . . 0.0 113.215 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 16.9 m -165.57 72.66 0.18 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.125 0.488 . . . . 0.0 112.006 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 9.7 p -163.79 -156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.938 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 4.2 tpt180 -130.2 25.26 5.21 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.162 -0.336 . . . . 0.0 111.505 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.439 ' H ' HG13 ' A' ' 39' ' ' VAL . 31.6 m-70 -143.0 -22.85 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.053 0.454 . . . . 0.0 111.976 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 125.64 -110.73 1.36 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -177.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.79 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.873 ' H ' HG21 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.67 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.858 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.858 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.916 ' HA ' HG23 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.643 HG21 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.643 ' H ' HG21 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.819 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.703 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.911 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.673 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.619 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.646 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.79 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.899 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' N ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.066 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.727 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.648 ' CB ' ' OG1' ' A' ' 86' ' ' THR . 14.4 t-20 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 70' ' ' VAL . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.738 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' CA ' ' CB ' ' A' ' 36' ' ' ASN . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.75 ' C ' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.721 ' O ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.8 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.626 ' O ' ' HB ' ' A' ' 86' ' ' THR . 8.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.75 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -64.95 -44.91 96.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' CB ' ' O ' ' A' ' 81' ' ' LYS . 29.1 tt0 -65.22 -32.33 73.96 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.158 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.648 ' OG1' ' CB ' ' A' ' 71' ' ' ASN . 2.0 t -79.28 -37.93 36.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.585 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.504 ' HA ' HG23 ' A' ' 90' ' ' THR . 3.7 pp -63.71 -36.37 83.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 3.4 mtt-85 -76.91 -31.27 56.58 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.968 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -99.81 -3.9 31.66 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 87' ' ' LEU . 1.5 p -40.38 166.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.925 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.87 -65.64 0.29 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.533 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.728 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.087 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.899 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -110.77 110.49 21.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.685 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.77 116.71 7.96 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.534 -178.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.54 34.23 0.5 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.958 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 1.6 mm100 -50.0 92.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.741 -0.729 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -176.82 65.3 0.21 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.78 170.93 0.82 Allowed 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 122.642 2.228 . . . . 0.0 112.754 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -72.18 60.26 0.42 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.795 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 44.84 29.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.628 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.39 52.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.18 117.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -64.79 -60.83 7.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 71.5 Cg_endo -74.52 111.24 3.27 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.598 2.199 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.61 54.04 4.93 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.528 2.152 . . . . 0.0 112.637 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 15.1 mtpp -153.44 154.75 30.98 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 121.303 0.573 . . . . 0.0 111.462 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 11' ' ' PHE . 10.5 Cg_exo -70.74 160.62 48.82 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 121.988 1.792 . . . . 0.0 113.014 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.84 5.02 3.65 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.87 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.779 HG11 ' O ' ' A' ' 59' ' ' GLY . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.729 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.618 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.885 HG23 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' ' 28' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.735 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.649 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.836 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.625 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.896 ' CG2' ' H ' ' A' ' 36' ' ' ASN . 3.3 p 158.5 -148.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.896 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 8.4 p-10 -144.09 23.81 1.67 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 38' ' ' SER . 3.6 t -3.22 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.667 -175.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.0 m 178.66 62.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.374 0.607 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 9.8 p -160.4 -176.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.444 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.48 29.48 7.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 57.7 m-70 -139.58 -29.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.603 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.704 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.58 -107.34 0.58 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.835 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.971 HG21 HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.836 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.845 HG12 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.649 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' HG12 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.885 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' N ' HG21 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.625 ' HB2' ' HA3' ' A' ' 23' ' ' GLY . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.815 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.638 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.429 ' O ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.665 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.779 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.769 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.692 HG21 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.666 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.835 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 99' ' ' GLU . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.043 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.771 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.742 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' VAL . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.514 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.775 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.4 t60 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.059 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' A' ' 86' ' ' THR . 9.0 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' A' ' 70' ' ' VAL . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.1 -40.68 89.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.059 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.4 tt0 -61.58 -36.84 81.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.625 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.742 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -67.55 -39.2 84.98 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.461 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD12 HG23 ' A' ' 26' ' ' VAL . 1.7 mt -62.6 -37.61 86.91 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -76.95 -30.99 56.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.957 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.79 -8.45 19.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -38.06 157.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.94 -63.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.138 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.729 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.043 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.916 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -128.01 119.21 24.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -65.77 129.09 38.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.631 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.23 35.48 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.797 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 20.2 mt-30 -54.66 -82.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.838 -0.681 . . . . 0.0 111.518 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -83.75 -64.1 0.24 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.441 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 36.2 Cg_endo -64.6 166.38 17.9 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 122.502 2.135 . . . . 0.0 112.923 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -168.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.347 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 t -104.48 30.32 5.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.832 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.48 -58.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 61.73 115.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.422 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -175.4 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.972 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 3' ' ' SER . 76.2 Cg_exo -50.52 147.67 16.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.084 . . . . 0.0 112.333 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.01 153.77 41.98 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -78.5 163.8 59.47 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-O 121.372 0.605 . . . . 0.0 111.262 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.72 179.47 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.799 1.666 . . . . 0.0 112.529 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.55 25.45 6.0 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.788 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.824 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.721 HD21 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 18' ' ' ASN . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.673 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 50' ' ' ILE . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.896 HG23 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.497 ' HB3' HG11 ' A' ' 28' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.765 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 26' ' ' VAL . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.657 ' CG2' ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.625 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.443 ' CE ' ' HB3' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.671 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 7.2 p 153.73 -167.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.663 ' H ' ' CG2' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.52 25.66 2.19 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 175.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.571 ' H ' HG21 ' A' ' 35' ' ' VAL . 11.1 t -6.46 -52.52 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.425 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.9 m -154.44 36.76 0.42 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' CG2' ' H ' ' A' ' 40' ' ' ARG . 5.8 p -142.5 -156.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.52 ' H ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.83 -12.76 5.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -95.04 -25.13 16.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.494 0.664 . . . . 0.0 110.719 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.23 -108.71 1.05 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.829 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.65 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.966 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.966 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.896 ' HA ' HG23 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' CD ' ' CG1' ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB1' ' HA3' ' A' ' 23' ' ' GLY . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.825 ' N ' ' O ' ' A' ' 22' ' ' LEU . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.702 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.786 ' O ' HG11 ' A' ' 13' ' ' VAL . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.788 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.661 HG21 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.66 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.599 ' N ' ' H ' ' A' ' 46' ' ' VAL . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.755 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.941 HG13 ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' CD2' HD11 ' A' ' 10' ' ' ILE . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 1.052 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.765 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.657 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 70' ' ' VAL . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.781 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.1 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.503 ' O ' ' CG2' ' A' ' 86' ' ' THR . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.615 ' O ' HG22 ' A' ' 86' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.09 -39.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 1.1 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.1 tt0 -61.55 -36.31 80.25 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.081 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.657 ' OG1' ' HB2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -70.64 -39.98 73.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.226 -176.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 84' ' ' VAL . 3.6 pp -63.1 -35.9 81.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 4.8 ttp180 -77.37 -31.12 54.11 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.182 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.6 m-20 -104.71 -7.2 19.72 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' THR . 0.6 OUTLIER -36.91 155.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.689 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.673 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.23 -59.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.538 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 92' ' ' GLN . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.824 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 1.052 HD23 ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.539 ' O ' HG13 ' A' ' 67' ' ' VAL . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.941 ' HA ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.4 mt-10 -125.53 109.32 12.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.643 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.7 112.16 4.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.943 -179.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.82 31.54 2.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.703 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 12.9 mm100 -89.14 -52.94 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.08 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.47 165.85 33.59 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.634 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.41 171.51 3.27 Favored 'Trans proline' 0 CA--C 1.501 -1.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.695 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 t -58.43 -29.37 66.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.444 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.1 t 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -140.83 -53.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.944 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.986 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.968 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.788 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.965 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.857 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.685 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 46' ' ' VAL . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.721 HG23 ' C ' ' A' ' 31' ' ' ASP . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.721 ' C ' HG23 ' A' ' 27' ' ' THR . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.526 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.842 ' H ' HD12 ' A' ' 75' ' ' LEU . 3.7 p . . . . . 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.188 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.108 HG22 HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.888 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.947 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.947 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.01 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.802 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.802 ' H ' HG23 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.955 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.968 ' HA ' HG11 ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.665 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.108 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.609 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.632 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.954 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.632 ' CD ' HG11 ' A' ' 73' ' ' VAL . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.954 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.52 0.364 0 CA-C-O 120.005 -0.331 . . . . 0.0 113.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.788 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.5 mt-10 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 13' ' ' VAL . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.057 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.982 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.593 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.846 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.95 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.901 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.021 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.901 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG11 ' CZ ' ' A' ' 30' ' ' PHE . 5.6 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.798 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.27 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.013 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.987 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.021 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.987 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.638 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 45.1 m170 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.801 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.013 HG22 ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.823 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.959 HG23 HD11 ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.697 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 32.7 t-20 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.8 t-80 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.79 ' N ' ' O ' ' A' ' 79' ' ' THR . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.689 ' HB3' HG11 ' A' ' 73' ' ' VAL . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.757 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.832 -0.427 . . . . 0.0 113.449 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 7.6 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.782 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.057 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 68' ' ' LEU . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.884 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.938 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.95 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.813 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.731 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.652 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.682 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.727 HG23 ' C ' ' A' ' 31' ' ' ASP . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.727 ' C ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE2' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.611 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.833 HG11 ' CE2' ' A' ' 30' ' ' PHE . 3.3 p . . . . . 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.101 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.883 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.099 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.803 ' H ' HG23 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.731 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.95 ' HA ' HG11 ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.808 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.829 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.101 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.899 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.114 HG23 HD11 ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.619 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.957 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.651 ' CD ' HG11 ' A' ' 73' ' ' VAL . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.503 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 ' OD2' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.114 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.886 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.842 HD11 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.043 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.781 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.999 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.857 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 31' ' ' ASP . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.044 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 27' ' ' THR . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.701 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.6 p . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.076 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.674 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.044 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.014 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.997 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.857 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.93 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.632 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.802 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.076 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.842 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG23 HD11 ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.63 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 82' ' ' GLN . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.925 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.947 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.703 ' CD ' HG11 ' A' ' 73' ' ' VAL . 5.9 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.947 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 CA-C-O 119.936 -0.369 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.781 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.043 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.627 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.885 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 98' ' ' LEU . 2.0 mt-10 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.06 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.97 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.785 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.966 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 15' ' ' LEU . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.595 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.832 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.976 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.048 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.976 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.781 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.751 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.4 p . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.046 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.746 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.955 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.048 ' HB3' HG21 ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.955 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 50' ' ' ILE . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.704 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.767 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.97 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.743 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 28.6 t-20 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.91 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.939 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 79' ' ' THR . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.748 ' HB3' HG11 ' A' ' 73' ' ' VAL . 35.9 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.939 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.756 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.876 -0.402 . . . . 0.0 113.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.785 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.06 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.873 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.027 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.827 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 15' ' ' LEU . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.679 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.765 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.928 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.732 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.3 p . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.743 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.488 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.031 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.716 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.043 ' HB3' HG21 ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.836 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.935 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.973 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.811 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.031 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.66 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.82 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.654 HG11 ' CD ' ' A' ' 82' ' ' GLN . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.946 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.654 ' CD ' HG11 ' A' ' 73' ' ' VAL . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.946 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.827 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.027 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.824 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.081 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.966 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.764 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.98 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.707 ' O ' HD12 ' A' ' 15' ' ' LEU . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.621 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.846 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.829 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.991 HG22 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 31' ' ' ASP . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.019 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 27' ' ' THR . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.614 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.809 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.9 p . . . . . 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.075 HG22 HG22 ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.887 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.019 ' HB3' HG21 ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.991 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.846 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.765 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.966 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.819 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.873 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.082 HG23 HD11 ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.633 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.648 HG11 ' CD ' ' A' ' 82' ' ' GLN . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.949 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.648 ' CD ' HG11 ' A' ' 73' ' ' VAL . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.949 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.886 -0.396 . . . . 0.0 113.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.764 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.082 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.016 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.792 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.973 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.642 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.001 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 31' ' ' ASP . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.076 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.1 p . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.035 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.72 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.941 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.076 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.941 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.001 ' HA ' HG22 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 50' ' ' ILE . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.702 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.726 ' HA ' HD23 ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.708 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.711 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.634 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' CD ' ' A' ' 82' ' ' GLN . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.951 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.705 ' CD ' HG11 ' A' ' 73' ' ' VAL . 5.1 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.333 0 CA-C-O 119.942 -0.366 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.711 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 13' ' ' VAL . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.064 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.767 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.001 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.845 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.0 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.062 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.843 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.093 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.949 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.062 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.949 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.0 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.553 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.66 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.093 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.782 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.691 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 27.3 t-20 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 82' ' ' GLN . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.945 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.738 ' HB3' HG11 ' A' ' 73' ' ' VAL . 36.2 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.945 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.365 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.001 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.064 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.894 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.703 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.071 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.613 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.985 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.964 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.015 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.788 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.712 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.995 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.015 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.995 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.985 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.963 ' HA ' HG11 ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.828 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.783 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.803 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.68 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 82' ' ' GLN . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.913 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.932 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.77 ' N ' ' O ' ' A' ' 79' ' ' THR . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.773 ' HB3' HG11 ' A' ' 73' ' ' VAL . 35.3 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.932 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.759 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.888 -0.396 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.994 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.071 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 13' ' ' VAL . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.967 HG22 ' HB2' ' A' ' 96' ' ' LEU . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.77 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.846 ' O ' HD12 ' A' ' 15' ' ' LEU . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.629 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.818 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.976 HG22 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.897 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 27' ' ' THR . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.809 ' H ' HD12 ' A' ' 75' ' ' LEU . 4.6 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.267 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.016 HG22 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.897 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.03 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.013 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.976 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 50' ' ' ILE . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.795 ' HA ' HD23 ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.65 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.837 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.971 HG23 HD11 ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.67 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t-20 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 82' ' ' GLN . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.876 HD11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.9 t-80 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.706 ' HB3' HG11 ' A' ' 73' ' ' VAL . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.767 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.854 -0.414 . . . . 0.0 113.455 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.77 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.686 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.832 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.616 ' HG3' HD22 ' A' ' 68' ' ' LEU . 7.0 mt-10 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.03 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.794 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.002 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.65 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.863 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.047 HG21 ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' THR . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.65 ' C ' HG12 ' A' ' 44' ' ' ILE . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.785 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.064 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.774 ' N ' HD13 ' A' ' 44' ' ' ILE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.926 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.047 ' HB3' HG21 ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.926 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.711 ' HA ' HG11 ' A' ' 49' ' ' VAL . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' ALA . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.745 HG22 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.7 m80 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.688 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.822 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.856 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.067 HG23 HD11 ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.645 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.692 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.933 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.938 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 79' ' ' THR . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.692 ' CD ' HG11 ' A' ' 73' ' ' VAL . 7.7 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.65 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.067 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 12' ' ' GLU . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.903 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' CG ' HD22 ' A' ' 68' ' ' LEU . 2.0 mm-40 . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.005 ' HE1' HG12 ' A' ' 13' ' ' VAL . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 ' HE1' ' A' ' 11' ' ' PHE . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.856 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.905 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 31' ' ' ASP . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.102 HG21 ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.666 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.745 ' H ' HD12 ' A' ' 75' ' ' LEU . 4.3 p . . . . . 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.9 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.922 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.102 ' HB3' HG21 ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.922 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 50' ' ' ILE . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.915 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.75 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.794 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 19.6 m170 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 HD11 ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 29.9 t-20 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.89 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.963 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' HB3' HG11 ' A' ' 73' ' ' VAL . 34.6 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.963 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.761 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 119.809 -0.44 . . . . 0.0 113.423 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.775 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.005 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.948 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.784 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.831 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.858 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.906 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.765 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.847 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.2 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.413 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.844 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.999 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.721 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.059 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 50' ' ' ILE . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.993 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.844 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.657 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 82' ' ' GLN . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.942 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.644 ' HB3' HG11 ' A' ' 73' ' ' VAL . 34.8 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.942 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.329 0 CA-C-O 119.893 -0.393 . . . . 0.0 113.268 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.784 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.709 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.864 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.568 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.799 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.955 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.828 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.838 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.785 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.4 p . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.058 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.728 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.954 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.028 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.954 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.839 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.616 HD21 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.816 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.979 HG23 HD11 ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.685 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 24.7 t-20 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.905 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.934 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HB3' HG11 ' A' ' 73' ' ' VAL . 34.2 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.766 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.294 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.413 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.799 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.063 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 12' ' ' GLU . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.875 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 13' ' ' VAL . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.994 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.002 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.967 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 15' ' ' LEU . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.671 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.808 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.882 ' HA ' HG23 ' A' ' 46' ' ' VAL . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 26' ' ' VAL . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.066 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.77 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.799 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.5 p . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.722 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.066 ' HB3' HG21 ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.992 ' HA ' HG22 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.944 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.806 ' HA ' HD23 ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 1.002 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.64 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.049 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.887 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.011 HG23 HD11 ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.62 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.96 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' A' ' 79' ' ' THR . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.706 ' CD ' HG11 ' A' ' 73' ' ' VAL . 5.1 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.96 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.124 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 ' OD2' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.814 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.011 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.931 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.214 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.849 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.95 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.672 ' O ' HD12 ' A' ' 15' ' ' LEU . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.631 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.833 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.842 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.93 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 28' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.793 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.9 p . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.666 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.93 HG23 ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.928 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.569 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.833 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.707 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.911 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 HD11 ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.616 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 82' ' ' GLN . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.912 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 73' ' ' VAL . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.962 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 119.945 -0.364 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 91' ' ' GLY . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.849 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.053 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' CB ' ' A' ' 12' ' ' GLU . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.864 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.14 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 60' ' ' ARG . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.8 ' O ' HD12 ' A' ' 15' ' ' LEU . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.998 HG22 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 32' ' ' LYS . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.09 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.845 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.848 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.2 p . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.13 HG22 HG22 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.945 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.945 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' HG23 ' A' ' 50' ' ' ILE . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.965 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.659 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.789 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.13 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.864 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.795 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.675 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.622 HG11 ' CD ' ' A' ' 82' ' ' GLN . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 70' ' ' VAL . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.72 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.921 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.72 ' CE1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.622 ' CD ' HG11 ' A' ' 73' ' ' VAL . 24.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.533 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.14 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.27 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 1.082 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.779 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.855 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.87 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 31' ' ' ASP . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.089 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HG11 ' A' ' 35' ' ' VAL . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 27' ' ' THR . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 30' ' ' PHE . 3.3 p . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.855 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.089 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.699 ' HA ' HD23 ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.601 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 HG22 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.754 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.854 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.062 HG23 HD11 ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.645 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.955 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.709 ' CD ' HG11 ' A' ' 73' ' ' VAL . 8.2 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.955 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.779 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.082 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.901 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.921 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.876 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.961 HG22 ' HA ' ' A' ' 32' ' ' LYS . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.051 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.657 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.746 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.2 p . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.371 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.04 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.633 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.925 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.051 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.925 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.898 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.662 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.772 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.04 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 HD11 ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.604 HG11 ' CD ' ' A' ' 82' ' ' GLN . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.952 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.964 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.604 ' CD ' HG11 ' A' ' 73' ' ' VAL . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.963 -0.354 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.921 HG23 ' HA ' ' A' ' 16' ' ' ALA . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.033 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.721 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.558 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -163.84 178.78 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 149.16 51.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 110.83 2.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.58 2.186 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.48 113.89 3.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.464 2.109 . . . . 0.0 112.491 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.67 160.68 55.6 Favored Pre-proline 0 CA--C 1.504 -0.814 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.63 168.3 7.03 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.624 1.549 . . . . 0.0 112.69 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' H ' ' HZ3' ' A' ' 100' ' ' LYS . . . 103.51 22.85 8.73 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.684 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.986 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.968 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.788 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.965 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.857 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.685 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.024 HG21 HD13 ' A' ' 87' ' ' LEU . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.721 HG23 ' C ' ' A' ' 31' ' ' ASP . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.721 ' C ' HG23 ' A' ' 27' ' ' THR . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.12 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.7 p 160.35 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.12 ' H ' HG22 ' A' ' 35' ' ' VAL . 4.8 p30 -144.6 22.8 1.63 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.926 ' H ' HG13 ' A' ' 35' ' ' VAL . 9.0 t -1.71 -54.68 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.794 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.6 m 178.02 54.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.39 0.614 . . . . 0.0 110.324 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.802 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.29 -176.95 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.477 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.28 29.93 7.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.671 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.776 ' H ' HG13 ' A' ' 39' ' ' VAL . 61.4 m-70 -138.83 -31.45 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.394 0.616 . . . . 0.0 111.323 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 147.68 -107.1 0.37 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.979 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.108 HG22 HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.888 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.947 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.947 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.01 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.802 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.802 ' H ' HG23 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.955 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.968 ' HA ' HG11 ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.665 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.108 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.76 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.632 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.954 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.096 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.039 ' O ' HG22 ' A' ' 86' ' ' THR . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.954 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.51 -40.94 90.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.096 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.3 tt0 -60.83 -36.68 79.71 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.157 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.039 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -68.18 -36.23 79.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.953 -177.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.024 HD13 HG21 ' A' ' 26' ' ' VAL . 1.3 mt -58.71 -43.59 90.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -30.98 56.22 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.572 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -99.39 -11.25 21.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -40.03 158.15 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.687 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 108.59 -62.82 0.29 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.148 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.788 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.881 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.5 mt-10 -124.32 109.3 13.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.881 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -67.04 109.85 3.16 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.188 -178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.19 35.97 1.13 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.648 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -57.58 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.141 -0.529 . . . . 0.0 111.175 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 1.3 m -136.94 -69.23 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.295 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 50.9 Cg_endo -68.23 169.97 15.64 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 122.249 1.966 . . . . 0.0 112.865 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -61.78 -170.23 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.403 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 105' ' ' THR . 1.3 p -77.39 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 -46.44 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.722 0.296 . . . . 0.0 110.984 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.886 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t 62.78 120.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -60.01 142.49 89.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.77 109.94 2.84 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.602 2.202 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.72 -176.69 2.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.234 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -132.74 156.72 79.76 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-O 121.327 0.584 . . . . 0.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.07 176.81 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.811 1.674 . . . . 0.0 112.602 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.11 24.17 8.14 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.674 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 13' ' ' VAL . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.057 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.982 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.593 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.846 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.95 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.901 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.021 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.901 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.046 HG22 ' H ' ' A' ' 36' ' ' ASN . 5.6 p 160.6 -154.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.046 ' H ' HG22 ' A' ' 35' ' ' VAL . 9.7 p-10 -141.7 23.52 2.1 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.673 HG21 ' HE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 1.4 -55.06 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.039 -2.346 . . . . 0.0 113.961 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.1 m -176.49 37.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.818 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.1 p -132.39 -150.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.818 ' H ' HG22 ' A' ' 39' ' ' VAL . 3.7 tmm_? -130.15 -2.7 4.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.662 ' H ' HG13 ' A' ' 39' ' ' VAL . 49.6 m-70 -106.99 -25.28 11.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.283 0.564 . . . . 0.0 110.849 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.798 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.31 -108.17 0.71 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.786 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.013 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.021 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.987 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.638 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 5.2 m-70 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.801 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.013 HG22 ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.823 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.959 HG23 HD11 ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.697 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.8 t-80 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.8 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.85 ' O ' ' HB ' ' A' ' 86' ' ' THR . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.789 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.89 -45.86 97.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 32.7 tt0 -63.6 -33.79 76.4 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.975 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.865 HG21 HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -73.78 -38.91 64.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.043 -175.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.5 mt -59.68 -38.02 80.38 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -76.35 -30.96 57.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.572 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -97.66 -3.95 38.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.853 HG22 ' CG2' ' A' ' 94' ' ' VAL . 3.1 p -46.21 176.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.969 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.92 -66.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.449 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.0 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.853 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.782 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.057 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 68' ' ' LEU . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.884 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -127.5 115.26 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -65.29 112.33 3.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.899 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.18 35.04 1.17 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.091 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -93.61 28.99 2.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.44 . . . . 0.0 111.4 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.96 109.58 1.99 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.32 173.83 8.08 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 C-N-CA 122.455 2.104 . . . . 0.0 112.743 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m -57.11 -27.51 61.86 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.518 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.4 29.77 18.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -139.62 -59.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.88 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 60.48 96.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -168.27 151.46 5.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.76 105.85 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.395 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.68 -52.95 7.89 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.496 2.13 . . . . 0.0 112.276 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 161.09 37.25 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-O 121.435 0.636 . . . . 0.0 111.273 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.74 176.41 0.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.91 1.74 . . . . 0.0 112.538 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.86 26.93 4.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.679 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.938 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.95 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.813 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.731 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.652 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.682 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.727 HG23 ' C ' ' A' ' 31' ' ' ASP . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.727 ' C ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE2' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.611 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.029 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.3 p 157.93 -147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.029 ' H ' HG22 ' A' ' 35' ' ' VAL . 13.6 p-10 -137.99 20.76 2.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.783 ' H ' HG13 ' A' ' 35' ' ' VAL . 9.3 t 1.42 -55.17 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 112.028 -2.351 . . . . 0.0 113.863 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.7 m 178.73 55.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.465 0.65 . . . . 0.0 110.508 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.802 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.72 -177.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.516 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.46 29.93 7.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.92 0.39 . . . . 0.0 111.697 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.776 ' H ' HG13 ' A' ' 39' ' ' VAL . 54.8 m-70 -139.96 -28.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 111.465 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 145.01 -107.51 0.44 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.101 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.883 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.099 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.803 ' H ' HG23 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.731 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.95 ' HA ' HG11 ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.808 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.829 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.101 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.899 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.114 HG23 HD11 ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.718 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.596 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.957 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.086 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.051 ' O ' HG22 ' A' ' 86' ' ' THR . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.762 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.84 -40.55 89.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.086 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 15.8 tt0 -61.44 -37.28 82.96 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.051 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -68.9 -38.8 79.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.661 -176.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 26' ' ' VAL . 2.2 mt -61.11 -38.95 88.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -77.04 -31.19 56.06 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.089 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 -8.41 20.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.12 156.91 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.715 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.44 -59.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.546 -1.311 . . . . 0.0 113.016 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.503 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.114 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.886 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 -127.17 110.63 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.731 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.73 112.13 4.05 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.78 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.51 38.76 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.253 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -66.0 -175.07 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.909 0.385 . . . . 0.0 111.179 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -177.77 86.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.87 168.81 1.58 Allowed 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 122.677 2.251 . . . . 0.0 112.811 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -69.66 0.21 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.418 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -169.27 58.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.41 85.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -103.11 88.87 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -176.66 88.82 0.26 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.44 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.651 2.234 . . . . 0.0 112.428 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.9 59.24 6.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -126.34 158.0 68.39 Favored Pre-proline 0 CA--C 1.504 -0.79 0 CA-C-O 121.343 0.592 . . . . 0.0 111.297 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.05 -171.53 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.79 1.66 . . . . 0.0 112.687 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 101.27 24.09 9.17 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.724 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.842 HD11 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.043 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.781 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.999 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.857 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 31' ' ' ASP . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.044 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 27' ' ' THR . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.701 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.01 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.6 p 155.23 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.01 ' H ' HG22 ' A' ' 35' ' ' VAL . 10.5 p-10 -143.2 25.97 1.69 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' VAL . 11.7 t -8.3 -53.8 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.453 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' ASN . 5.2 m -162.38 67.33 0.24 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 40' ' ' ARG . 8.1 p -167.41 -175.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.686 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.813 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.2 ttt-85 -114.54 24.46 11.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.621 ' H ' HG13 ' A' ' 39' ' ' VAL . 50.3 m-70 -136.31 -26.06 1.15 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.296 0.569 . . . . 0.0 111.786 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.71 -108.92 1.04 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.076 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.674 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.044 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.014 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.997 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.857 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.93 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.632 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.802 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.076 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.842 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG23 HD11 ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.68 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 82' ' ' GLN . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.925 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.947 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.074 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.074 ' O ' HG22 ' A' ' 86' ' ' THR . 5.9 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.947 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.9 -41.1 91.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.074 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.6 tt0 -61.49 -37.04 82.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.506 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.074 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -66.56 -39.09 88.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.431 -176.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.877 HD13 HG21 ' A' ' 26' ' ' VAL . 3.6 mt -62.26 -39.47 93.02 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.329 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -103.52 -10.66 18.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.029 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -38.04 156.43 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.723 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 111.87 -63.93 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.151 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.029 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.781 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.043 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.627 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.927 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 98' ' ' LEU . 2.0 mt-10 -120.1 110.12 16.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.927 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.84 109.21 2.82 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.365 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.51 34.49 1.37 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 6.5 mt-30 -61.08 -19.54 61.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.529 . . . . 0.0 111.241 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.405 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 1.1 m 64.63 53.97 1.28 Allowed Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.693 ' O ' HG23 ' A' ' 105' ' ' THR . 72.7 Cg_endo -73.46 67.21 4.51 Favored 'Trans proline' 0 CA--C 1.501 -1.158 0 C-N-CA 122.799 2.332 . . . . 0.0 112.795 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -174.71 37.6 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.186 177.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m -141.61 -47.29 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -106.27 -35.89 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.92 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -86.58 -67.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -134.77 72.15 69.23 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.79 110.2 2.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.91 177.96 5.8 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.444 2.096 . . . . 0.0 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 mtmt -150.22 162.2 28.48 Favored Pre-proline 0 CA--C 1.504 -0.795 0 CA-C-O 121.327 0.584 . . . . 0.0 111.266 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.6 -173.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.892 1.728 . . . . 0.0 112.606 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.06 25.07 7.67 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.699 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.06 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.97 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.785 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.966 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 15' ' ' LEU . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.595 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.832 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.976 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.048 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.976 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.781 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.029 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.4 p 156.94 -162.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.029 ' H ' HG22 ' A' ' 35' ' ' VAL . 16.9 p-10 -139.64 23.72 2.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.1 t -6.38 -53.45 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.008 -2.36 . . . . 0.0 114.182 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.7 m -158.86 35.87 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.2 p -141.87 -155.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.848 ' H ' HG22 ' A' ' 39' ' ' VAL . 44.4 ttm-85 -126.23 -16.89 5.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 59.2 m-70 -89.2 -26.11 21.42 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.556 0.693 . . . . 0.0 110.566 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.03 -108.7 0.75 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.484 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.046 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.746 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.955 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.048 ' HB3' HG21 ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.955 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 50' ' ' ILE . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.704 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.767 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.97 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.743 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.91 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.939 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.831 ' O ' ' HB ' ' A' ' 86' ' ' THR . 35.9 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.939 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.756 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.7 -46.66 94.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 26.7 tt0 -61.94 -33.26 73.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.916 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.831 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.34 -34.43 61.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.221 -175.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 8.3 mt -62.33 -40.36 96.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -75.56 -30.69 59.78 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.49 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.1 m120 -96.56 -4.74 40.73 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.6 p -45.71 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.785 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.2 -65.39 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.45 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.785 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.06 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.878 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 -123.56 109.47 13.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.878 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.75 110.03 3.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.144 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.9 37.61 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.788 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.5 mt-30 -54.78 -79.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.176 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -178.17 56.74 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.86 171.65 14.18 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.605 2.203 . . . . 0.0 112.745 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 108' ' ' GLU . 29.3 p -60.06 -31.51 70.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.339 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 23.16 10.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 tpmp? 179.91 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.431 ' HB3' HG21 ' A' ' 105' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 t -108.46 31.58 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.36 75.96 11.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.58 111.82 3.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.306 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 132.47 47.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.459 2.106 . . . . 0.0 112.272 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.74 162.98 35.68 Favored Pre-proline 0 CA--C 1.504 -0.817 0 CA-C-O 121.41 0.624 . . . . 0.0 111.314 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.15 -174.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.88 1.72 . . . . 0.0 112.526 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.49 26.86 5.48 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.708 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.027 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.827 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 15' ' ' LEU . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.679 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.765 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.981 HG11 HD13 ' A' ' 87' ' ' LEU . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.017 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.3 p 156.82 -163.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.017 ' H ' HG22 ' A' ' 35' ' ' VAL . 33.2 p-10 -140.07 23.97 2.37 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.7 t -5.42 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 112.122 -2.308 . . . . 0.0 114.176 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.6 m -158.72 35.66 0.22 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.17 -155.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.843 ' H ' HG22 ' A' ' 39' ' ' VAL . 19.2 ttm180 -126.72 -16.14 5.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 60.9 m-70 -89.86 -27.94 19.58 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.614 0.721 . . . . 0.0 110.58 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.743 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.91 -108.35 0.7 Allowed Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.515 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.031 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.716 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.043 ' HB3' HG21 ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.836 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.935 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.973 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.811 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.031 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.66 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.82 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.654 HG11 ' CD ' ' A' ' 82' ' ' GLN . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.946 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.779 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.808 ' O ' ' HB ' ' A' ' 86' ' ' THR . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.946 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.36 -44.92 99.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.779 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.3 tt0 -65.54 -33.19 75.35 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.14 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.808 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.23 -41.59 27.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.272 -175.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.981 HD13 HG11 ' A' ' 26' ' ' VAL . 3.9 pp -59.99 -36.4 77.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.878 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.0 -31.15 56.28 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.447 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.39 -2.01 46.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.981 HG22 HG21 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -40.72 166.5 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.825 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.67 -64.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.474 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.827 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.027 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 -124.28 110.62 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.806 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.69 109.93 3.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.221 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.95 37.41 0.66 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.793 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.3 mt-30 -56.04 -40.94 74.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.146 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.91 127.8 5.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.84 170.52 0.61 Allowed 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 122.52 2.146 . . . . 0.0 112.786 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -174.3 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.388 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.98 30.88 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -176.75 -54.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.921 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m -151.4 146.95 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.24 163.94 1.45 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.47 110.57 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.244 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.52 59.32 6.15 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.479 2.119 . . . . 0.0 112.438 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 140.13 21.18 Favored Pre-proline 0 CA--C 1.503 -0.841 0 CA-C-O 121.59 0.71 . . . . 0.0 111.304 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.1 178.38 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.157 1.904 . . . . 0.0 112.799 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 97.66 23.57 13.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.733 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.824 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.081 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.966 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.764 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.98 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.707 ' O ' HD12 ' A' ' 15' ' ' LEU . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.621 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.846 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.829 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.991 HG22 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.959 HG21 HD13 ' A' ' 87' ' ' LEU . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 31' ' ' ASP . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.019 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 27' ' ' THR . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.614 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.59 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.008 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.1 t-20 -144.75 25.48 1.46 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.583 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.2 t -12.98 -52.67 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 111.947 -2.388 . . . . 0.0 113.975 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -166.14 36.28 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.845 HG22 ' H ' ' A' ' 40' ' ' ARG . 6.0 p -134.1 -154.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.955 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.845 ' H ' HG22 ' A' ' 39' ' ' VAL . 41.3 ttm-85 -132.17 0.18 3.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' H ' HG13 ' A' ' 39' ' ' VAL . 50.4 m-70 -110.54 -23.22 11.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . 139.39 -108.83 0.61 Allowed Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.075 HG22 HG22 ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.887 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.019 ' HB3' HG21 ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.991 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.846 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.765 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.966 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.819 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.873 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.082 HG23 HD11 ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.746 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.648 HG11 ' CD ' ' A' ' 82' ' ' GLN . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.949 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.079 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.068 ' O ' HG22 ' A' ' 86' ' ' THR . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.949 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.15 -40.79 90.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.079 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 19.2 tt0 -61.57 -36.63 81.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.526 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.068 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -67.95 -39.69 83.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.411 -176.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.959 HD13 HG21 ' A' ' 26' ' ' VAL . 6.3 mt -61.54 -38.33 87.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -76.93 -30.98 56.32 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.187 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.34 -10.41 17.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.046 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -37.18 155.72 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.964 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.45 -63.1 0.31 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.504 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.046 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.764 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.082 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.958 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -111.97 110.02 20.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.958 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.87 107.94 2.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.446 -178.234 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.46 31.58 2.23 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.372 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -61.74 -171.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.954 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.9 p -104.17 89.94 2.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.877 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.15 137.45 34.34 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 122.831 2.354 . . . . 0.0 112.937 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 49.54 34.83 7.39 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.603 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -82.97 -29.51 28.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.769 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -40.93 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.92 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.49 -46.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.407 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 2.0 t -178.05 -61.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 45.0 Cg_endo -67.96 173.93 8.55 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.445 2.097 . . . . 0.0 112.271 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.16 90.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -129.89 161.28 60.62 Favored Pre-proline 0 CA--C 1.504 -0.793 0 CA-C-O 121.425 0.631 . . . . 0.0 111.284 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.49 171.88 1.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.912 1.742 . . . . 0.0 112.643 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 118.84 29.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.711 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.016 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.792 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.973 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.642 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.001 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 87' ' ' LEU . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 31' ' ' ASP . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.076 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.019 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.1 p 156.08 -162.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.019 ' H ' HG22 ' A' ' 35' ' ' VAL . 21.0 p-10 -141.18 24.31 2.14 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -2.72 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 112.189 -2.278 . . . . 0.0 114.098 -175.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -170.64 41.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG13 ' H ' ' A' ' 41' ' ' HIS . 2.6 p -131.11 -154.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.5 ttt-85 -133.5 32.71 3.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 111.194 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.785 ' H ' HG13 ' A' ' 39' ' ' VAL . 37.4 m-70 -148.45 -27.63 0.32 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.033 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.76 -109.77 0.83 Allowed Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.035 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.72 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.941 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.076 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.941 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.001 ' HA ' HG22 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 50' ' ' ILE . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.702 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.726 ' HA ' HD23 ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.708 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.711 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.784 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' CD ' ' A' ' 82' ' ' GLN . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.951 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.126 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.053 ' O ' HG22 ' A' ' 86' ' ' THR . 5.1 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.12 -39.07 84.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.126 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.5 tt0 -61.61 -36.61 81.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.001 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.053 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -71.74 -42.94 66.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.02 -176.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 26' ' ' VAL . 3.1 pp -62.09 -35.91 80.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.662 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.665 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.6 mtt85 -77.3 -31.33 54.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.405 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.7 m-80 -106.79 -6.27 17.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.066 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -35.49 155.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.884 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.81 -62.48 0.33 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.803 -1.189 . . . . 0.0 113.234 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.066 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.711 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -125.76 115.74 20.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.81 122.96 18.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.264 -179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.43 33.97 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.802 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 16.6 mt-30 -51.71 128.35 23.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.657 -0.772 . . . . 0.0 111.26 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.406 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -63.53 -61.45 7.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 58.8 Cg_endo -71.31 169.92 19.58 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.596 2.198 . . . . 0.0 112.853 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -69.22 0.26 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.342 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 t -134.77 -44.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -128.96 -67.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.853 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -128.96 -75.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.13 65.41 2.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.976 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 31.9 Cg_exo -57.31 -47.15 23.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.566 2.178 . . . . 0.0 112.583 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 4' ' ' PRO . 93.5 Cg_endo -80.65 95.23 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.346 2.031 . . . . 0.0 112.499 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -127.59 158.99 68.26 Favored Pre-proline 0 CA--C 1.505 -0.781 0 CA-C-O 121.421 0.629 . . . . 0.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.21 149.23 81.85 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.79 1.66 . . . . 0.0 112.643 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.588 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.66 26.44 6.81 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.726 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 13' ' ' VAL . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.064 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.767 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.001 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.845 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.0 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.062 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.049 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 159.4 -160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.049 ' H ' HG22 ' A' ' 35' ' ' VAL . 12.9 t30 -143.52 26.03 1.63 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.3 t -9.86 -53.55 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.003 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.6 m -165.07 46.32 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.6 p -143.55 -151.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.829 ' H ' HG22 ' A' ' 39' ' ' VAL . 42.0 ttt-85 -129.28 -6.41 4.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' H ' HG13 ' A' ' 39' ' ' VAL . 51.7 m-70 -106.72 -24.66 12.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.08 -107.87 0.72 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.093 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.949 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.062 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.949 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.0 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.553 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.66 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.093 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.782 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.691 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 82' ' ' GLN . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.517 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.945 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.811 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.831 ' O ' ' HB ' ' A' ' 86' ' ' THR . 36.2 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.945 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.57 -45.94 96.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.811 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.1 tt0 -63.33 -33.23 75.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.083 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.831 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.41 -37.46 60.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.572 -0.851 . . . . 0.0 112.269 -175.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.722 HD21 HG21 ' A' ' 70' ' ' VAL . 5.1 mt -62.07 -38.38 88.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -30.78 58.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.556 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -97.93 -3.91 37.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.27 175.16 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.913 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.38 -64.78 0.38 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.985 -1.103 . . . . 0.0 113.365 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.001 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.064 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.894 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.703 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -120.65 114.68 22.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.726 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.76 109.95 3.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.238 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.35 36.06 0.81 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.936 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 5.2 mm100 -69.43 -75.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.371 -0.414 . . . . 0.0 111.161 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t -92.98 149.09 37.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 105' ' ' THR . 71.3 Cg_endo -71.78 67.31 3.09 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.709 2.273 . . . . 0.0 112.75 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -174.87 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.359 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 t 63.06 37.52 11.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.748 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -167.7 -41.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.5 m -119.06 111.05 17.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.72 86.96 0.26 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.41 148.59 25.74 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.513 2.142 . . . . 0.0 112.311 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 51.2 Cg_exo -54.24 157.19 11.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.492 2.128 . . . . 0.0 112.288 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -138.92 161.47 57.97 Favored Pre-proline 0 CA--C 1.505 -0.779 0 CA-C-O 121.338 0.59 . . . . 0.0 111.184 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.15 179.68 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.745 1.63 . . . . 0.0 112.543 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 106.51 23.27 7.31 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.766 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.071 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.613 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.985 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.964 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.015 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.051 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.35 -161.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.051 ' H ' HG22 ' A' ' 35' ' ' VAL . 5.8 t30 -143.9 25.96 1.57 Allowed 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.4 t -9.95 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 112.095 -2.32 . . . . 0.0 113.195 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 9.0 m -165.48 69.96 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.178 0.514 . . . . 0.0 111.865 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.928 HG22 ' H ' ' A' ' 40' ' ' ARG . 8.0 p -165.07 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.826 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.928 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -128.15 0.56 5.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.517 ' H ' HG13 ' A' ' 39' ' ' VAL . 46.8 m-70 -115.54 -26.16 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.254 0.549 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 132.98 -108.04 0.73 Allowed Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.712 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.995 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.015 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.995 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.985 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.963 ' HA ' HG11 ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.828 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.783 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.803 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.68 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 82' ' ' GLN . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.913 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.524 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.932 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.792 ' O ' ' HB ' ' A' ' 86' ' ' THR . 35.3 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.932 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.759 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.51 -46.45 95.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.6 tt0 -62.5 -33.25 74.51 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.022 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -76.22 -36.95 58.33 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.461 -175.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.9 mt -61.05 -38.29 85.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -30.84 58.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.752 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -98.35 -4.73 34.27 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.853 HG22 ' CG2' ' A' ' 94' ' ' VAL . 3.1 p -44.81 174.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.37 -64.89 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.372 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.994 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.853 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.071 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.917 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -116.71 121.23 41.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.917 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.04 110.78 13.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.579 -177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.02 35.56 0.84 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.696 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 10.9 mt-30 -53.47 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.306 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -90.97 -51.83 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 103' ' ' SER . 49.2 Cg_exo -54.14 166.18 1.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 122.507 2.138 . . . . 0.0 112.97 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.3 m -71.62 77.47 0.82 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.297 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.26 -60.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -167.5 33.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.921 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -138.2 31.48 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 152.99 38.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 32.0 Cg_exo -57.06 -47.1 24.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.521 2.147 . . . . 0.0 112.629 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 4' ' ' PRO . 96.8 Cg_endo -80.63 92.04 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.322 2.014 . . . . 0.0 112.371 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 157.41 42.76 Favored Pre-proline 0 CA--C 1.502 -0.867 0 CA-C-O 121.367 0.604 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -86.94 178.73 3.52 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 C-N-CA 121.752 1.635 . . . . 0.0 112.965 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.42 24.85 6.28 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.755 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 13' ' ' VAL . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.967 HG22 ' HB2' ' A' ' 96' ' ' LEU . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.77 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.846 ' O ' HD12 ' A' ' 15' ' ' LEU . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.629 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.818 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.976 HG22 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.897 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 27' ' ' THR . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.031 HG22 ' H ' ' A' ' 36' ' ' ASN . 4.6 p 160.64 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.031 ' H ' HG22 ' A' ' 35' ' ' VAL . 10.0 p-10 -141.76 22.45 2.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.685 ' H ' HG13 ' A' ' 35' ' ' VAL . 13.0 t 1.43 -53.78 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.217 -2.265 . . . . 0.0 114.052 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.0 m 178.17 39.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.191 0.519 . . . . 0.0 110.808 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.809 HG13 ' H ' ' A' ' 41' ' ' HIS . 3.3 p -131.89 -153.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.116 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -134.32 32.13 3.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.178 0.513 . . . . 0.0 111.022 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.809 ' H ' HG13 ' A' ' 39' ' ' VAL . 52.0 m-70 -143.03 -34.54 0.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.845 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 149.36 -107.91 0.38 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.659 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.016 HG22 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.897 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.03 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.013 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.976 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 50' ' ' ILE . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.795 ' HA ' HD23 ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.65 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.837 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.971 HG23 HD11 ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.67 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 82' ' ' GLN . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.876 HD11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 36' ' ' ASN . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.9 t-80 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.887 ' O ' ' HB ' ' A' ' 86' ' ' THR . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.821 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.72 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.791 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.4 tt0 -64.72 -33.52 76.17 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.99 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.887 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.4 -39.51 62.61 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.014 -175.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -60.39 -37.46 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -30.92 57.6 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.702 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m-20 -98.56 -5.11 32.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.9 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.968 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.89 -65.13 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.455 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.77 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.686 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.928 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.616 ' HG3' HD22 ' A' ' 68' ' ' LEU . 7.0 mt-10 -119.57 116.18 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.928 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -73.39 111.12 8.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.622 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.57 35.72 1.02 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.805 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.9 mt-30 -58.22 -173.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.367 -0.417 . . . . 0.0 111.164 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.44 ' CB ' ' HD3' ' A' ' 104' ' ' PRO . 0.5 OUTLIER 179.2 -55.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 103' ' ' SER . 72.8 Cg_exo -49.78 132.76 32.15 Favored 'Trans proline' 0 CA--C 1.502 -1.092 0 C-N-CA 122.662 2.241 . . . . 0.0 113.134 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' THR . 24.5 m 43.71 31.46 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.752 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -36.24 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -118.37 33.69 5.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.05 -31.38 15.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m 60.89 70.51 0.94 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.4 170.84 16.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.581 2.187 . . . . 0.0 112.333 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.37 124.39 11.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.533 2.155 . . . . 0.0 112.208 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 162.54 39.85 Favored Pre-proline 0 CA--C 1.505 -0.765 0 CA-C-O 121.428 0.632 . . . . 0.0 111.34 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.37 171.23 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.972 1.781 . . . . 0.0 112.415 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.91 24.3 5.83 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.651 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.03 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.794 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.002 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.65 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.863 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.047 HG21 ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' THR . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.65 ' C ' HG12 ' A' ' 44' ' ' ILE . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.644 ' H ' HD11 ' A' ' 87' ' ' LEU . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.044 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.04 -160.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.044 ' H ' HG22 ' A' ' 35' ' ' VAL . 13.6 t30 -144.62 26.41 1.42 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.2 t -10.58 -55.28 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.139 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 19.3 m -171.13 70.27 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.824 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.6 p -158.81 -154.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.857 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.824 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.6 tpt180 -130.68 30.1 4.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.789 ' H ' HG13 ' A' ' 39' ' ' VAL . 33.4 m-70 -148.64 -30.33 0.27 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 111.719 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.71 -108.59 0.62 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.064 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.774 ' N ' HD13 ' A' ' 44' ' ' ILE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.926 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.047 ' HB3' HG21 ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.926 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.711 ' HA ' HG11 ' A' ' 49' ' ' VAL . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' ALA . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.745 HG22 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.602 ' CE1' ' HE3' ' A' ' 100' ' ' LYS . 11.7 m80 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.688 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.822 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.856 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.067 HG23 HD11 ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.701 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.692 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.933 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.583 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.938 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.072 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.074 ' O ' HG22 ' A' ' 86' ' ' THR . 7.7 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.87 -41.35 92.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.072 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.9 tt0 -61.31 -35.97 78.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.074 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -66.5 -38.71 87.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.2 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.86 HD13 HG21 ' A' ' 26' ' ' VAL . 6.6 mt -62.23 -38.96 91.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -76.87 -31.02 56.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.983 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 -9.51 19.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.009 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.86 157.58 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.704 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.65 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 109.47 -63.8 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.092 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.009 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.067 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 12' ' ' GLU . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.903 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' CG ' HD22 ' A' ' 68' ' ' LEU . 2.0 mm-40 -128.94 117.15 20.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.651 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.7 110.48 3.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.117 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.09 36.61 1.03 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.878 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -89.64 -176.73 5.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.158 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.95 86.65 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.83 172.22 11.01 Favored 'Trans proline' 0 CA--C 1.502 -1.118 0 C-N-CA 122.627 2.218 . . . . 0.0 112.755 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 p -58.03 -35.43 71.27 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.528 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -45.02 93.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -90.95 -66.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.827 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -164.06 35.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.8 -53.1 2.53 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.88 105.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.548 2.165 . . . . 0.0 112.407 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -176.5 2.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.537 2.158 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.81 161.8 60.28 Favored Pre-proline 0 CA--C 1.505 -0.786 0 CA-C-O 121.345 0.593 . . . . 0.0 111.223 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 26.7 Cg_exo -61.33 160.47 27.01 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.738 1.625 . . . . 0.0 112.491 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.59 26.34 6.21 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.711 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.005 ' HE1' HG12 ' A' ' 13' ' ' VAL . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 ' HE1' ' A' ' 11' ' ' PHE . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.856 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.905 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 31' ' ' ASP . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.102 HG21 ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.666 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.064 HG22 ' H ' ' A' ' 36' ' ' ASN . 4.3 p 160.69 -147.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.064 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.1 t30 -144.98 23.58 1.52 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.783 HG21 ' HE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -10.59 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.134 -176.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER 172.65 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.502 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' H ' ' A' ' 41' ' ' HIS . 11.6 p -113.04 -2.25 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 112.346 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 61.98 19.3 10.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.069 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.579 ' H ' HG13 ' A' ' 39' ' ' VAL . 31.4 m80 -139.67 -25.9 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 146.78 -107.05 0.39 Allowed Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.9 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.922 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.102 ' HB3' HG21 ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.922 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 50' ' ' ILE . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.915 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.75 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.794 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 26.4 m-70 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 HD11 ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.89 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.473 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.624 ' CA ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.963 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.801 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.849 ' O ' ' HB ' ' A' ' 86' ' ' THR . 34.6 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.963 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.819 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.15 -45.62 98.07 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 21.6 tt0 -63.96 -33.59 76.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.45 -38.39 62.98 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.107 -175.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.2 mt -60.57 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -76.46 -30.93 57.51 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.695 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.2 m120 -97.95 -3.91 37.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.857 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.4 174.76 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.953 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.47 -67.13 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.423 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.857 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.775 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.005 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.948 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -129.77 119.04 22.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -65.99 112.06 3.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.063 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.55 33.26 0.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.969 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -77.38 81.76 3.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.196 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -125.48 75.58 69.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.1 170.83 0.97 Allowed 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.661 2.241 . . . . 0.0 112.711 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 m -56.28 -49.72 73.42 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.58 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -166.85 38.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.13 31.35 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.919 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -69.27 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -178.2 80.11 0.23 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.11 110.75 2.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.614 2.209 . . . . 0.0 112.275 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.37 -169.88 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.496 2.131 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.99 93.46 Favored Pre-proline 0 CA--C 1.503 -0.833 0 CA-C-O 121.637 0.732 . . . . 0.0 111.211 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.41 171.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.763 2.309 . . . . 0.0 112.838 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.84 26.12 6.23 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.701 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.784 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.831 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG11 HD13 ' A' ' 87' ' ' LEU . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.906 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.765 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.018 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.2 p 157.17 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.018 ' H ' HG22 ' A' ' 35' ' ' VAL . 13.8 p-10 -142.09 25.05 1.95 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 175.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.515 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.8 t -5.47 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 111.972 -2.376 . . . . 0.0 114.137 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.624 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.8 m -159.38 37.97 0.2 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.25 -155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 39' ' ' VAL . 22.9 ttt85 -126.64 -16.48 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -89.88 -26.91 20.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 110.522 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 129.83 -108.51 0.87 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.435 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.844 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.999 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.721 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.059 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 50' ' ' ILE . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.993 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.844 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.657 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 82' ' ' GLN . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.942 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.821 ' O ' ' HB ' ' A' ' 86' ' ' THR . 34.8 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.942 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.13 -44.88 97.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.7 tt0 -64.94 -32.97 74.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.948 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.821 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.05 -42.61 26.02 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.315 -175.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 88' ' ' ARG . 3.8 pp -58.66 -37.58 76.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.876 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.3 tpt180 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.786 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m120 -97.1 -2.56 42.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.832 HG22 ' CG2' ' A' ' 94' ' ' VAL . 4.0 p -44.23 175.43 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.096 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.07 -64.69 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.268 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.832 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.784 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.709 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.864 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.568 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 -126.47 110.52 13.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.747 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.64 111.3 3.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.876 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.15 36.96 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.831 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -80.08 -49.41 11.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.333 -0.433 . . . . 0.0 111.217 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -59.96 -52.17 75.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.65 ' O ' HG23 ' A' ' 105' ' ' THR . 35.5 Cg_exo -41.9 95.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 123.109 2.54 . . . . 0.0 113.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.74 HG21 ' CD ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER 176.63 -174.24 0.11 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.052 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -88.92 53.69 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt 59.7 32.82 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.74 ' CD ' HG21 ' A' ' 105' ' ' THR . 21.1 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -49.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -178.36 -61.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 60.1 Cg_endo -72.41 169.74 20.98 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.93 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.595 2.196 . . . . 0.0 112.205 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -179.23 139.99 0.35 Allowed Pre-proline 0 CA--C 1.504 -0.809 0 CA-C-O 121.542 0.687 . . . . 0.0 111.065 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.47 168.62 0.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.209 1.939 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 104.91 28.2 5.69 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.799 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.955 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.828 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.838 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.853 HG11 HD13 ' A' ' 87' ' ' LEU . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' N ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.4 p 156.65 -161.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.005 ' H ' HG22 ' A' ' 35' ' ' VAL . 16.1 t-20 -142.33 25.23 1.89 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.737 HG21 ' OH ' ' A' ' 45' ' ' TYR . 1.7 t -4.86 -56.05 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.11 -2.314 . . . . 0.0 113.315 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 36' ' ' ASN . 18.1 m -171.19 66.6 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.164 0.506 . . . . 0.0 111.828 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -156.61 -155.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.026 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' VAL . 17.0 ttt180 -131.09 30.07 4.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.795 ' H ' HG13 ' A' ' 39' ' ' VAL . 38.3 m-70 -147.42 -31.03 0.32 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.428 0.633 . . . . 0.0 111.587 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 140.75 -108.31 0.55 Allowed Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.058 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.737 ' OH ' HG21 ' A' ' 37' ' ' THR . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.954 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.028 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.954 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.839 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.616 HD21 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.816 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.979 HG23 HD11 ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.685 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.905 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.934 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HB3' HG11 ' A' ' 73' ' ' VAL . 34.2 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.766 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.41 -45.37 98.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.4 tt0 -65.56 -33.62 76.33 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.129 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.769 HG21 HG13 ' A' ' 70' ' ' VAL . 1.9 t -79.38 -38.78 34.13 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.608 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 88' ' ' ARG . 3.9 pp -61.84 -37.26 83.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.882 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -76.94 -31.02 56.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.695 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.64 -2.54 44.51 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.848 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.7 p -43.84 173.86 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.031 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 106.86 -65.82 0.25 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.413 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.848 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.799 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.063 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 12' ' ' GLU . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.875 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -132.94 121.86 23.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.713 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -66.02 119.87 12.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.704 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 66' ' ' ARG . . . -158.05 34.8 0.52 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.598 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -90.18 -27.58 19.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.356 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.4 -53.95 50.74 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.206 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.07 133.19 14.83 Favored 'Trans proline' 0 CA--C 1.493 -1.529 0 C-N-CA 122.792 2.328 . . . . 0.0 113.308 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 108' ' ' GLU . 1.6 t -107.81 56.63 0.63 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.338 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m 63.23 49.44 3.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.37 70.62 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' CG ' ' CG2' ' A' ' 105' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -95.0 169.91 9.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 145.21 49.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.37 170.13 20.92 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.571 2.181 . . . . 0.0 112.307 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -167.94 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.646 2.23 . . . . 0.0 112.305 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -103.49 142.1 23.88 Favored Pre-proline 0 CA--C 1.504 -0.804 0 CA-C-O 121.643 0.735 . . . . 0.0 111.268 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' HB2' ' HE1' ' A' ' 62' ' ' HIS . 12.2 Cg_endo -56.33 173.14 0.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.284 1.989 . . . . 0.0 112.758 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.84 24.04 5.95 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.653 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 13' ' ' VAL . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.994 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.002 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.967 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 15' ' ' LEU . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.671 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.808 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.013 HG21 HD22 ' A' ' 87' ' ' LEU . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 26' ' ' VAL . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.066 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.77 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.016 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.5 p 156.56 -161.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.016 ' H ' HG22 ' A' ' 35' ' ' VAL . 12.2 t30 -143.06 25.8 1.73 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 175.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -8.94 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 111.817 -2.447 . . . . 0.0 114.149 -175.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.5 m -165.12 44.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.808 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.9 p -141.25 -151.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.808 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -129.81 -3.97 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' H ' HG13 ' A' ' 39' ' ' VAL . 49.6 m-70 -109.19 -26.87 9.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.43 0.633 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.722 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.19 -108.41 0.62 Allowed Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.066 ' HB3' HG21 ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.992 ' HA ' HG22 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.944 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.806 ' HA ' HD23 ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 1.002 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.64 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.049 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.887 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.011 HG23 HD11 ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.713 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.96 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.6 t-80 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.118 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.073 ' O ' HG22 ' A' ' 86' ' ' THR . 5.1 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.96 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.02 -39.36 85.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.118 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.9 tt0 -61.59 -36.33 80.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.044 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.073 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -70.02 -39.79 75.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.729 -0.788 . . . . 0.0 112.214 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.013 HD22 HG21 ' A' ' 26' ' ' VAL . 3.6 pp -64.0 -36.23 83.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.938 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.33 -31.31 54.47 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.276 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.7 m-20 -104.64 -9.38 18.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.021 HG22 HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -34.66 151.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 112.94 -58.37 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.639 -1.267 . . . . 0.0 113.124 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.021 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.814 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.011 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.931 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 -128.71 116.43 19.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.653 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 111.25 3.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.256 -179.12 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.78 34.78 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.741 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -88.28 -31.98 18.72 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.187 -0.507 . . . . 0.0 111.228 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.406 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -57.97 -51.82 78.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.372 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 103' ' ' SER . 27.5 Cg_exo -60.65 158.35 32.96 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 122.635 2.223 . . . . 0.0 112.725 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -42.8 65.66 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.325 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.0 m 66.09 20.45 11.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.178 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttt 176.69 -48.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.96 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -176.68 134.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.65 142.78 91.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.63 110.17 2.9 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.582 2.188 . . . . 0.0 112.443 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.27 179.8 5.12 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.407 2.071 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -121.61 150.31 54.79 Favored Pre-proline 0 CA--C 1.501 -0.94 0 CA-C-O 121.513 0.673 . . . . 0.0 111.324 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 70.7 Cg_endo -87.87 148.06 7.0 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 C-N-CA 121.886 1.724 . . . . 0.0 113.018 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.63 12.07 3.85 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.65 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.581 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.849 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.95 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.672 ' O ' HD12 ' A' ' 15' ' ' LEU . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.631 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.833 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.842 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.017 HG11 HD13 ' A' ' 87' ' ' LEU . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 28' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.793 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.04 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.13 -161.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.04 ' H ' HG22 ' A' ' 35' ' ' VAL . 14.3 t30 -144.11 26.34 1.51 Allowed 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' VAL . 7.4 t -10.25 -54.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 112.141 -2.3 . . . . 0.0 113.361 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASN . 24.1 m -169.63 64.64 0.05 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.798 HG22 ' H ' ' A' ' 40' ' ' ARG . 4.6 p -154.09 -155.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.947 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.798 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -130.17 29.82 4.86 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 122.096 -0.377 . . . . 0.0 111.512 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.784 ' H ' HG13 ' A' ' 39' ' ' VAL . 33.1 m-70 -148.97 -28.41 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.62 -108.85 0.66 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.666 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.93 HG23 ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.928 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.569 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.833 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.707 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.911 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 HD11 ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 82' ' ' GLN . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.912 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.106 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.022 ' O ' HG22 ' A' ' 86' ' ' THR . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.962 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.97 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.106 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 20.5 tt0 -60.94 -36.27 78.91 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.993 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -68.3 -38.85 82.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.605 -176.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.017 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 pp -59.33 -43.19 92.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.511 0.672 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.63 ' N ' HD12 ' A' ' 87' ' ' LEU . 3.6 ttt180 -76.55 -31.11 57.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.595 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.9 m-20 -100.44 -11.48 20.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.047 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.19 155.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.775 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.3 -62.36 0.29 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.056 -1.068 . . . . 0.0 113.017 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 91' ' ' GLY . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.047 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.849 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.053 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' CB ' ' A' ' 12' ' ' GLU . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -127.26 114.4 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.46 112.17 3.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.766 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.27 36.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.067 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -72.48 -174.7 1.42 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.399 . . . . 0.0 111.27 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -156.43 117.01 2.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.79 169.88 9.49 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.536 2.157 . . . . 0.0 112.857 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -28.78 66.38 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.05 30.94 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -145.96 -52.04 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.883 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.94 76.63 1.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m 61.78 152.31 0.11 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.21 121.25 7.63 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.66 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.396 2.064 . . . . 0.0 112.268 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -113.83 140.12 24.35 Favored Pre-proline 0 CA--C 1.504 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.0 111.201 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.91 -169.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.364 2.042 . . . . 0.0 112.851 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.78 26.18 6.89 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.732 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.864 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.14 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 60' ' ' ARG . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.8 ' O ' HD12 ' A' ' 15' ' ' LEU . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.998 HG22 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 87' ' ' LEU . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 32' ' ' LYS . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.09 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.845 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.044 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.2 p 156.59 -162.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.044 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.9 t30 -145.46 26.98 1.27 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 35' ' ' VAL . 8.0 t -9.77 -54.79 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 112.247 -2.251 . . . . 0.0 113.215 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 16.9 m -165.57 72.66 0.18 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.125 0.488 . . . . 0.0 112.006 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.7 p -163.79 -156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.938 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.2 tpt180 -130.2 25.26 5.21 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.162 -0.336 . . . . 0.0 111.505 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.744 ' H ' HG13 ' A' ' 39' ' ' VAL . 31.6 m-70 -143.0 -22.85 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.053 0.454 . . . . 0.0 111.976 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 125.64 -110.73 1.36 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -177.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.13 HG22 HG22 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.945 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.945 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' HG23 ' A' ' 50' ' ' ILE . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.965 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.659 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.789 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.13 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.864 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.795 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.675 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.622 HG11 ' CD ' ' A' ' 82' ' ' GLN . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 70' ' ' VAL . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.72 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.921 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.72 ' CE1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.8 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 86' ' ' THR . 24.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -64.95 -44.91 96.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' CB ' ' O ' ' A' ' 81' ' ' LYS . 29.1 tt0 -65.22 -32.33 73.96 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.158 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.787 HG21 HG13 ' A' ' 70' ' ' VAL . 2.0 t -79.28 -37.93 36.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.585 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 26' ' ' VAL . 3.7 pp -63.71 -36.37 83.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.884 ' N ' HD12 ' A' ' 87' ' ' LEU . 3.4 mtt-85 -76.91 -31.27 56.58 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.968 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -99.81 -3.9 31.66 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.902 HG22 ' CG2' ' A' ' 94' ' ' VAL . 1.5 p -40.38 166.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.925 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.87 -65.64 0.29 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.533 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.902 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.14 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.978 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -110.77 110.49 21.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.978 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.77 116.71 7.96 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.534 -178.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.54 34.23 0.5 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.958 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 1.6 mm100 -50.0 92.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.741 -0.729 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -176.82 65.3 0.21 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.78 170.93 0.82 Allowed 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 122.642 2.228 . . . . 0.0 112.754 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -72.18 60.26 0.42 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.795 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 44.84 29.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.628 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.39 52.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.18 117.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -64.79 -60.83 7.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 71.5 Cg_endo -74.52 111.24 3.27 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.598 2.199 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.61 54.04 4.93 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.528 2.152 . . . . 0.0 112.637 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 15.1 mtpp -153.44 154.75 30.98 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 121.303 0.573 . . . . 0.0 111.462 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 11' ' ' PHE . 10.5 Cg_exo -70.74 160.62 48.82 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 121.988 1.792 . . . . 0.0 113.014 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.84 5.02 3.65 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.87 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 1.082 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.779 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.855 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 87' ' ' LEU . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 31' ' ' ASP . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.089 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HG11 ' A' ' 35' ' ' VAL . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 27' ' ' THR . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.003 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.3 p 158.5 -148.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.003 ' H ' HG22 ' A' ' 35' ' ' VAL . 8.4 p-10 -144.09 23.81 1.67 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.66 ' H ' HG13 ' A' ' 35' ' ' VAL . 3.6 t -3.22 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.667 -175.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.0 m 178.66 62.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.374 0.607 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.795 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.8 p -160.4 -176.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.444 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.795 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.48 29.48 7.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.747 ' H ' HG13 ' A' ' 39' ' ' VAL . 57.7 m-70 -139.58 -29.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.603 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.58 -107.34 0.58 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.855 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.089 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.699 ' HA ' HD23 ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.601 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 HG22 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.754 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.854 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.062 HG23 HD11 ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.77 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.513 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.955 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.7 t-80 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.079 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.053 ' O ' HG22 ' A' ' 86' ' ' THR . 8.2 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.955 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.1 -40.68 89.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.079 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.4 tt0 -61.58 -36.84 81.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.625 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.053 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -67.55 -39.2 84.98 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.461 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.921 HD13 HG21 ' A' ' 26' ' ' VAL . 1.7 mt -62.6 -37.61 86.91 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -76.95 -30.99 56.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.957 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.79 -8.45 19.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.038 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.06 157.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.94 -63.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.138 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.038 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.779 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.082 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.901 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -128.01 119.21 24.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -65.77 129.09 38.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.631 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.23 35.48 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.797 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 20.2 mt-30 -54.66 -82.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.838 -0.681 . . . . 0.0 111.518 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -83.75 -64.1 0.24 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.441 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 36.2 Cg_endo -64.6 166.38 17.9 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 122.502 2.135 . . . . 0.0 112.923 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -61.33 -168.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.347 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 105' ' ' THR . 34.6 t -104.48 30.32 5.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.48 -58.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 61.73 115.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -175.4 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.972 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 3' ' ' SER . 76.2 Cg_exo -50.52 147.67 16.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.084 . . . . 0.0 112.333 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.01 153.77 41.98 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -78.5 163.8 59.47 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-O 121.372 0.605 . . . . 0.0 111.262 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.72 179.47 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.799 1.666 . . . . 0.0 112.529 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.55 25.45 6.0 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.678 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.921 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.991 HG21 HD22 ' A' ' 87' ' ' LEU . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.961 HG22 ' HA ' ' A' ' 32' ' ' LYS . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.051 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.657 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.2 p 153.73 -167.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.941 ' H ' HG22 ' A' ' 35' ' ' VAL . 9.9 p-10 -140.52 25.66 2.19 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 11.1 t -6.46 -52.52 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.425 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.9 m -154.44 36.76 0.42 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.8 p -142.5 -156.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.83 -12.76 5.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -95.04 -25.13 16.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.494 0.664 . . . . 0.0 110.719 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.23 -108.71 1.05 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.04 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.633 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.925 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.051 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.925 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.898 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.662 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.772 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.04 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 HD11 ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.684 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.604 HG11 ' CD ' ' A' ' 82' ' ' GLN . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.952 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.51 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.964 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 1.5 t-80 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.119 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 1.044 ' O ' HG22 ' A' ' 86' ' ' THR . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.09 -39.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 1.119 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.1 tt0 -61.55 -36.31 80.25 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.081 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.044 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -70.64 -39.98 73.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.226 -176.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.991 HD22 HG21 ' A' ' 26' ' ' VAL . 3.6 pp -63.1 -35.9 81.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.929 ' N ' HD12 ' A' ' 87' ' ' LEU . 4.8 ttp180 -77.37 -31.12 54.11 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.182 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.6 m-20 -104.71 -7.2 19.72 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.044 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -36.91 155.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.689 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.23 -59.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.921 HG23 ' HA ' ' A' ' 16' ' ' ALA . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.033 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.721 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.558 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 -125.53 109.32 12.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.843 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.7 112.16 4.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.943 -179.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.82 31.54 2.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.703 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 12.9 mm100 -89.14 -52.94 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.08 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.47 165.85 33.59 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.634 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.41 171.51 3.27 Favored 'Trans proline' 0 CA--C 1.501 -1.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.695 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 t -58.43 -29.37 66.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.444 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.1 t 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -140.83 -53.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.944 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.986 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.968 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.788 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.965 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.857 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.685 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.904 ' HA ' HG23 ' A' ' 46' ' ' VAL . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.721 HG23 ' C ' ' A' ' 31' ' ' ASP . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.721 ' C ' HG23 ' A' ' 27' ' ' THR . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.526 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.842 ' H ' HD12 ' A' ' 75' ' ' LEU . 3.7 p . . . . . 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.188 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.108 HG22 HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.888 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.947 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.947 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.01 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.802 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.802 ' H ' HG23 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.955 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.968 ' HA ' HG11 ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.665 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.108 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.609 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.632 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.954 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.632 ' CD ' HG11 ' A' ' 73' ' ' VAL . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.954 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.52 0.364 0 CA-C-O 120.005 -0.331 . . . . 0.0 113.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.788 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.86 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.5 mt-10 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 13' ' ' VAL . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.057 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.982 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.593 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.846 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.95 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.901 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.021 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.901 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG11 ' CZ ' ' A' ' 30' ' ' PHE . 5.6 p . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.798 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.27 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.013 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.987 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.021 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.987 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.638 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 5.2 m-70 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.801 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.013 HG22 ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.823 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.959 HG23 HD11 ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.697 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 32.7 t-20 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 7.0 t60 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.79 ' N ' ' O ' ' A' ' 79' ' ' THR . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.689 ' HB3' HG11 ' A' ' 73' ' ' VAL . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.757 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.832 -0.427 . . . . 0.0 113.449 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 7.6 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.782 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.057 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 68' ' ' LEU . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.884 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.938 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.95 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.813 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.731 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.652 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.682 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.727 HG23 ' C ' ' A' ' 31' ' ' ASP . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.727 ' C ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE2' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.611 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.833 HG11 ' CE2' ' A' ' 30' ' ' PHE . 3.3 p . . . . . 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.101 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.883 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.099 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.803 ' H ' HG23 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.731 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.95 ' HA ' HG11 ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.808 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.829 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.101 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.899 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.114 HG23 HD11 ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.619 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.957 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.651 ' CD ' HG11 ' A' ' 73' ' ' VAL . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.016 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.503 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.568 HG11 ' OD2' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.813 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.114 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.886 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.842 HD11 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.043 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.781 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.999 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.857 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 31' ' ' ASP . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.044 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 27' ' ' THR . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.701 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.6 p . . . . . 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.076 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.674 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.044 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.014 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.997 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.857 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.93 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.632 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.802 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.076 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.842 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG23 HD11 ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.63 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 82' ' ' GLN . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.925 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.947 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.7 t60 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.703 ' CD ' HG11 ' A' ' 73' ' ' VAL . 7.7 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.947 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 CA-C-O 119.936 -0.369 . . . . 0.0 113.151 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.781 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.043 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.627 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.885 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 98' ' ' LEU . 2.0 mt-10 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.06 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.97 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.785 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.966 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 15' ' ' LEU . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.595 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.832 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.976 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.048 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.976 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.781 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.751 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.4 p . . . . . 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.046 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.746 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.955 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.048 ' HB3' HG21 ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.955 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 50' ' ' ILE . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.704 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.767 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.97 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.743 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 28.6 t-20 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.91 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.939 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.2 t60 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 79' ' ' THR . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.748 ' HB3' HG11 ' A' ' 73' ' ' VAL . 10.5 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.939 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.756 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.876 -0.402 . . . . 0.0 113.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.785 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.06 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.873 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.027 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.827 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 15' ' ' LEU . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.679 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.765 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.928 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.732 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.3 p . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.743 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.488 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.031 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.716 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.043 ' HB3' HG21 ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.836 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.935 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.973 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.811 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.031 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.66 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.82 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 17.3 t-20 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.654 HG11 ' CD ' ' A' ' 82' ' ' GLN . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.946 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.8 t60 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.654 ' CD ' HG11 ' A' ' 73' ' ' VAL . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.946 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.827 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.027 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.824 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.081 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.966 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.764 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.98 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.707 ' O ' HD12 ' A' ' 15' ' ' LEU . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.621 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.846 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.829 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.991 HG22 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.943 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 31' ' ' ASP . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.019 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 27' ' ' THR . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.614 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.809 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.9 p . . . . . 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.075 HG22 HG22 ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.887 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.019 ' HB3' HG21 ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.991 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.846 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.765 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.966 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.819 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.873 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.082 HG23 HD11 ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.633 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.648 HG11 ' CD ' ' A' ' 82' ' ' GLN . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.949 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.9 t60 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.774 ' N ' ' O ' ' A' ' 79' ' ' THR . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.648 ' CD ' HG11 ' A' ' 73' ' ' VAL . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.949 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.886 -0.396 . . . . 0.0 113.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.764 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.082 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.016 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.792 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.973 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.642 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.001 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 31' ' ' ASP . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.076 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.1 p . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.035 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.72 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.941 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.076 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.941 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.001 ' HA ' HG22 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 50' ' ' ILE . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.702 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.726 ' HA ' HD23 ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.708 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.711 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.634 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' CD ' ' A' ' 82' ' ' GLN . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.951 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.5 t60 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.705 ' CD ' HG11 ' A' ' 73' ' ' VAL . 7.5 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.333 0 CA-C-O 119.942 -0.366 . . . . 0.0 113.234 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.711 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CG2' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 13' ' ' VAL . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.064 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.767 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.001 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.845 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.0 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.062 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.843 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.093 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.949 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.062 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.949 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.0 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.553 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.66 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.093 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.782 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.691 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 27.3 t-20 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 82' ' ' GLN . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.945 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.738 ' HB3' HG11 ' A' ' 73' ' ' VAL . 10.4 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.945 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.365 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.001 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.064 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.894 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.703 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.071 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.613 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.985 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.964 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.015 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.788 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.712 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.995 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.015 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.995 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.985 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.963 ' HA ' HG11 ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.828 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.783 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.803 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.68 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 82' ' ' GLN . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.913 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.932 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.5 t60 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.77 ' N ' ' O ' ' A' ' 79' ' ' THR . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.773 ' HB3' HG11 ' A' ' 73' ' ' VAL . 10.0 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.932 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.759 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.888 -0.396 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.994 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.071 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 13' ' ' VAL . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.967 HG22 ' HB2' ' A' ' 96' ' ' LEU . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.77 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.846 ' O ' HD12 ' A' ' 15' ' ' LEU . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.629 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.818 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.976 HG22 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.897 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 27' ' ' THR . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.809 ' H ' HD12 ' A' ' 75' ' ' LEU . 4.6 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.267 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.016 HG22 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.897 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.03 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.013 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.976 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 50' ' ' ILE . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.795 ' HA ' HD23 ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.65 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.837 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.971 HG23 HD11 ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.67 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t-20 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 82' ' ' GLN . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.876 HD11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 8.0 t60 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.773 ' N ' ' O ' ' A' ' 79' ' ' THR . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.706 ' HB3' HG11 ' A' ' 73' ' ' VAL . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.767 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.854 -0.414 . . . . 0.0 113.455 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.77 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.686 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.832 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.616 ' HG3' HD22 ' A' ' 68' ' ' LEU . 7.0 mt-10 . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.03 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.794 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.002 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.65 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.863 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.047 HG21 ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' THR . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.65 ' C ' HG12 ' A' ' 44' ' ' ILE . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.785 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.0 p . . . . . 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.064 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.774 ' N ' HD13 ' A' ' 44' ' ' ILE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.926 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.047 ' HB3' HG21 ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.926 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.711 ' HA ' HG11 ' A' ' 49' ' ' VAL . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' ALA . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.745 HG22 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 32.4 m-70 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.688 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.822 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.856 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.067 HG23 HD11 ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.645 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.692 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.933 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.938 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' A' ' 79' ' ' THR . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.692 ' CD ' HG11 ' A' ' 73' ' ' VAL . 8.5 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.65 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 119.992 -0.338 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.067 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 12' ' ' GLU . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.903 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.725 ' CG ' HD22 ' A' ' 68' ' ' LEU . 2.0 mm-40 . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.613 ' CG2' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.005 ' HE1' HG12 ' A' ' 13' ' ' VAL . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 ' HE1' ' A' ' 11' ' ' PHE . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.856 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.905 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 31' ' ' ASP . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.102 HG21 ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.666 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.745 ' H ' HD12 ' A' ' 75' ' ' LEU . 4.3 p . . . . . 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.9 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.922 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.102 ' HB3' HG21 ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.922 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 50' ' ' ILE . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.915 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.75 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.794 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 26.4 m-70 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.667 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 HD11 ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 29.9 t-20 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.89 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.963 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.625 ' HB3' HG11 ' A' ' 73' ' ' VAL . 11.2 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.963 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.761 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 119.809 -0.44 . . . . 0.0 113.423 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.775 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.005 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.948 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.784 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.831 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.858 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.906 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.765 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.847 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.2 p . . . . . 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.413 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.844 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.999 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.721 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.059 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 50' ' ' ILE . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.993 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.844 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.657 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 82' ' ' GLN . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.942 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.644 ' HB3' HG11 ' A' ' 73' ' ' VAL . 9.7 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.942 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.329 0 CA-C-O 119.893 -0.393 . . . . 0.0 113.268 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.784 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.709 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.864 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.568 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.799 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.955 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.828 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.838 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.785 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.4 p . . . . . 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.058 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.728 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.954 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.028 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.954 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.839 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.616 HD21 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.816 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.979 HG23 HD11 ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.685 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 24.7 t-20 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.905 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.934 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.772 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HB3' HG11 ' A' ' 73' ' ' VAL . 9.5 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.766 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.294 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.413 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.799 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.063 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 12' ' ' GLU . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.875 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 13' ' ' VAL . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.994 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.002 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.967 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 15' ' ' LEU . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.671 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.808 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.882 ' HA ' HG23 ' A' ' 46' ' ' VAL . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 26' ' ' VAL . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.066 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.77 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.799 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.5 p . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.722 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.066 ' HB3' HG21 ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.992 ' HA ' HG22 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.944 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.806 ' HA ' HD23 ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 1.002 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.64 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 31.3 m-70 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.049 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.887 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.011 HG23 HD11 ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.62 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.96 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' A' ' 79' ' ' THR . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.706 ' CD ' HG11 ' A' ' 73' ' ' VAL . 7.3 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.96 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.124 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.667 HG11 ' OD2' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.814 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.011 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.931 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 . . . . . 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.214 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.849 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.95 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.672 ' O ' HD12 ' A' ' 15' ' ' LEU . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.631 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.833 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.842 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.93 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 28' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.793 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.791 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.9 p . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.666 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.93 HG23 ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.928 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.569 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.833 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.707 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.911 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 HD11 ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.616 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 82' ' ' GLN . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.912 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.6 t60 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.783 ' N ' ' O ' ' A' ' 79' ' ' THR . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 73' ' ' VAL . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.962 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 119.945 -0.364 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 91' ' ' GLY . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.849 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.053 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' CB ' ' A' ' 12' ' ' GLU . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.864 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.14 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 60' ' ' ARG . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.8 ' O ' HD12 ' A' ' 15' ' ' LEU . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.998 HG22 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 32' ' ' LYS . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.09 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.845 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.848 ' H ' HD12 ' A' ' 75' ' ' LEU . 6.2 p . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.13 HG22 HG22 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.945 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.945 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' HG23 ' A' ' 50' ' ' ILE . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.965 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.659 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.789 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.13 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.864 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.795 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.675 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 14.4 t-20 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.622 HG11 ' CD ' ' A' ' 82' ' ' GLN . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 70' ' ' VAL . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.921 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.695 ' O ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.622 ' CD ' HG11 ' A' ' 73' ' ' VAL . 8.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.533 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.14 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.27 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 1.082 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.779 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.855 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.87 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 31' ' ' ASP . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.089 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HG11 ' A' ' 35' ' ' VAL . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 27' ' ' THR . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.862 HG11 ' CE2' ' A' ' 30' ' ' PHE . 3.3 p . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.855 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.089 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.699 ' HA ' HD23 ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.601 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 HG22 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.754 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.854 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.062 HG23 HD11 ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.645 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.955 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.4 t60 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 79' ' ' THR . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.709 ' CD ' HG11 ' A' ' 73' ' ' VAL . 9.0 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.955 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.779 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.082 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.901 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.921 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.876 ' HA ' HG23 ' A' ' 46' ' ' VAL . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.961 HG22 ' HA ' ' A' ' 32' ' ' LYS . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.051 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.657 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.746 ' H ' HD12 ' A' ' 75' ' ' LEU . 7.2 p . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . . . . . . 0 N--CA 1.435 -1.371 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.04 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.633 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.925 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.051 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.925 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.898 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.662 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.772 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.04 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 HD11 ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.604 HG11 ' CD ' ' A' ' 82' ' ' GLN . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.952 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.964 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' A' ' 79' ' ' THR . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.604 ' CD ' HG11 ' A' ' 73' ' ' VAL . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 119.963 -0.354 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.921 HG23 ' HA ' ' A' ' 16' ' ' ALA . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.033 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.721 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.558 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 . . . . . 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -163.84 178.78 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.896 0.379 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.14 149.16 51.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 110.83 2.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.58 2.186 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.48 113.89 3.41 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.464 2.109 . . . . 0.0 112.491 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.67 160.68 55.6 Favored Pre-proline 0 CA--C 1.504 -0.814 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.63 168.3 7.03 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.624 1.549 . . . . 0.0 112.69 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' H ' ' HZ3' ' A' ' 100' ' ' LYS . . . 103.51 22.85 8.73 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.684 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 174.85 -138.81 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -78.81 100.57 3.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-O 122.098 0.951 . . . . 0.0 109.17 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.9 t80 -118.89 140.67 49.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.986 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -114.55 151.1 33.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.13 178.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.968 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -126.43 109.96 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 118.926 -1.109 . . . . 0.0 110.416 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.788 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 21.7 pt-20 -116.64 127.29 54.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.44 148.5 34.67 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.958 0.903 . . . . 0.0 109.626 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.965 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.89 122.92 48.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.35 91.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.486 -178.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.3 t-20 -135.87 -58.06 0.77 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.842 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -122.09 -37.44 2.83 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.212 1.006 . . . . 0.0 108.325 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 28.0 m120 -166.03 154.61 11.1 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.856 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.7 t -166.12 35.28 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.807 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.41 179.57 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.219 -1.81 . . . . 0.0 107.895 -177.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.857 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.44 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.155 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.01 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.0 pt -120.82 150.15 23.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.685 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -99.32 113.77 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.024 HG21 HD13 ' A' ' 87' ' ' LEU . 9.8 p -99.95 157.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 111.566 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.721 HG23 ' C ' ' A' ' 31' ' ' ASP . 5.4 m 77.61 3.22 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.37 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.2 m -75.74 -40.46 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.03 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.4 mt -111.3 -13.03 14.0 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.888 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -129.38 -176.02 3.76 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.688 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.721 ' C ' HG23 ' A' ' 27' ' ' THR . 1.7 m-20 -87.33 -16.16 35.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.627 0.251 . . . . 0.0 111.059 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.539 ' O ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 179.32 43.89 0.0 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.108 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.33 -102.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.095 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.615 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -55.49 164.62 4.12 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.713 -0.279 . . . . 0.0 113.233 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.12 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.7 p 160.35 -140.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.12 ' H ' HG22 ' A' ' 35' ' ' VAL . 4.8 p30 -144.6 22.8 1.63 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.926 ' H ' HG13 ' A' ' 35' ' ' VAL . 9.0 t -1.71 -54.68 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.794 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.68 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.6 m 178.02 54.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.39 0.614 . . . . 0.0 110.324 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.802 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.29 -176.95 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.477 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.28 29.93 7.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.818 0.342 . . . . 0.0 111.671 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.776 ' H ' HG13 ' A' ' 39' ' ' VAL . 61.4 m-70 -138.83 -31.45 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.394 0.616 . . . . 0.0 111.323 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 147.68 -107.1 0.37 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.979 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 124.12 61.95 0.19 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.108 HG22 HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -70.39 128.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 118.407 1.104 . . . . 0.0 112.16 177.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.888 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 42.0 m-85 -123.72 129.64 51.41 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.185 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.947 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.4 p -154.2 -171.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.8 pttp -92.11 -19.67 22.05 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.947 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.55 -143.25 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.766 176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.01 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.8 m -77.53 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 -174.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.802 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -43.9 163.42 0.17 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 110.887 -2.869 . . . . 0.0 110.663 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -79.98 -28.69 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.47 2.114 . . . . 0.0 113.175 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.802 ' H ' HG23 ' A' ' 50' ' ' ILE . 6.5 pt20 -92.14 23.35 3.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.561 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.55 2.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.361 -0.923 . . . . 0.0 114.257 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.11 -112.87 0.39 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.955 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.81 60.62 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 122.175 0.988 . . . . 0.0 108.722 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -55.7 -30.9 61.89 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.566 -1.652 . . . . 0.0 108.157 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' ALA . 2.0 t -78.33 -41.56 33.28 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -59.77 -22.84 62.67 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 53.73 7.53 Favored Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.358 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.968 ' HA ' HG11 ' A' ' 13' ' ' VAL . 43.3 ttt180 -119.74 57.15 0.92 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -91.01 141.39 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.098 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -176.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.665 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 132.1 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 112.71 -2.041 . . . . 0.0 109.815 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -85.1 110.14 18.75 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.616 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.21 106.85 0.23 Allowed Glycine 0 CA--C 1.501 -0.821 0 C-N-CA 118.345 -1.884 . . . . 0.0 110.866 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.07 -168.71 0.42 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.53 -178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.809 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.28 108.83 10.3 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.108 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -82.04 141.96 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.448 0 C-N-CA 126.309 1.844 . . . . 0.0 115.425 177.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.9 pp -83.81 -49.3 9.2 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.868 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.74 148.39 51.41 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 96' ' ' LEU . 11.7 p -122.65 143.68 34.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.76 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 50.4 t30 49.09 15.72 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.59 -22.03 37.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.116 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.632 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.5 t -86.81 142.94 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -78.87 116.42 19.19 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.903 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.79 77.32 2.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.65 37.46 1.01 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.844 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 106.39 11.7 26.73 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -76.38 -54.06 7.28 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.954 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.93 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 119.197 -0.43 . . . . 0.0 111.4 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.05 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 125.198 1.561 . . . . 0.0 108.494 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.096 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 12.1 tptm -83.66 -61.81 1.74 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.039 ' O ' HG22 ' A' ' 86' ' ' THR . 28.7 mt-30 -71.49 -55.57 7.62 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.954 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.23 -48.14 21.42 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 118.469 -1.293 . . . . 0.0 114.392 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.51 -40.94 90.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.309 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.096 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.3 tt0 -60.83 -36.68 79.71 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.157 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.039 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -68.18 -36.23 79.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.953 -177.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.024 HD13 HG21 ' A' ' 26' ' ' VAL . 1.3 mt -58.71 -43.59 90.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -30.98 56.22 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.572 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -99.39 -11.25 21.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -40.03 158.15 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.687 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 108.59 -62.82 0.29 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.148 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 14.3 pt20 -35.28 -40.5 0.14 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.763 0.792 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.76 108.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.99 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.9 136.76 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 CA-C-O 122.963 1.363 . . . . 0.0 113.716 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.788 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -133.68 115.71 14.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.0 -2.364 . . . . 0.0 110.704 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.11 138.58 53.21 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -177.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -112.2 113.98 26.53 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.261 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.881 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -113.69 153.28 29.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.566 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.5 mt-10 -124.32 109.3 13.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.117 0.961 . . . . 0.0 111.093 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.881 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -67.04 109.85 3.16 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.188 -178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.19 35.97 1.13 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.648 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -57.58 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.141 -0.529 . . . . 0.0 111.175 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.499 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 1.3 m -136.94 -69.23 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.295 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 50.9 Cg_endo -68.23 169.97 15.64 Favored 'Trans proline' 0 CA--C 1.502 -1.106 0 C-N-CA 122.249 1.966 . . . . 0.0 112.865 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -61.78 -170.23 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.403 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.431 ' H ' HG22 ' A' ' 105' ' ' THR . 1.3 p -77.39 -10.85 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 -46.44 0.44 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.722 0.296 . . . . 0.0 110.984 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.886 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t 62.78 120.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -60.01 142.49 89.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.77 109.94 2.84 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.602 2.202 . . . . 0.0 112.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.72 -176.69 2.42 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.234 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -132.74 156.72 79.76 Favored Pre-proline 0 CA--C 1.506 -0.74 0 CA-C-O 121.327 0.584 . . . . 0.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.07 176.81 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.811 1.674 . . . . 0.0 112.602 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.11 24.17 8.14 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.674 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 173.28 -141.15 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -79.9 100.98 4.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 122.318 1.056 . . . . 0.0 109.344 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 13' ' ' VAL . 6.6 t80 -119.49 144.38 47.03 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.057 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -118.43 150.52 39.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.248 0.476 . . . . 0.0 109.874 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -125.15 110.9 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.524 -178.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 18.0 pt-20 -115.82 128.63 55.97 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.22 148.09 34.47 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.365 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.982 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.34 123.14 48.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.9 OUTLIER -41.86 91.32 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.436 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 3.6 t30 -136.65 -56.96 0.74 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.08 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.56 -36.28 2.8 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.11 0.957 . . . . 0.0 108.546 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 75.4 m-20 -165.37 155.06 12.8 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.322 -1.763 . . . . 0.0 108.055 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.593 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -168.68 36.81 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.79 179.29 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.127 -177.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.846 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.49 36.79 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.77 150.69 21.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 121.361 0.6 . . . . 0.0 112.378 -178.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.2 t -102.22 114.02 27.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.95 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.8 p -99.57 157.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.0 111.456 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.901 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.8 p 79.15 1.08 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.667 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.021 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.9 m -73.01 -42.69 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.652 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.0 mt -111.48 -11.26 14.11 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.055 0.931 . . . . 0.0 108.586 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 5.1 t80 -130.19 -175.24 3.57 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.845 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 1.2 m-20 -82.65 -48.95 10.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.901 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -146.93 40.33 1.06 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.704 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 60.1 -101.46 0.27 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.091 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -54.72 168.12 2.03 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.44 -0.41 . . . . 0.0 112.666 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.046 HG22 ' H ' ' A' ' 36' ' ' ASN . 5.6 p 160.6 -154.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.046 ' H ' HG22 ' A' ' 35' ' ' VAL . 9.7 p-10 -141.7 23.52 2.1 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.673 HG21 ' HE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER 1.4 -55.06 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.039 -2.346 . . . . 0.0 113.961 -176.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.1 m -176.49 37.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.027 0.441 . . . . 0.0 111.297 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.818 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.1 p -132.39 -150.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.818 ' H ' HG22 ' A' ' 39' ' ' VAL . 3.7 tmm_? -130.15 -2.7 4.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.662 ' H ' HG13 ' A' ' 39' ' ' VAL . 49.6 m-70 -106.99 -25.28 11.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.283 0.564 . . . . 0.0 110.849 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.798 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.31 -108.17 0.71 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.786 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.82 84.82 1.1 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.013 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -83.73 133.85 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.279 0.562 . . . . 0.0 111.58 177.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 88.3 m-85 -123.76 131.47 53.6 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.289 176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.6 p -157.54 -170.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.021 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.88 -18.07 25.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.987 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.61 -143.75 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 112.035 -2.348 . . . . 0.0 112.244 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -78.0 138.05 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.29 161.32 0.13 Allowed Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 111.111 -2.768 . . . . 0.0 111.09 177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.81 -25.8 5.02 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.414 2.076 . . . . 0.0 112.651 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 10.8 pt20 -91.37 17.07 8.94 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.161 -1.381 . . . . 0.0 112.659 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.1 -95.99 1.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.373 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.03 -110.74 0.11 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.87 -35.81 61.95 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 122.373 1.082 . . . . 0.0 108.609 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.5 tm-20 -56.17 -31.13 63.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.973 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 m -77.54 -41.01 40.61 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.4 t0 -60.32 -22.98 63.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.78 51.74 10.74 Favored Glycine 0 CA--C 1.495 -1.205 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.453 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -112.08 49.03 0.93 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.638 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.69 142.53 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.205 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -177.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 5.2 m-70 128.88 104.91 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.92 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.04 17.97 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.459 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.801 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.7 107.21 0.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 118.245 -1.931 . . . . 0.0 111.147 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.533 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -174.08 -168.24 0.39 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.331 -0.435 . . . . 0.0 110.76 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.28 10.0 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.013 HG22 ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.03 142.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 177.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.823 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.47 -51.37 7.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 112.671 -2.059 . . . . 0.0 107.015 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.22 152.36 51.78 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.959 HG23 HD11 ' A' ' 96' ' ' LEU . 13.4 p -123.58 143.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.697 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 32.7 t-20 43.64 17.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.074 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.35 -24.88 24.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.037 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.689 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.9 t -86.6 142.27 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -79.06 114.78 18.28 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -97.32 77.93 2.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -93.02 34.5 1.1 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.14 11.23 20.78 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.596 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.64 -53.81 6.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.501 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.971 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.41 -99.52 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 119.087 -0.482 . . . . 0.0 111.532 -179.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.675 ' C ' ' O ' ' A' ' 79' ' ' THR . 7.0 t60 17.78 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.215 1.572 . . . . 0.0 108.49 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.8 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 47.0 tttp -83.45 -62.02 1.69 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.85 ' O ' ' HB ' ' A' ' 86' ' ' THR . 32.6 mt-30 -71.44 -55.81 7.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.31 -49.74 16.13 Favored 'General case' 0 CA--C 1.483 -1.601 0 C-N-CA 117.817 -1.553 . . . . 0.0 114.249 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.789 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.89 -45.86 97.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.732 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 32.7 tt0 -63.6 -33.79 76.4 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.975 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.865 HG21 HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -73.78 -38.91 64.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 119.561 -0.856 . . . . 0.0 112.043 -175.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.5 mt -59.68 -38.02 80.38 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -76.35 -30.96 57.82 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.572 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -97.66 -3.95 38.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.853 HG22 ' CG2' ' A' ' 94' ' ' VAL . 3.1 p -46.21 176.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.969 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.92 -66.96 0.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.449 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 91' ' ' GLY . 7.6 pt20 -32.73 -42.49 0.08 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.718 0.771 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.982 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 175.04 109.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.853 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.02 136.78 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 CA-C-O 122.968 1.366 . . . . 0.0 113.839 -174.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.782 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -134.11 115.12 13.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 111.96 -2.382 . . . . 0.0 110.374 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.057 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.64 135.91 54.2 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 68' ' ' LEU . 20.5 mt -110.88 113.43 26.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.677 174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.884 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.36 153.57 25.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.91 -178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.606 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -127.5 115.26 18.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.8 0.81 . . . . 0.0 111.798 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -65.29 112.33 3.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.899 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.18 35.04 1.17 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.091 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -93.61 28.99 2.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.44 . . . . 0.0 111.4 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.96 109.58 1.99 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.32 173.83 8.08 Favored 'Trans proline' 0 CA--C 1.501 -1.134 0 C-N-CA 122.455 2.104 . . . . 0.0 112.743 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m -57.11 -27.51 61.86 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.518 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.4 29.77 18.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -139.62 -59.12 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.88 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m 60.48 96.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -168.27 151.46 5.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.906 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.76 105.85 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.619 2.213 . . . . 0.0 112.395 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.68 -52.95 7.89 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.496 2.13 . . . . 0.0 112.276 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 161.09 37.25 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-O 121.435 0.636 . . . . 0.0 111.273 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.74 176.41 0.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.91 1.74 . . . . 0.0 112.538 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.86 26.93 4.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.679 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 173.95 -136.66 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.28 100.8 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.176 0.989 . . . . 0.0 109.422 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.3 t80 -118.8 138.82 52.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.938 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -113.3 151.25 31.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.911 178.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.95 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -128.07 109.59 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.813 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.0 pt-20 -116.5 127.76 54.84 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.731 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.48 148.49 34.6 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 123.816 0.846 . . . . 0.0 109.636 175.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.96 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.74 123.64 49.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -40.48 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.511 -178.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.5 t-20 -135.19 -59.06 0.79 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.734 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -121.87 -37.52 2.85 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.24 1.019 . . . . 0.0 108.317 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.5 m-80 -166.3 155.24 11.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.746 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.652 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.6 t -166.42 35.02 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.312 1.053 . . . . 0.0 108.163 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.809 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 168.02 179.04 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.942 -177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 38.01 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.374 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.071 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -120.48 151.05 23.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.341 0.591 . . . . 0.0 112.586 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.682 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.9 t -100.3 114.0 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.914 ' HA ' HG23 ' A' ' 46' ' ' VAL . 14.3 p -99.74 157.63 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.678 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.727 HG23 ' C ' ' A' ' 31' ' ' ASP . 4.6 m 78.23 2.55 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.455 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.3 m -75.68 -39.45 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -112.09 -12.88 13.63 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 3.0 t80 -130.67 -174.11 3.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.7 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.727 ' C ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -89.04 -15.45 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.507 0.194 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE2' ' CB ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -179.64 36.87 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.283 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 57.8 -102.41 0.24 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.771 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.611 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.02 164.73 2.66 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.623 -0.322 . . . . 0.0 113.036 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.029 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.3 p 157.93 -147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.029 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -137.99 20.76 2.83 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 175.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.783 ' H ' HG13 ' A' ' 35' ' ' VAL . 9.3 t 1.42 -55.17 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 112.028 -2.351 . . . . 0.0 113.863 -176.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.717 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.7 m 178.73 55.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.465 0.65 . . . . 0.0 110.508 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.802 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.5 p -156.72 -177.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.516 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.46 29.93 7.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.92 0.39 . . . . 0.0 111.697 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.776 ' H ' HG13 ' A' ' 39' ' ' VAL . 54.8 m-70 -139.96 -28.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 111.465 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 145.01 -107.51 0.44 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.54 66.47 0.25 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.129 1.612 . . . . 0.0 117.129 176.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.101 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -73.09 129.94 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.155 0.977 . . . . 0.0 112.005 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.883 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 46.5 m-85 -123.73 129.33 50.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.313 176.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -154.06 -171.21 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.099 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.1 ptmt -92.51 -19.09 22.33 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 174.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.95 -142.53 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.889 0 CA-C-N 112.205 -2.27 . . . . 0.0 112.741 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.52 138.24 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.1 OUTLIER -44.08 163.43 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 110.861 -2.881 . . . . 0.0 110.799 177.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' N ' HG23 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -80.03 -28.58 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.455 2.103 . . . . 0.0 113.141 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.803 ' H ' HG23 ' A' ' 50' ' ' ILE . 9.6 pt20 -92.06 23.17 3.89 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.227 -1.352 . . . . 0.0 112.543 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 97.01 -101.65 2.63 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.224 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.06 -112.56 0.37 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.9 -34.79 60.55 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.207 1.003 . . . . 0.0 108.743 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -55.69 -30.78 61.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.078 178.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -78.28 -41.4 34.08 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.731 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.5 t0 -59.71 -22.82 62.54 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.51 52.72 9.68 Favored Glycine 0 CA--C 1.495 -1.165 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.159 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.95 ' HA ' HG11 ' A' ' 13' ' ' VAL . 2.2 ttp85 -117.89 56.28 0.86 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.7 m80 131.95 107.9 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.969 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -84.42 110.02 18.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.446 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.808 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.18 109.94 0.22 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 118.339 -1.886 . . . . 0.0 110.651 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -177.56 -169.76 0.24 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.4 . . . . 0.0 111.1 -178.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.829 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.18 108.78 10.3 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.101 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.8 142.11 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 C-N-CA 126.246 1.818 . . . . 0.0 115.413 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.1 pp -84.93 -48.47 9.25 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.028 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.899 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.89 146.84 50.93 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.114 HG23 HD11 ' A' ' 96' ' ' LEU . 9.4 p -122.68 143.7 34.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.718 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 36.1 t30 50.23 15.49 0.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.044 0.449 . . . . 0.0 110.218 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.3 -20.95 43.07 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.886 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.2 t -86.8 142.92 12.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 p -78.96 114.94 18.32 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.18 77.22 3.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -92.92 36.36 1.03 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.596 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.8 9.58 26.27 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -73.47 -53.77 9.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.957 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.45 -100.0 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.13 0 CA-C-O 119.089 -0.482 . . . . 0.0 111.408 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 18.09 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 125.121 1.513 . . . . 0.0 108.499 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.086 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 20.4 tptt -83.66 -61.86 1.73 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.051 ' O ' HG22 ' A' ' 86' ' ' THR . 32.4 mt-30 -71.31 -55.6 7.71 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 -173.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.25 20.43 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 118.475 -1.29 . . . . 0.0 114.288 -174.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.762 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.84 -40.55 89.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.369 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.086 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 15.8 tt0 -61.44 -37.28 82.96 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.051 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -68.9 -38.8 79.83 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.661 -176.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 26' ' ' VAL . 2.2 mt -61.11 -38.95 88.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.7 ttm105 -77.04 -31.19 56.06 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.089 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 -8.41 20.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.04 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.12 156.91 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.715 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.44 -59.06 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.546 -1.311 . . . . 0.0 113.016 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.503 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 12.7 pt20 -37.69 -38.31 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.812 0.815 . . . . 0.0 109.434 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.2 p 167.69 105.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.04 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -115.07 136.98 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-O 123.068 1.413 . . . . 0.0 113.581 -174.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.813 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.0 m80 -133.39 116.28 15.87 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 111.534 -2.576 . . . . 0.0 110.444 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.114 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.57 140.06 51.98 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.8 mt -113.21 114.22 26.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.722 -1.581 . . . . 0.0 108.263 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.886 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.23 28.43 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.265 -178.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 66' ' ' ARG . 1.7 mt-10 -127.17 110.63 13.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.579 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.731 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.73 112.13 4.05 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.78 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.51 38.76 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.253 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -66.0 -175.07 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.909 0.385 . . . . 0.0 111.179 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -177.77 86.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.811 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.87 168.81 1.58 Allowed 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 122.677 2.251 . . . . 0.0 112.811 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -69.66 0.21 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.418 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -169.27 58.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.41 85.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.123 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -103.11 88.87 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -176.66 88.82 0.26 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.44 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.651 2.234 . . . . 0.0 112.428 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.9 59.24 6.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -126.34 158.0 68.39 Favored Pre-proline 0 CA--C 1.504 -0.79 0 CA-C-O 121.343 0.592 . . . . 0.0 111.297 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -62.05 -171.53 0.1 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.79 1.66 . . . . 0.0 112.687 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 101.27 24.09 9.17 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.724 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.54 -140.19 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.842 HD11 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -79.49 100.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 122.301 1.048 . . . . 0.0 109.411 179.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 5.3 t80 -118.94 146.45 44.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.043 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.42 151.01 37.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.309 0.504 . . . . 0.0 110.378 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -125.07 110.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.527 -178.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.781 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 10.8 pt-20 -116.08 127.27 54.73 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.13 145.93 32.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.999 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.25 123.32 48.13 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -40.72 90.89 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.367 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.1 t30 -135.1 -58.04 0.8 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.958 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -121.51 -37.48 2.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 76.9 m-20 -166.75 156.3 11.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.799 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -168.05 35.68 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.3 1.048 . . . . 0.0 108.362 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.857 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.03 179.08 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.073 -177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.82 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.59 37.77 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.997 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.3 pp -117.84 151.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -102.59 114.46 28.7 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.1 p -99.9 157.72 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.493 . . . . 0.0 112.15 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 31' ' ' ASP . 2.8 m 79.02 4.39 2.36 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.592 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.044 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -79.33 -38.83 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.31 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.85 -12.6 12.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.994 0.902 . . . . 0.0 109.111 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -125.54 -164.04 1.26 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.656 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 27' ' ' THR . 9.0 m-20 -102.7 -11.74 18.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 178.42 37.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.703 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.45 -102.25 0.07 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.697 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.701 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -53.52 155.02 6.69 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.219 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.01 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.6 p 155.23 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.01 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.2 25.97 1.69 Allowed 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 175.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' VAL . 11.7 t -8.3 -53.8 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.233 -2.258 . . . . 0.0 113.453 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 36' ' ' ASN . 5.2 m -162.38 67.33 0.24 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.813 HG22 ' H ' ' A' ' 40' ' ' ARG . 8.1 p -167.41 -175.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.686 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.813 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.2 ttt-85 -114.54 24.46 11.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.621 ' H ' HG13 ' A' ' 39' ' ' VAL . 50.3 m-70 -136.31 -26.06 1.15 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.296 0.569 . . . . 0.0 111.786 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.71 -108.92 1.04 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 106.53 76.85 1.04 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 117.575 1.79 . . . . 0.0 117.575 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.076 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -69.89 133.23 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.463 0.649 . . . . 0.0 112.085 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.674 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 47.6 m-85 -124.39 133.79 53.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.948 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -158.19 -170.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -173.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.044 ' HB3' HG21 ' A' ' 28' ' ' VAL . 8.9 ptmt -89.51 -18.31 26.92 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.014 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.63 -144.46 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 111.92 -2.4 . . . . 0.0 112.289 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.997 ' HA ' HG22 ' A' ' 24' ' ' ILE . 9.3 m -78.08 138.1 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.656 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -39.54 162.29 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.855 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -79.85 -26.22 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.381 2.054 . . . . 0.0 112.909 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 3.6 pm0 -94.1 18.83 10.06 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.902 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.64 -96.54 1.41 Allowed Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.718 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.857 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.94 -111.59 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.93 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.61 -35.79 61.28 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.317 1.056 . . . . 0.0 108.578 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -56.19 -31.08 63.12 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.378 -1.737 . . . . 0.0 108.971 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -78.27 -40.79 35.99 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t70 -59.87 -23.21 63.24 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.54 50.87 10.54 Favored Glycine 0 CA--C 1.497 -1.086 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.193 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.872 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.76 56.1 0.81 Allowed 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -89.72 141.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.192 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.632 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 9.4 m80 131.68 107.53 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.941 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.77 110.37 17.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.58 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.818 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.83 103.62 0.18 Allowed Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 118.211 -1.947 . . . . 0.0 110.829 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -168.73 -170.01 1.12 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.744 -178.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.802 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.38 108.3 9.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.076 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.17 141.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 126.255 1.822 . . . . 0.0 115.87 177.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.842 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -82.27 -50.86 8.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 113.381 -1.736 . . . . 0.0 107.314 175.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.03 151.39 51.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG23 HD11 ' A' ' 96' ' ' LEU . 11.5 p -123.35 143.75 35.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.68 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 47.2 t30 47.68 16.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.821 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.52 -22.25 36.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 119.941 -1.123 . . . . 0.0 112.184 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 82' ' ' GLN . 73.8 t -86.8 142.72 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -78.82 115.52 18.56 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.925 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.43 77.87 3.88 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.37 30.38 1.98 Allowed 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.04 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 110.44 21.02 7.08 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.556 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.15 -53.12 5.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.197 -0.502 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.947 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.41 -100.14 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.09 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.542 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.7 t60 18.72 -80.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.198 1.561 . . . . 0.0 108.506 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.074 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.0 tptp -83.92 -61.86 1.72 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.074 ' O ' HG22 ' A' ' 86' ' ' THR . 7.7 mt-30 -71.49 -55.45 7.84 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.947 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.22 -47.99 22.0 Favored 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 118.505 -1.278 . . . . 0.0 114.145 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -62.9 -41.1 91.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.401 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.074 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.6 tt0 -61.49 -37.04 82.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.506 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.074 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -66.56 -39.09 88.34 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.431 -176.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.877 HD13 HG21 ' A' ' 26' ' ' VAL . 3.6 mt -62.26 -39.47 93.02 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.329 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -103.52 -10.66 18.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.029 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -38.04 156.43 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.723 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 111.87 -63.93 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.151 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.9 pt20 -33.8 -42.84 0.12 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.76 0.791 . . . . 0.0 109.581 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.999 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.75 109.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.352 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.029 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.62 137.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 122.964 1.364 . . . . 0.0 113.726 -174.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.781 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -133.67 115.45 14.64 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.076 -2.329 . . . . 0.0 110.658 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.043 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -126.65 137.86 53.35 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.627 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.7 mt -111.81 113.49 25.87 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.478 174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.927 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.74 152.06 29.55 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.251 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 98' ' ' LEU . 2.0 mt-10 -120.1 110.12 16.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.071 0.938 . . . . 0.0 110.648 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.927 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.84 109.21 2.82 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.365 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.51 34.49 1.37 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.927 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 6.5 mt-30 -61.08 -19.54 61.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.143 -0.529 . . . . 0.0 111.241 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.405 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 1.1 m 64.63 53.97 1.28 Allowed Pre-proline 0 C--N 1.332 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.693 ' O ' HG23 ' A' ' 105' ' ' THR . 72.7 Cg_endo -73.46 67.21 4.51 Favored 'Trans proline' 0 CA--C 1.501 -1.158 0 C-N-CA 122.799 2.332 . . . . 0.0 112.795 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -174.71 37.6 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.186 177.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 m -141.61 -47.29 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -106.27 -35.89 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.92 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -86.58 -67.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -134.77 72.15 69.23 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.79 110.2 2.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.91 177.96 5.8 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.444 2.096 . . . . 0.0 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 mtmt -150.22 162.2 28.48 Favored Pre-proline 0 CA--C 1.504 -0.795 0 CA-C-O 121.327 0.584 . . . . 0.0 111.266 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.6 -173.7 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.892 1.728 . . . . 0.0 112.606 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.06 25.07 7.67 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.699 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER 174.81 -141.65 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.17 101.04 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.28 1.038 . . . . 0.0 108.867 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.3 t80 -118.98 142.78 47.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.434 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.06 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -114.86 151.07 34.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.305 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.97 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.2 m -124.83 110.52 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 C-N-CA 119.109 -1.036 . . . . 0.0 110.056 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.785 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 0.2 OUTLIER -116.15 130.09 56.63 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.87 148.81 34.37 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.304 1.042 . . . . 0.0 109.295 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.966 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.08 121.78 45.88 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.6 OUTLIER -41.04 91.75 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.439 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 7.2 t-20 -137.4 -57.06 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.975 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -125.34 -34.94 2.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.741 ' O ' HD12 ' A' ' 15' ' ' LEU . 30.0 m120 -164.68 154.91 14.12 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.171 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.595 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -169.12 36.9 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.01 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.305 -1.771 . . . . 0.0 108.075 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.832 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.18 36.99 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.303 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.993 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.99 147.93 23.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.2 m -99.81 115.16 28.92 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.5 p -99.74 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.247 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.976 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.37 0.8 2.29 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.406 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.048 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.3 m -74.62 -44.05 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.593 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' HG23 ' A' ' 28' ' ' VAL . 7.1 mt -109.24 -14.13 14.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 122.184 0.992 . . . . 0.0 108.466 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -122.87 -161.34 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.552 -1.658 . . . . 0.0 109.903 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.67 -25.95 13.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.422 . . . . 0.0 110.22 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.976 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -165.89 30.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.738 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 59.37 -96.04 0.07 OUTLIER Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.506 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.781 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -59.13 160.26 16.74 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.718 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.029 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.4 p 156.94 -162.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.029 ' H ' HG22 ' A' ' 35' ' ' VAL . 16.9 p-10 -139.64 23.72 2.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.1 t -6.38 -53.45 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.008 -2.36 . . . . 0.0 114.182 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.7 m -158.86 35.87 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.2 p -141.87 -155.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.848 ' H ' HG22 ' A' ' 39' ' ' VAL . 44.4 ttm-85 -126.23 -16.89 5.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 59.2 m-70 -89.2 -26.11 21.42 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.556 0.693 . . . . 0.0 110.566 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.03 -108.7 0.75 Allowed Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.484 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 120.8 66.9 0.27 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 117.022 1.569 . . . . 0.0 117.022 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.046 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.88 130.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 117.82 0.81 . . . . 0.0 112.96 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.746 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.3 m-85 -124.02 133.38 53.68 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.717 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.955 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -158.31 -171.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.048 ' HB3' HG21 ' A' ' 28' ' ' VAL . 12.9 ptmt -90.53 -20.57 22.51 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 174.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.955 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.5 -142.62 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.927 0 CA-C-N 112.106 -2.316 . . . . 0.0 112.237 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.993 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.5 m -77.88 137.82 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.06 161.09 0.16 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 110.96 -2.836 . . . . 0.0 111.289 178.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.3 Cg_exo -80.04 -25.94 4.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.556 2.171 . . . . 0.0 112.598 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 50' ' ' ILE . 25.0 pt20 -91.06 16.79 8.97 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.633 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.96 -96.97 1.62 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.426 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.4 -111.68 0.13 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.944 ' CB ' HG12 ' A' ' 49' ' ' VAL . . . -54.01 -35.81 62.29 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.264 1.03 . . . . 0.0 108.665 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.704 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.23 -31.24 63.35 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.449 -1.705 . . . . 0.0 108.785 179.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.19 -40.65 37.01 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.767 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.3 t0 -59.91 -22.99 63.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.91 52.85 8.63 Favored Glycine 0 CA--C 1.495 -1.18 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.602 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.97 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.77 53.32 0.85 Allowed 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -87.66 141.56 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -176.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.7 m-70 130.57 106.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.691 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.62 110.2 18.55 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.404 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.743 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.07 107.06 0.27 Allowed Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 118.282 -1.913 . . . . 0.0 111.004 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -174.51 -169.09 0.42 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.996 -178.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.39 108.26 9.85 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.82 142.44 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.94 -50.76 8.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 112.962 -1.927 . . . . 0.0 107.071 174.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.818 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 152.68 51.94 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 96' ' ' LEU . 13.5 p -123.29 143.64 35.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 28.6 t-20 44.22 17.74 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.05 -25.17 24.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.934 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 82' ' ' GLN . 98.7 t -86.99 142.56 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.5 p -78.7 118.31 20.66 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.91 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -97.33 77.71 2.67 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.89 32.79 1.4 Allowed 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.804 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.49 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.7 17.32 11.31 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.578 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.07 -52.37 5.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.542 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.939 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.83 -99.25 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.53 -179.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.2 t60 17.68 -79.82 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 125.187 1.554 . . . . 0.0 108.537 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.819 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 26.9 tttm -83.42 -62.03 1.69 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.831 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.5 mt-30 -71.69 -55.82 6.98 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -173.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.939 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.44 -49.88 15.54 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.723 -1.591 . . . . 0.0 114.139 -174.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.756 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.7 -46.66 94.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.901 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.819 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 26.7 tt0 -61.94 -33.26 73.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.916 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.831 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.34 -34.43 61.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.221 -175.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 8.3 mt -62.33 -40.36 96.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -75.56 -30.69 59.78 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.49 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.1 m120 -96.56 -4.74 40.73 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.6 p -45.71 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.785 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 102.2 -65.39 0.43 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.45 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.3 pt20 -33.53 -41.36 0.09 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.764 0.793 . . . . 0.0 109.771 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.26 109.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -115.44 136.47 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.305 0 CA-C-O 122.932 1.348 . . . . 0.0 113.533 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.785 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.2 m80 -134.27 115.08 13.7 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.575 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.06 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.18 135.67 54.42 Favored 'General case' 0 N--CA 1.408 -2.529 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -110.24 113.62 26.44 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.386 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.878 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.48 153.03 28.04 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.09 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.602 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 -123.56 109.47 13.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.104 0.954 . . . . 0.0 110.897 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.878 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.75 110.03 3.1 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.361 -1.291 . . . . 0.0 112.144 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.9 37.61 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.788 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.5 mt-30 -54.78 -79.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.452 -0.374 . . . . 0.0 111.176 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -178.17 56.74 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.86 171.65 14.18 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.605 2.203 . . . . 0.0 112.745 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 108' ' ' GLU . 29.3 p -60.06 -31.51 70.07 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.339 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 23.16 10.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.102 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.3 tpmp? 179.91 -54.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.431 ' HB3' HG21 ' A' ' 105' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 t -108.46 31.58 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.36 75.96 11.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.58 111.82 3.07 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.55 2.167 . . . . 0.0 112.306 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.94 132.47 47.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.459 2.106 . . . . 0.0 112.272 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.74 162.98 35.68 Favored Pre-proline 0 CA--C 1.504 -0.817 0 CA-C-O 121.41 0.624 . . . . 0.0 111.314 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.15 -174.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.88 1.72 . . . . 0.0 112.526 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.49 26.86 5.48 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.708 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER 173.26 -138.01 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.47 100.63 4.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.213 1.006 . . . . 0.0 109.293 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 8.7 t80 -118.74 141.78 48.3 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.448 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.027 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.34 151.17 35.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.963 0.347 . . . . 0.0 110.422 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -124.22 110.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.813 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.827 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.6 OUTLIER -116.15 127.87 55.17 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.757 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.84 147.82 33.28 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.045 0.938 . . . . 0.0 109.585 175.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 122.52 47.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -40.53 91.61 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.455 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -136.69 -57.98 0.73 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.975 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -125.03 -35.48 2.65 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 122.064 0.935 . . . . 0.0 108.642 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.679 ' O ' HD12 ' A' ' 15' ' ' LEU . 73.0 m-20 -165.22 153.67 11.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.437 -1.71 . . . . 0.0 108.035 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.679 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.4 t -168.02 35.92 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.09 -179.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.406 -1.725 . . . . 0.0 108.168 -177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.835 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.68 36.77 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.205 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 32.5 pt -118.71 150.45 20.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.765 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 t -102.05 115.3 30.25 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.574 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.981 HG11 HD13 ' A' ' 87' ' ' LEU . 7.8 p -99.85 157.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.096 0.474 . . . . 0.0 112.029 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.3 m 78.53 4.23 2.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.674 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 47' ' ' LYS . 18.7 m -78.72 -39.96 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.75 -12.72 13.31 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.022 0.915 . . . . 0.0 108.996 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.77 -162.92 1.13 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.877 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 27' ' ' THR . 1.0 OUTLIER -103.39 -14.5 16.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 110.451 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -179.01 36.99 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.63 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' CA ' HG13 ' A' ' 44' ' ' ILE . . . 52.13 -99.41 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.859 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.763 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.89 159.01 7.82 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.626 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.017 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.3 p 156.82 -163.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.017 ' H ' HG22 ' A' ' 35' ' ' VAL . 33.2 p-10 -140.07 23.97 2.37 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.7 t -5.42 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 112.122 -2.308 . . . . 0.0 114.176 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.6 m -158.72 35.66 0.22 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.843 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.17 -155.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.843 ' H ' HG22 ' A' ' 39' ' ' VAL . 19.2 ttm180 -126.72 -16.14 5.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 60.9 m-70 -89.86 -27.94 19.58 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.614 0.721 . . . . 0.0 110.58 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.743 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 134.91 -108.35 0.7 Allowed Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.515 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 119.42 67.12 0.3 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.995 1.558 . . . . 0.0 116.995 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.031 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.84 130.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.733 0.778 . . . . 0.0 112.665 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.716 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 53.4 m-85 -124.04 130.53 52.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.799 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.11 -170.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.043 ' HB3' HG21 ' A' ' 28' ' ' VAL . 26.9 pttt -89.14 -18.78 26.5 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.34 -143.27 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 111.866 -2.424 . . . . 0.0 112.094 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.2 m -77.89 137.93 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 117.633 2.457 . . . . 0.0 117.633 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.77 161.77 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 111.123 -2.762 . . . . 0.0 110.886 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.21 -25.93 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.279 1.986 . . . . 0.0 112.53 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.2 pt20 -91.91 17.64 8.93 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.711 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.29 -95.28 1.51 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.446 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.836 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.32 -109.72 0.1 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.935 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.7 61.55 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.375 1.083 . . . . 0.0 108.56 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.7 tt0 -56.48 -31.37 63.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.037 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -40.5 36.48 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.757 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.7 t0 -59.86 -23.05 63.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 174.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.8 52.41 8.2 Favored Glycine 0 CA--C 1.493 -1.326 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.792 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.973 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -117.63 53.72 0.92 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.26 141.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 10.2 m80 131.3 107.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.807 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.45 110.34 18.58 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.453 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.811 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.26 106.45 0.23 Allowed Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.189 -1.957 . . . . 0.0 111.023 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -173.36 -169.36 0.52 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.883 -178.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.32 108.16 9.8 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.031 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.79 142.31 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.36 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.66 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -81.62 -50.9 8.8 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.04 -1.891 . . . . 0.0 107.091 174.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.82 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.88 152.7 51.95 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 96' ' ' LEU . 13.6 p -123.39 143.71 35.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.676 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 17.3 t-20 43.95 18.07 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.131 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.5 -25.78 21.99 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.04 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.654 HG11 ' CD ' ' A' ' 82' ' ' GLN . 95.8 t -86.95 142.67 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.6 m -78.47 117.59 19.82 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -95.96 77.66 3.17 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.7 33.64 1.27 Allowed 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.11 14.49 16.67 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -81.17 -53.5 6.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.107 -0.547 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.946 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.87 -99.57 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.051 0 CA-C-O 119.18 -0.438 . . . . 0.0 111.654 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.8 t60 18.13 -80.33 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 125.105 1.503 . . . . 0.0 108.459 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.779 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 4.4 tptm -83.65 -61.82 1.74 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.808 ' O ' ' HB ' ' A' ' 86' ' ' THR . 8.7 mt-30 -71.5 -55.8 7.16 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.946 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.35 -49.64 16.32 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 117.77 -1.572 . . . . 0.0 114.171 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.36 -44.92 99.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.998 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.779 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.3 tt0 -65.54 -33.19 75.35 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.14 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.808 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.23 -41.59 27.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.272 -175.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.981 HD13 HG11 ' A' ' 26' ' ' VAL . 3.9 pp -59.99 -36.4 77.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.878 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.0 -31.15 56.28 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.447 178.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.39 -2.01 46.47 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -177.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.981 HG22 HG21 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -40.72 166.5 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.825 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.679 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.67 -64.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.474 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 5.3 pt20 -33.98 -40.87 0.09 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.728 0.775 . . . . 0.0 109.579 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.9 p 170.59 105.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.356 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -114.83 136.88 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 CA-C-O 123.033 1.397 . . . . 0.0 113.879 -174.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.827 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 60.3 m80 -133.96 114.82 13.67 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 111.551 -2.568 . . . . 0.0 110.137 175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.027 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.68 137.22 54.75 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -177.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.6 mt -111.27 113.78 26.5 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.442 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.39 153.11 27.81 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.196 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.3 mt-10 -124.28 110.62 14.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.085 0.945 . . . . 0.0 111.077 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.806 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.69 109.93 3.03 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.221 -179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.95 37.41 0.66 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.793 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 2.3 mt-30 -56.04 -40.94 74.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.146 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.91 127.8 5.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.84 170.52 0.61 Allowed 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 122.52 2.146 . . . . 0.0 112.786 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -174.3 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.388 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.98 30.88 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -176.75 -54.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.921 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m -151.4 146.95 26.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.24 163.94 1.45 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.47 110.57 2.09 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.597 2.198 . . . . 0.0 112.244 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.52 59.32 6.15 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.479 2.119 . . . . 0.0 112.438 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.36 140.13 21.18 Favored Pre-proline 0 CA--C 1.503 -0.841 0 CA-C-O 121.59 0.71 . . . . 0.0 111.304 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.1 178.38 0.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.157 1.904 . . . . 0.0 112.799 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 97.66 23.57 13.64 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.733 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 172.8 -141.54 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.824 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.91 100.77 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.367 1.079 . . . . 0.0 109.032 178.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.7 t80 -119.14 145.61 45.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.931 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.081 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -114.83 151.08 34.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.248 0.476 . . . . 0.0 110.617 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.966 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.03 109.72 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.652 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.764 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 13.4 pt-20 -116.68 128.5 55.41 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.59 148.53 34.49 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.005 0.922 . . . . 0.0 109.452 175.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.98 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.43 121.7 45.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.7 OUTLIER -41.12 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.419 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.0 t-20 -137.03 -57.61 0.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.007 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.29 -35.95 2.72 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 122.114 0.959 . . . . 0.0 108.569 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.707 ' O ' HD12 ' A' ' 15' ' ' LEU . 28.8 m120 -164.76 153.86 12.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.302 -1.772 . . . . 0.0 108.101 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.621 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.8 t -167.49 35.6 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.846 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.21 -179.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.325 -1.762 . . . . 0.0 108.095 -177.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.829 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.78 36.6 0.05 OUTLIER Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.991 HG22 ' HA ' ' A' ' 49' ' ' VAL . 22.8 pt -118.44 150.34 20.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.347 0.594 . . . . 0.0 112.463 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.771 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.1 t -101.32 114.02 27.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.959 HG21 HD13 ' A' ' 87' ' ' LEU . 14.7 p -99.75 157.59 3.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.149 0.5 . . . . 0.0 111.87 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 31' ' ' ASP . 14.4 m 78.3 2.84 2.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.538 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.019 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.8 m -76.01 -38.68 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.1 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.1 mt -112.79 -10.9 13.55 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.128 0.966 . . . . 0.0 108.716 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 1.8 t80 -133.71 -174.01 3.4 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.877 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 27' ' ' THR . 1.1 t0 -86.42 -26.56 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.052 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -171.85 47.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 50.07 -103.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.501 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.614 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -57.63 164.64 6.97 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 121.769 -0.253 . . . . 0.0 113.54 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.59 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.008 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.1 t-20 -144.75 25.48 1.46 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.583 ' H ' HG13 ' A' ' 35' ' ' VAL . 1.2 t -12.98 -52.67 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 111.947 -2.388 . . . . 0.0 113.975 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -166.14 36.28 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.845 HG22 ' H ' ' A' ' 40' ' ' ARG . 6.0 p -134.1 -154.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.955 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.845 ' H ' HG22 ' A' ' 39' ' ' VAL . 41.3 ttm-85 -132.17 0.18 3.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' H ' HG13 ' A' ' 39' ' ' VAL . 50.4 m-70 -110.54 -23.22 11.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.403 0.62 . . . . 0.0 111.038 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 75' ' ' LEU . . . 139.39 -108.83 0.61 Allowed Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 127.99 55.48 0.12 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 118.592 -1.766 . . . . 0.0 117.485 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.075 HG22 HG22 ' A' ' 67' ' ' VAL . 1.1 tt -69.81 126.39 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.75 1.275 . . . . 0.0 111.911 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.887 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 91.4 m-85 -123.48 129.8 51.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.106 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.998 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.3 p -155.53 -170.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.019 ' HB3' HG21 ' A' ' 28' ' ' VAL . 27.0 pttt -89.82 -18.56 26.02 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.998 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.05 -144.57 0.01 OUTLIER 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 111.983 -2.372 . . . . 0.0 112.252 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.991 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.0 137.92 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -174.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.23 162.03 0.1 OUTLIER Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 111.114 -2.766 . . . . 0.0 110.945 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.1 Cg_exo -80.15 -26.1 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.38 2.053 . . . . 0.0 112.828 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.6 pp0? -93.26 18.16 9.99 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.928 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 102.31 -96.85 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.699 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.846 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.42 -111.41 0.12 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.68 -35.79 61.47 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.295 1.045 . . . . 0.0 108.724 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.45 -31.11 63.66 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.006 179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.21 -40.91 36.09 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.765 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.2 t0 -59.91 -23.2 63.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.32 53.01 7.97 Favored Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.612 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.966 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.28 52.74 0.95 Allowed 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.96 141.55 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.116 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.9 m-70 130.49 108.06 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.632 -2.076 . . . . 0.0 109.968 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.48 110.31 18.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.819 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.14 104.39 0.19 Allowed Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 118.202 -1.952 . . . . 0.0 111.165 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -168.87 -169.95 1.08 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.834 -178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.0 108.29 9.99 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.35 141.83 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.491 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 177.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.824 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -83.48 -50.99 7.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.901 174.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.873 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.27 149.4 50.93 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.082 HG23 HD11 ' A' ' 96' ' ' LEU . 9.5 p -123.04 143.6 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.746 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 34.8 t30 49.66 14.66 0.12 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 0.0 110.47 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.37 -22.07 35.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.045 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.648 HG11 ' CD ' ' A' ' 82' ' ' GLN . 78.9 t -86.73 142.84 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 2.9 t -78.87 115.97 18.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.99 77.23 3.55 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.524 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 11.0 mt-10 -91.75 38.84 0.99 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.619 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.97 13.26 27.73 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -78.06 -53.46 7.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.609 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.949 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.78 -99.88 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.111 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.9 t60 17.92 -80.15 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 125.127 1.517 . . . . 0.0 108.512 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.079 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 15.1 ttpt -83.8 -61.71 1.76 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.068 ' O ' HG22 ' A' ' 86' ' ' THR . 28.8 mt-30 -71.44 -55.57 7.64 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.949 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.29 -48.21 20.94 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.315 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.752 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.15 -40.79 90.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.461 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.079 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 19.2 tt0 -61.57 -36.63 81.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.526 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.068 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -67.95 -39.69 83.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.411 -176.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.959 HD13 HG21 ' A' ' 26' ' ' VAL . 6.3 mt -61.54 -38.33 87.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -76.93 -30.98 56.32 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.187 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.34 -10.41 17.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.046 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -37.18 155.72 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.964 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.45 -63.1 0.31 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.918 -1.134 . . . . 0.0 113.504 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.5 pm0 -34.16 -42.51 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.787 0.803 . . . . 0.0 109.758 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.29 109.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.387 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.046 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.49 136.89 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.377 0 CA-C-O 122.935 1.35 . . . . 0.0 113.677 -174.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.764 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 64.7 m80 -133.48 115.73 15.12 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 111.958 -2.383 . . . . 0.0 110.607 176.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.082 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.69 135.82 51.65 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.3 mt -110.06 113.34 25.97 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.625 174.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.958 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -112.45 146.47 38.35 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.285 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -111.97 110.02 20.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.02 0.914 . . . . 0.0 110.344 177.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.958 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.87 107.94 2.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.446 -178.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.46 31.58 2.23 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.372 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -61.74 -171.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.964 -0.618 . . . . 0.0 110.954 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.9 p -104.17 89.94 2.81 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.877 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.15 137.45 34.34 Favored 'Trans proline' 0 CA--C 1.502 -1.117 0 C-N-CA 122.831 2.354 . . . . 0.0 112.937 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 49.54 34.83 7.39 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.603 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.5 t -82.97 -29.51 28.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.769 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -40.93 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.92 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.49 -46.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.793 0.33 . . . . 0.0 110.939 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.407 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 2.0 t -178.05 -61.92 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 45.0 Cg_endo -67.96 173.93 8.55 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.445 2.097 . . . . 0.0 112.271 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.16 90.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -129.89 161.28 60.62 Favored Pre-proline 0 CA--C 1.504 -0.793 0 CA-C-O 121.425 0.631 . . . . 0.0 111.284 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.49 171.88 1.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 121.912 1.742 . . . . 0.0 112.643 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.619 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 118.84 29.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.711 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.2 t0 172.88 -132.28 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.54 99.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.033 0.921 . . . . 0.0 109.406 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 10.3 t80 -119.15 138.65 52.78 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.016 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -115.05 151.26 34.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.138 178.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.976 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.13 109.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.114 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.792 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 16.4 pt-20 -116.82 126.75 53.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.57 148.56 34.55 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.688 175.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.973 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.0 121.9 46.11 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.0 OUTLIER -40.26 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.371 -178.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.6 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -135.59 -57.64 0.78 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.828 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -122.75 -36.79 2.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.3 m120 -166.8 154.96 9.89 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.831 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.642 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.13 34.52 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.16 0.981 . . . . 0.0 108.417 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.72 179.72 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.158 -177.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.66 37.82 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.001 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -117.72 149.36 20.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.6 t -100.89 114.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.526 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.05 HG11 HD13 ' A' ' 87' ' ' LEU . 7.2 p -99.66 157.82 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.516 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.829 HG23 ' O ' ' A' ' 31' ' ' ASP . 1.4 m 81.61 -3.6 1.61 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.612 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.076 HG21 ' HB3' ' A' ' 47' ' ' LYS . 22.8 m -70.94 -41.89 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.26 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.9 mt -112.98 -13.86 13.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.965 0.888 . . . . 0.0 108.873 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.02 -167.35 1.62 Allowed 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.964 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -100.81 -22.33 14.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.926 0.393 . . . . 0.0 110.227 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -168.11 38.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 50.37 -100.88 0.04 OUTLIER Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.193 -1.004 . . . . 0.0 110.913 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.69 160.16 6.78 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.098 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.019 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.1 p 156.08 -162.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.019 ' H ' HG22 ' A' ' 35' ' ' VAL . 21.0 p-10 -141.18 24.31 2.14 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 104.155 -2.535 . . . . 0.0 104.155 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -2.72 -53.69 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 112.189 -2.278 . . . . 0.0 114.098 -175.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -170.64 41.16 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG13 ' H ' ' A' ' 41' ' ' HIS . 2.6 p -131.11 -154.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.5 ttt-85 -133.5 32.71 3.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.0 111.194 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.785 ' H ' HG13 ' A' ' 39' ' ' VAL . 37.4 m-70 -148.45 -27.63 0.32 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.033 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.76 -109.77 0.83 Allowed Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.806 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 110.71 82.76 1.33 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.035 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -77.19 132.5 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.438 0.637 . . . . 0.0 111.888 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.72 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.2 m-85 -123.79 136.7 54.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.806 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.941 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.9 p -162.09 -171.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.076 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.17 -19.29 23.24 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.941 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.33 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.933 0 CA-C-N 112.015 -2.357 . . . . 0.0 112.67 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.001 ' HA ' HG22 ' A' ' 24' ' ' ILE . 7.8 m -77.51 138.02 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.67 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.5 162.01 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.512 0 CA-C-N 111.058 -2.792 . . . . 0.0 110.793 177.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.19 -25.95 5.5 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.282 1.988 . . . . 0.0 112.545 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.559 ' N ' HG23 ' A' ' 50' ' ' ILE . 30.0 pt20 -91.88 17.66 8.87 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.74 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.28 -94.46 1.41 Allowed Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.412 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.54 -109.75 0.1 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.48 -35.75 60.93 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.42 1.105 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.702 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.8 tt0 -56.52 -31.28 63.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.905 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -78.28 -40.55 36.64 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.726 ' HA ' HD23 ' A' ' 15' ' ' LEU . 4.5 t0 -59.91 -23.16 63.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.52 52.29 8.64 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.634 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.21 55.97 0.93 Allowed 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.25 141.27 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.157 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -176.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.646 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.1 m-70 132.3 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.115 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.54 110.41 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.563 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.708 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.67 104.07 0.18 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 118.233 -1.937 . . . . 0.0 110.884 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.51 -170.62 1.1 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.391 -0.404 . . . . 0.0 110.551 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.25 108.16 9.82 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.035 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.3 142.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 C-N-CA 126.36 1.864 . . . . 0.0 115.974 177.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.711 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.24 -48.7 8.84 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.225 -1.807 . . . . 0.0 107.879 174.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.891 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.29 149.22 50.89 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 96' ' ' LEU . 10.3 p -123.24 143.67 35.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.784 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.0 t30 48.74 16.11 0.11 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.982 0.42 . . . . 0.0 110.659 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.65 -21.52 40.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.928 -1.129 . . . . 0.0 112.018 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 ' CD ' ' A' ' 82' ' ' GLN . 71.4 t -86.8 142.64 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.1 m -78.99 114.95 18.35 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.941 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -94.24 77.59 3.98 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -94.55 33.76 1.39 Allowed 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.653 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.52 23.36 6.62 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.99 -53.91 4.37 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.237 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.951 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 22.38 -100.46 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.114 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.461 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.5 t60 18.61 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 125.162 1.538 . . . . 0.0 108.371 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.126 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 1.0 OUTLIER -83.77 -61.83 1.73 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.053 ' O ' HG22 ' A' ' 86' ' ' THR . 7.5 mt-30 -71.51 -55.5 7.73 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 -173.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.1 -47.81 23.08 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 118.532 -1.267 . . . . 0.0 114.285 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.12 -39.07 84.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.437 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.126 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.5 tt0 -61.61 -36.61 81.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.001 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.053 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -71.74 -42.94 66.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.02 -176.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.05 HD13 HG11 ' A' ' 26' ' ' VAL . 3.1 pp -62.09 -35.91 80.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.662 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.665 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.6 mtt85 -77.3 -31.33 54.64 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.405 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.7 m-80 -106.79 -6.27 17.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.066 HG22 HG21 ' A' ' 94' ' ' VAL . 0.7 OUTLIER -35.49 155.1 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.884 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.81 -62.48 0.33 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.803 -1.189 . . . . 0.0 113.234 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.4 pt20 -34.48 -41.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.761 0.791 . . . . 0.0 109.742 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG23 ' HA ' ' A' ' 16' ' ' ALA . 2.1 p 171.71 108.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.317 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.066 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.56 136.79 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-O 123.002 1.382 . . . . 0.0 113.628 -174.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.792 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.6 m80 -133.79 115.75 14.89 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.599 175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.87 138.32 52.64 Favored 'General case' 0 N--CA 1.412 -2.334 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.9 mt -111.75 113.87 26.51 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.313 174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -112.42 153.18 27.74 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.172 -178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.711 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -125.76 115.74 20.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.376 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.81 122.96 18.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.264 -179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -166.43 33.97 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.802 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 16.6 mt-30 -51.71 128.35 23.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.657 -0.772 . . . . 0.0 111.26 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.406 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -63.53 -61.45 7.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 58.8 Cg_endo -71.31 169.92 19.58 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.596 2.198 . . . . 0.0 112.853 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -69.22 0.26 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.673 -1.148 . . . . 0.0 111.342 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.7 t -134.77 -44.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.897 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -128.96 -67.05 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.853 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.2 m -128.96 -75.13 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.956 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.13 65.41 2.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.976 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 31.9 Cg_exo -57.31 -47.15 23.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.566 2.178 . . . . 0.0 112.583 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 4' ' ' PRO . 93.5 Cg_endo -80.65 95.23 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.346 2.031 . . . . 0.0 112.499 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -127.59 158.99 68.26 Favored Pre-proline 0 CA--C 1.505 -0.781 0 CA-C-O 121.421 0.629 . . . . 0.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.21 149.23 81.85 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.79 1.66 . . . . 0.0 112.643 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.588 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.66 26.44 6.81 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.726 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 3.9 t0 170.82 -129.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.614 ' CG2' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.37 100.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.502 1.144 . . . . 0.0 108.928 178.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.786 ' CE2' HG12 ' A' ' 13' ' ' VAL . 39.3 t80 -119.26 155.38 31.88 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.923 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.064 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.21 150.9 51.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.559 0.618 . . . . 0.0 110.478 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.913 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.1 110.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.122 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.767 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.5 pt-20 -116.53 127.05 54.18 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -144.42 148.86 35.17 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.018 0.927 . . . . 0.0 109.515 175.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.001 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.76 123.33 48.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.43 91.68 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.329 -178.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 16' ' ' ALA . 27.1 t-20 -136.9 -57.65 0.72 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.157 -0.928 . . . . 0.0 112.045 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -124.58 -35.52 2.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.088 0.947 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.604 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 80.5 m-20 -165.07 155.04 13.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.017 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.664 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -168.93 37.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.71 179.57 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.199 -177.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.845 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.32 36.77 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.281 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.0 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -119.28 149.36 21.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -101.94 115.32 30.28 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.495 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.866 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.4 p -99.78 157.62 3.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.3 m 79.65 1.43 2.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.519 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.062 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.0 m -75.23 -43.25 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.208 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -110.48 -14.22 14.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 122.082 0.944 . . . . 0.0 108.586 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.5 -168.75 1.82 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.041 179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -96.86 -22.66 16.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.937 0.399 . . . . 0.0 110.187 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -170.08 39.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.866 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 51.05 -102.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.163 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.24 159.8 4.89 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.433 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.049 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 159.4 -160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.049 ' H ' HG22 ' A' ' 35' ' ' VAL . 12.9 t30 -143.52 26.03 1.63 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 175.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.3 t -9.86 -53.55 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.003 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.6 m -165.07 46.32 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.6 p -143.55 -151.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.829 ' H ' HG22 ' A' ' 39' ' ' VAL . 42.0 ttt-85 -129.28 -6.41 4.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' H ' HG13 ' A' ' 39' ' ' VAL . 51.7 m-70 -106.72 -24.66 12.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.407 0.622 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.724 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 133.08 -107.87 0.72 Allowed Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.83 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.56 82.36 1.06 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 117.199 1.639 . . . . 0.0 117.199 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.093 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -79.35 132.75 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.484 0.659 . . . . 0.0 112.37 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.715 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.79 134.23 53.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.42 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.949 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.7 p -159.47 -171.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.062 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.0 ptmt -91.33 -19.96 22.38 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.949 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.54 -141.26 0.01 OUTLIER 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 111.986 -2.37 . . . . 0.0 112.236 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.0 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.4 m -77.81 137.94 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.667 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.58 161.64 0.14 Allowed Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 111.012 -2.813 . . . . 0.0 110.998 177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.56 -25.95 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.419 2.079 . . . . 0.0 112.562 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.553 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.8 pt20 -91.47 17.1 9.05 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.162 -1.381 . . . . 0.0 112.688 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.87 -95.24 1.46 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.389 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.01 -110.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.73 -35.83 61.63 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 122.282 1.039 . . . . 0.0 108.71 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 1.5 tm-20 -56.31 -31.25 63.5 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.078 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -78.23 -40.97 35.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.747 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.8 t0 -60.17 -23.08 63.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 174.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.9 53.65 7.01 Favored Glycine 0 CA--C 1.494 -1.268 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.764 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.913 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -116.56 52.21 0.94 Allowed 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.66 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -87.94 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.178 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -176.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 14.5 m80 129.42 105.57 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 112.593 -2.094 . . . . 0.0 109.957 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.89 110.23 17.7 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.384 179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 80.27 107.04 0.28 Allowed Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 118.186 -1.959 . . . . 0.0 110.846 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.33 -170.63 0.63 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.676 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.83 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.07 108.33 10.0 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.093 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.92 142.5 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.275 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 177.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -85.93 -47.78 9.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 112.904 -1.953 . . . . 0.0 107.389 174.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.782 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.98 151.52 51.5 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 96' ' ' LEU . 13.2 p -123.74 143.58 36.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.691 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 27.3 t-20 43.53 18.51 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.8 -24.52 28.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.946 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 82' ' ' GLN . 91.1 t -86.57 142.35 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.3 m -78.83 116.41 19.15 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.892 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.6 77.81 2.92 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 17.6 mt-10 -93.21 33.37 1.21 Allowed 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.93 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.517 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.55 19.9 9.45 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.567 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.42 -52.89 4.94 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.945 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.81 -98.95 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.08 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.646 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 17.42 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 125.241 1.588 . . . . 0.0 108.533 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.811 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.8 tptt -83.48 -62.07 1.68 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.831 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.4 mt-30 -71.66 -55.73 7.18 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.945 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.84 15.65 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 117.668 -1.613 . . . . 0.0 114.218 -174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.57 -45.94 96.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.875 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.811 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.1 tt0 -63.33 -33.23 75.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.083 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.831 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -75.41 -37.46 60.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 119.572 -0.851 . . . . 0.0 112.269 -175.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.722 HD21 HG21 ' A' ' 70' ' ' VAL . 5.1 mt -62.07 -38.38 88.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -30.78 58.55 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.556 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -97.93 -3.91 37.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.27 175.16 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.913 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.664 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.38 -64.78 0.38 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.985 -1.103 . . . . 0.0 113.365 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' GLY . 5.5 pt20 -33.47 -42.56 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.727 0.775 . . . . 0.0 109.645 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.001 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.19 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.325 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.73 136.78 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.327 0 CA-C-O 122.907 1.337 . . . . 0.0 113.756 -174.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.767 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.7 m80 -134.2 114.89 13.56 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.465 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.064 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -124.65 136.95 54.35 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD23 ' CB ' ' A' ' 12' ' ' GLU . 19.6 mt -112.92 113.01 24.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.398 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.894 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -110.42 151.14 27.86 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.701 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.703 ' CG ' HD22 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -120.65 114.68 22.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.07 0.938 . . . . 0.0 111.218 178.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.726 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.76 109.95 3.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.238 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.35 36.06 0.81 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.936 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 5.2 mm100 -69.43 -75.42 0.11 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.371 -0.414 . . . . 0.0 111.161 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t -92.98 149.09 37.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.684 ' O ' HG23 ' A' ' 105' ' ' THR . 71.3 Cg_endo -71.78 67.31 3.09 Favored 'Trans proline' 0 CA--C 1.501 -1.13 0 C-N-CA 122.709 2.273 . . . . 0.0 112.75 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -174.87 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.359 177.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.8 t 63.06 37.52 11.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.748 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -167.7 -41.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.824 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.911 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.433 -0.267 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.5 m -119.06 111.05 17.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.72 86.96 0.26 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.41 148.59 25.74 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.513 2.142 . . . . 0.0 112.311 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 51.2 Cg_exo -54.24 157.19 11.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.492 2.128 . . . . 0.0 112.288 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -138.92 161.47 57.97 Favored Pre-proline 0 CA--C 1.505 -0.779 0 CA-C-O 121.338 0.59 . . . . 0.0 111.184 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.15 179.68 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.745 1.63 . . . . 0.0 112.543 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 106.51 23.27 7.31 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.766 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.5 OUTLIER 172.48 -137.76 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.719 HD11 HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.59 100.5 4.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.307 1.051 . . . . 0.0 109.229 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 7.8 t80 -119.17 142.92 47.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.071 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -116.0 151.1 36.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.13 0.423 . . . . 0.0 110.251 178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -123.02 109.92 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.885 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 17.7 pt-20 -116.45 127.4 54.55 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.53 148.85 34.97 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 123.97 0.908 . . . . 0.0 109.463 175.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.81 122.96 48.27 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.67 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.339 -178.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 22.2 t-20 -137.07 -57.39 0.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.986 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -35.55 2.69 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 122.122 0.963 . . . . 0.0 108.611 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 29.9 m120 -164.88 154.35 13.13 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.107 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.613 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.3 t -168.47 36.59 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 165.9 179.93 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.294 -1.776 . . . . 0.0 108.143 -177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.834 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.52 36.26 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.202 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.985 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -118.83 149.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.757 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.0 m -102.51 116.03 31.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.629 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.964 ' HA ' HG23 ' A' ' 46' ' ' VAL . 7.6 p -99.75 157.62 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.355 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.483 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.9 m 80.93 -0.21 1.78 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.58 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.015 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.61 -39.68 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.265 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -114.03 -12.44 12.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.006 0.908 . . . . 0.0 109.173 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.712 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.08 -162.84 1.16 Allowed 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.156 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 4.7 m-20 -105.3 -13.21 15.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.855 0.359 . . . . 0.0 110.545 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -177.43 31.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.932 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 56.55 -101.1 0.13 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.468 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.79 160.68 5.15 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.647 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.051 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.35 -161.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.051 ' H ' HG22 ' A' ' 35' ' ' VAL . 20.0 t-20 -143.9 25.96 1.57 Allowed 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.4 t -9.95 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 112.095 -2.32 . . . . 0.0 113.195 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 9.0 m -165.48 69.96 0.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.178 0.514 . . . . 0.0 111.865 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.928 HG22 ' H ' ' A' ' 40' ' ' ARG . 8.0 p -165.07 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.826 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.928 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -128.15 0.56 5.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.517 ' H ' HG13 ' A' ' 39' ' ' VAL . 46.8 m-70 -115.54 -26.16 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.254 0.549 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 132.98 -108.04 0.73 Allowed Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.783 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 113.67 83.54 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.3 133.31 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.383 0.611 . . . . 0.0 111.813 177.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.712 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.6 m-85 -123.8 130.98 53.47 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.888 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.995 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.4 p -156.58 -170.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.015 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.1 ptmt -89.36 -18.75 26.27 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.995 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.26 -143.63 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 111.892 -2.413 . . . . 0.0 112.011 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.985 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.8 m -78.02 137.8 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -40.68 161.59 0.11 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 111.143 -2.753 . . . . 0.0 111.054 177.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.7 Cg_exo -79.56 -25.83 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.397 2.065 . . . . 0.0 112.611 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.554 ' N ' HG23 ' A' ' 50' ' ' ILE . 12.5 pt20 -91.56 17.2 9.04 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.593 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.83 -95.35 1.48 Allowed Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.422 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.21 -110.56 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.7 -35.83 61.55 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.379 1.085 . . . . 0.0 108.622 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.724 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -56.35 -31.19 63.54 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.29 -1.777 . . . . 0.0 108.956 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.34 -40.7 35.71 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.1 t0 -59.89 -23.18 63.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.76 52.78 7.82 Favored Glycine 0 CA--C 1.495 -1.183 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.714 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.963 ' HA ' HG11 ' A' ' 13' ' ' VAL . 13.3 ttm180 -117.08 52.27 0.96 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.639 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -86.46 141.65 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.069 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.6 m-70 130.35 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.046 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.71 110.32 18.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.828 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.07 103.73 0.19 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 118.253 -1.927 . . . . 0.0 110.788 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -168.7 -170.28 1.17 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.673 -178.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.783 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.14 108.31 9.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.08 142.27 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 126.574 1.95 . . . . 0.0 115.666 177.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -85.91 -47.18 9.89 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.7 174.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.803 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.03 149.55 52.19 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.017 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.29 143.88 34.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.68 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER 44.49 18.52 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.918 -178.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.81 -23.44 32.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.617 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 82' ' ' GLN . 94.8 t -86.72 142.49 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 45.9 m -78.98 115.69 18.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.913 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -96.21 77.8 3.08 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 1.4 tt0 -93.35 33.09 1.26 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.888 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.524 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.61 17.22 12.46 Favored Glycine 0 N--CA 1.434 -1.476 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.559 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.2 -53.15 5.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.019 -0.591 . . . . 0.0 110.6 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.932 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.31 -99.02 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.124 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.584 -179.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.5 t60 17.57 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 125.197 1.56 . . . . 0.0 108.605 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 23.7 tptt -83.51 -62.05 1.68 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.792 ' O ' ' HB ' ' A' ' 86' ' ' THR . 10.0 mt-30 -71.62 -55.79 7.09 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.932 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.45 -49.83 15.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 C-N-CA 117.627 -1.629 . . . . 0.0 114.252 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.759 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.51 -46.45 95.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.969 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.6 tt0 -62.5 -33.25 74.51 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.022 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -76.22 -36.95 58.33 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.461 -175.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.9 mt -61.05 -38.29 85.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -30.84 58.54 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.752 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -98.35 -4.73 34.27 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.853 HG22 ' CG2' ' A' ' 94' ' ' VAL . 3.1 p -44.81 174.83 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.88 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 103.37 -64.89 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.372 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.0 pt20 -33.74 -41.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.994 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 173.8 109.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.326 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.853 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.47 136.47 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-O 122.955 1.36 . . . . 0.0 113.747 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.768 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.1 m80 -134.15 115.12 13.85 Favored 'General case' 0 C--N 1.283 -2.293 0 CA-C-N 112.077 -2.329 . . . . 0.0 110.583 175.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.071 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.09 136.13 53.35 Favored 'General case' 0 N--CA 1.41 -2.471 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.658 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.1 mt -109.71 113.67 26.63 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.597 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.917 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -114.43 150.01 35.36 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.509 -178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -116.71 121.23 41.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.241 1.019 . . . . 0.0 110.261 176.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.917 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -78.04 110.78 13.28 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.579 -177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.02 35.56 0.84 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.696 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 10.9 mt-30 -53.47 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.153 -0.524 . . . . 0.0 111.306 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -90.97 -51.83 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 103' ' ' SER . 49.2 Cg_exo -54.14 166.18 1.74 Allowed 'Trans proline' 0 CA--C 1.5 -1.214 0 C-N-CA 122.507 2.138 . . . . 0.0 112.97 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.3 m -71.62 77.47 0.82 Allowed 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.297 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.26 -60.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.013 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -167.5 33.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.921 179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -138.2 31.48 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 152.99 38.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 32.0 Cg_exo -57.06 -47.1 24.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.521 2.147 . . . . 0.0 112.629 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 4' ' ' PRO . 96.8 Cg_endo -80.63 92.04 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.322 2.014 . . . . 0.0 112.371 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 157.41 42.76 Favored Pre-proline 0 CA--C 1.502 -0.867 0 CA-C-O 121.367 0.604 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -86.94 178.73 3.52 Favored 'Trans proline' 0 N--CA 1.432 -2.141 0 C-N-CA 121.752 1.635 . . . . 0.0 112.965 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.526 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.42 24.85 6.28 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.755 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.7 OUTLIER 172.68 -135.96 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -79.52 100.01 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 122.256 1.027 . . . . 0.0 109.285 179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 13' ' ' VAL . 12.0 t80 -119.46 140.61 50.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.494 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -114.65 151.23 33.9 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.982 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.967 HG22 ' HB2' ' A' ' 96' ' ' LEU . 1.3 m -124.15 109.9 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.989 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.77 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 16.6 pt-20 -116.04 128.54 55.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.846 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.68 147.72 33.37 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.247 1.019 . . . . 0.0 109.677 175.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.35 123.44 48.83 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -42.6 91.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.359 -178.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 t-20 -137.57 -57.37 0.69 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.111 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.56 -34.36 2.67 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.01 0.909 . . . . 0.0 108.658 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.846 ' O ' HD12 ' A' ' 15' ' ' LEU . 72.3 m-80 -164.42 155.44 15.29 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.041 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.629 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.2 t -169.35 37.43 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.83 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 165.18 -179.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 113.213 -1.812 . . . . 0.0 108.084 -177.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.818 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.07 35.76 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.976 HG22 ' HA ' ' A' ' 49' ' ' VAL . 21.9 pt -120.39 149.44 23.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.306 0.575 . . . . 0.0 112.492 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.0 m -100.34 114.6 28.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 46' ' ' VAL . 12.0 p -99.46 157.45 3.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.481 . . . . 0.0 111.694 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 31' ' ' ASP . 7.2 m 78.79 1.68 2.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.563 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -74.76 -38.25 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.3 mt -113.54 -10.94 13.11 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.974 0.893 . . . . 0.0 108.811 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.897 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 2.2 t80 -133.19 -176.3 4.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.965 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 27' ' ' THR . 5.4 m-20 -82.98 -24.14 33.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 111.099 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.93 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.36 -102.46 0.08 OUTLIER Glycine 0 CA--C 1.522 0.499 0 C-N-CA 119.946 -1.121 . . . . 0.0 111.269 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -54.28 164.63 2.91 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.369 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.031 HG22 ' H ' ' A' ' 36' ' ' ASN . 4.6 p 160.64 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.031 ' H ' HG22 ' A' ' 35' ' ' VAL . 10.0 p-10 -141.76 22.45 2.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.685 ' H ' HG13 ' A' ' 35' ' ' VAL . 13.0 t 1.43 -53.78 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.217 -2.265 . . . . 0.0 114.052 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' ASN . 2.0 m 178.17 39.83 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.191 0.519 . . . . 0.0 110.808 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.809 HG13 ' H ' ' A' ' 41' ' ' HIS . 3.3 p -131.89 -153.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.116 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -134.32 32.13 3.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.178 0.513 . . . . 0.0 111.022 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.809 ' H ' HG13 ' A' ' 39' ' ' VAL . 52.0 m-70 -143.03 -34.54 0.42 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.845 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 149.36 -107.91 0.38 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.659 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.852 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 123.97 66.47 0.2 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.016 HG22 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -75.83 128.77 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.217 1.009 . . . . 0.0 111.865 177.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.897 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 66.4 m-85 -123.61 128.33 49.54 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.035 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' N ' ' A' ' 48' ' ' ALA . 1.2 p -154.26 -170.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -172.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.03 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.5 ptmt -89.15 -18.92 26.2 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.013 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.91 -144.67 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.731 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.213 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.976 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.0 m -77.91 137.91 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.666 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.39 161.39 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-N 110.962 -2.835 . . . . 0.0 111.02 177.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.5 Cg_exo -79.87 -25.84 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.456 2.104 . . . . 0.0 112.59 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 50' ' ' ILE . 28.2 pt20 -91.55 17.13 9.12 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.69 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 100.31 -95.83 1.51 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.428 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.24 -111.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.95 -35.89 62.25 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.338 1.066 . . . . 0.0 108.709 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.8 tt0 -56.34 -31.31 63.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.016 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.29 -40.72 36.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.795 ' HA ' HD23 ' A' ' 15' ' ' LEU . 24.9 t0 -60.02 -22.96 63.28 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.71 54.29 7.53 Favored Glycine 0 CA--C 1.494 -1.225 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.345 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' A' ' 13' ' ' VAL . 28.9 ttm180 -118.45 52.77 1.01 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.65 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -86.73 141.49 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.095 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -176.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.65 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 2.6 m-70 131.64 107.72 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.684 -2.053 . . . . 0.0 109.931 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -84.59 110.32 18.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.443 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.837 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.22 104.44 0.19 Allowed Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 118.209 -1.948 . . . . 0.0 110.928 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -169.79 -169.28 0.87 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.561 -0.32 . . . . 0.0 110.962 -178.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.852 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -129.95 108.55 10.2 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.016 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -83.21 142.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.441 0 C-N-CA 126.401 1.881 . . . . 0.0 115.715 177.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -84.06 -48.55 9.78 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.51 174.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.53 150.23 51.68 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.971 HG23 HD11 ' A' ' 96' ' ' LEU . 14.7 p -123.35 143.76 35.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.67 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 34.8 t-20 45.08 17.32 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.863 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.15 -24.75 25.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.837 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 82' ' ' GLN . 89.3 t -86.67 142.34 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.85 116.41 19.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.876 HD11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -97.34 77.33 2.64 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 36' ' ' ASN . 0.9 OUTLIER -92.07 36.49 0.98 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 107.78 8.97 29.34 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.609 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -75.41 -53.13 9.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.984 -0.608 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.971 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 19.69 -99.37 0.0 OUTLIER 'General case' 0 CA--C 1.47 -2.096 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.459 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.672 ' C ' ' O ' ' A' ' 79' ' ' THR . 8.0 t60 17.04 -79.98 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 125.172 1.545 . . . . 0.0 108.501 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.791 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 11.4 tttt -83.48 -61.89 1.72 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.887 ' O ' ' HB ' ' A' ' 86' ' ' THR . 31.6 mt-30 -71.47 -55.93 6.93 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.971 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.42 -49.83 15.7 Favored 'General case' 0 CA--C 1.484 -1.593 0 C-N-CA 117.8 -1.56 . . . . 0.0 114.157 -174.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.821 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.72 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.846 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.791 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.4 tt0 -64.72 -33.52 76.17 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.99 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.887 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.4 -39.51 62.61 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.014 -175.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.821 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -60.39 -37.46 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -30.92 57.6 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.702 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m-20 -98.56 -5.11 32.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.864 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.9 174.99 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.968 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.89 -65.13 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.455 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 16.0 pt20 -33.16 -42.1 0.08 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.665 0.745 . . . . 0.0 109.889 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.68 109.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.308 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.864 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.44 137.19 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.397 0 CA-C-O 122.866 1.317 . . . . 0.0 113.948 -174.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.77 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.67 115.01 14.11 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 112.137 -2.302 . . . . 0.0 110.42 175.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -121.7 135.89 54.95 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.686 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.7 mt -110.71 114.06 27.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.641 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.928 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -114.43 152.07 32.15 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.67 -178.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.616 ' HG3' HD22 ' A' ' 68' ' ' LEU . 7.0 mt-10 -119.57 116.18 25.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.251 177.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.928 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -73.39 111.12 8.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.622 -178.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.57 35.72 1.02 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.805 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 8.1 mt-30 -58.22 -173.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.367 -0.417 . . . . 0.0 111.164 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.44 ' CB ' ' HD3' ' A' ' 104' ' ' PRO . 0.5 OUTLIER 179.2 -55.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.93 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 103' ' ' SER . 72.8 Cg_exo -49.78 132.76 32.15 Favored 'Trans proline' 0 CA--C 1.502 -1.092 0 C-N-CA 122.662 2.241 . . . . 0.0 113.134 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' THR . 24.5 m 43.71 31.46 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.752 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -36.24 9.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -118.37 33.69 5.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.89 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.05 -31.38 15.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m 60.89 70.51 0.94 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.4 170.84 16.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.581 2.187 . . . . 0.0 112.333 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.37 124.39 11.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.533 2.155 . . . . 0.0 112.208 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.59 162.54 39.85 Favored Pre-proline 0 CA--C 1.505 -0.765 0 CA-C-O 121.428 0.632 . . . . 0.0 111.34 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.37 171.23 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 121.972 1.781 . . . . 0.0 112.415 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.564 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.91 24.3 5.83 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.651 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER 172.68 -135.77 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -178.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.36 99.77 3.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.137 0.97 . . . . 0.0 109.597 179.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.1 t80 -119.25 140.38 50.35 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.251 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.03 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 1.2 pm0 -117.36 150.44 38.85 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.352 0.524 . . . . 0.0 109.738 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -126.81 110.47 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.861 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.794 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 20.5 pt-20 -115.87 127.05 54.72 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.296 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -144.22 145.14 31.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.641 175.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.002 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.03 123.46 48.24 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 16' ' ' ALA . 7.0 tmtm? -40.84 90.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.286 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 16' ' ' ALA . 5.7 t-20 -134.93 -57.41 0.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.934 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -122.12 -37.61 2.81 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 122.141 0.972 . . . . 0.0 108.457 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.591 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 78.9 m-20 -166.69 155.39 10.48 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.156 -1.838 . . . . 0.0 107.716 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.65 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.5 t -167.41 34.63 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.108 0.956 . . . . 0.0 108.484 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.33 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.3 -177.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.863 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.93 37.35 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.265 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 176.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -119.32 149.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 m -102.04 116.35 32.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.861 ' HA ' HG23 ' A' ' 46' ' ' VAL . 4.8 p -99.93 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.398 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 31' ' ' ASP . 3.8 m 80.97 0.1 1.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.235 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.047 HG21 ' HB3' ' A' ' 47' ' ' LYS . 30.4 m -74.4 -42.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.908 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -111.63 -14.08 13.69 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.004 0.907 . . . . 0.0 108.679 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -123.91 -164.48 1.24 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.002 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.764 ' O ' HG23 ' A' ' 27' ' ' THR . 0.7 OUTLIER -102.54 -21.88 14.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.218 179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -169.69 36.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.832 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.65 ' C ' HG12 ' A' ' 44' ' ' ILE . . . 53.69 -103.04 0.13 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.965 -1.112 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.644 ' H ' HD11 ' A' ' 87' ' ' LEU . . . -54.95 162.35 4.53 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.413 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.044 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.0 p 157.04 -160.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.044 ' H ' HG22 ' A' ' 35' ' ' VAL . 13.6 t30 -144.62 26.41 1.42 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.2 t -10.58 -55.28 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.139 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 36' ' ' ASN . 19.3 m -171.13 70.27 0.05 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.824 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.6 p -158.81 -154.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.857 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.824 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.6 tpt180 -130.68 30.1 4.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.389 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.789 ' H ' HG13 ' A' ' 39' ' ' VAL . 33.4 m-70 -148.64 -30.33 0.27 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 111.719 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.71 -108.59 0.62 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.92 80.72 0.8 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.064 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.54 129.34 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.443 0.639 . . . . 0.0 111.68 177.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.774 ' N ' HD13 ' A' ' 44' ' ' ILE . 1.1 m-85 -123.65 137.01 54.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.0 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.926 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.0 p -161.77 -171.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.047 ' HB3' HG21 ' A' ' 28' ' ' VAL . 19.7 pttt -92.14 -20.03 21.67 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.053 -2.202 . . . . 0.0 105.053 174.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.926 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.01 -137.69 0.01 OUTLIER 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 111.734 -2.484 . . . . 0.0 112.993 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.7 m -77.03 138.18 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 -174.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.65 163.91 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-N 110.712 -2.949 . . . . 0.0 110.454 177.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 50' ' ' ILE . 5.5 Cg_exo -78.36 -26.3 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.122 1.882 . . . . 0.0 112.496 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.6 pt20 -92.91 18.76 8.56 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.674 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 95.27 -92.33 1.47 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.679 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.73 -105.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.18 -35.67 60.07 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.505 1.145 . . . . 0.0 108.511 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.711 ' HA ' HG11 ' A' ' 49' ' ' VAL . 3.6 tm-20 -56.45 -31.02 63.57 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.015 -1.902 . . . . 0.0 109.098 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 54' ' ' ALA . 9.6 t -78.15 -40.57 37.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.681 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 4.6 t0 -59.8 -23.37 63.26 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 71.8 46.76 36.26 Favored Glycine 0 CA--C 1.497 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.052 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -113.51 50.72 0.89 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.745 HG22 ' CG2' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.44 141.83 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.199 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.109 -177.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 32.4 m-70 131.56 105.68 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.185 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -81.42 110.26 16.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.009 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.688 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.43 107.22 0.2 Allowed Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.024 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.526 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -173.84 -172.4 0.74 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.776 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.822 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.63 108.2 10.03 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.38 142.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.382 0 C-N-CA 126.588 1.955 . . . . 0.0 116.078 177.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -85.07 -48.75 8.89 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.755 174.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.856 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.46 148.66 50.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.067 HG23 HD11 ' A' ' 96' ' ' LEU . 8.6 p -123.31 143.61 35.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.701 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 21.0 t30 49.17 15.77 0.12 Allowed 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 120.996 0.426 . . . . 0.0 110.439 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 102.35 -21.07 42.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.877 -1.154 . . . . 0.0 112.079 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.692 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.6 t -86.76 142.51 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 42.2 m -79.08 114.77 18.3 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.933 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -93.3 77.7 4.51 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 15.0 mt-10 -93.46 33.4 1.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.952 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.583 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 107.33 23.55 6.91 Favored Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.45 -53.69 4.33 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.983 -0.608 . . . . 0.0 110.468 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.938 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.53 -99.94 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.065 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.498 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.653 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.34 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.216 1.573 . . . . 0.0 108.513 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.072 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 14.4 tttp -83.79 -61.95 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.074 ' O ' HG22 ' A' ' 86' ' ' THR . 8.5 mt-30 -71.65 -55.41 7.78 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -173.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.4 -48.1 20.98 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 118.496 -1.282 . . . . 0.0 114.333 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.87 -41.35 92.25 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.497 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.072 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 22.9 tt0 -61.31 -35.97 78.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.074 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -66.5 -38.71 87.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.2 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.86 HD13 HG21 ' A' ' 26' ' ' VAL . 6.6 mt -62.23 -38.96 91.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -76.87 -31.02 56.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.983 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.94 -9.51 19.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.009 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.86 157.58 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.704 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.65 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 109.47 -63.8 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.092 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 91' ' ' GLY . 20.8 pt20 -34.35 -42.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.662 0.744 . . . . 0.0 109.565 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.002 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.6 p 173.5 109.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.348 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.009 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.11 136.8 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-O 122.97 1.366 . . . . 0.0 113.636 -174.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.4 m80 -133.72 116.22 15.52 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 111.959 -2.382 . . . . 0.0 110.728 176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.067 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.35 136.97 51.67 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -177.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 12' ' ' GLU . 20.5 mt -110.35 113.86 26.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.402 174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.903 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -111.35 153.57 25.82 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.041 -178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.725 ' CG ' HD22 ' A' ' 68' ' ' LEU . 2.0 mm-40 -128.94 117.15 20.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 122.09 0.948 . . . . 0.0 112.008 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.651 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.7 110.48 3.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.117 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.09 36.61 1.03 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.878 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -89.64 -176.73 5.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.158 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.95 86.65 0.29 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.83 172.22 11.01 Favored 'Trans proline' 0 CA--C 1.502 -1.118 0 C-N-CA 122.627 2.218 . . . . 0.0 112.755 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.7 p -58.03 -35.43 71.27 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.528 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -45.02 93.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -90.95 -66.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.827 179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -164.06 35.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.8 -53.1 2.53 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.88 105.5 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.548 2.165 . . . . 0.0 112.407 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -176.5 2.05 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.537 2.158 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.81 161.8 60.28 Favored Pre-proline 0 CA--C 1.505 -0.786 0 CA-C-O 121.345 0.593 . . . . 0.0 111.223 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 26.7 Cg_exo -61.33 160.47 27.01 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 121.738 1.625 . . . . 0.0 112.491 -178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.59 26.34 6.21 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.711 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 2.0 t0 174.73 -135.02 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' CG2' ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -79.47 100.37 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 122.465 1.126 . . . . 0.0 109.494 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.005 ' HE1' HG12 ' A' ' 13' ' ' VAL . 1.6 t80 -119.29 155.22 32.21 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.992 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -133.51 151.45 51.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.709 0.686 . . . . 0.0 110.643 178.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 ' HE1' ' A' ' 11' ' ' PHE . 0.8 OUTLIER -121.23 109.35 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.003 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.775 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 10.3 pt-20 -117.36 125.67 51.4 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.65 150.25 37.07 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.956 0.902 . . . . 0.0 109.752 175.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.977 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -110.11 120.39 42.31 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.94 92.24 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.562 -178.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 16' ' ' ALA . 10.4 p30 -139.3 -49.64 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.239 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.0 -36.18 1.35 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.089 0.947 . . . . 0.0 108.939 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 27.8 m120 -164.06 151.85 12.52 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.444 -1.707 . . . . 0.0 107.878 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.622 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.6 t -167.57 36.33 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.834 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.68 179.89 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.262 -1.79 . . . . 0.0 108.199 -177.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.856 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 35.9 0.06 OUTLIER Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.74 150.69 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.9 t -103.33 114.52 28.87 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.392 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.905 ' HA ' HG23 ' A' ' 46' ' ' VAL . 8.7 p -99.54 157.69 3.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.251 -177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 31' ' ' ASP . 92.1 m 79.21 -0.05 2.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.638 -177.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.102 HG21 ' HB3' ' A' ' 47' ' ' LYS . 29.8 m -71.57 -44.42 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.99 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 28' ' ' VAL . 5.4 mt -110.67 -13.03 14.26 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 122.037 0.923 . . . . 0.0 108.571 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 45' ' ' TYR . 6.4 t80 -125.03 -178.72 4.28 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.116 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -82.0 -44.57 16.49 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.11 46.06 0.75 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.321 178.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.2 -97.69 0.05 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.226 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.666 ' N ' HG13 ' A' ' 44' ' ' ILE . . . -63.6 171.61 15.06 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 113.757 0.263 . . . . 0.0 113.757 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.064 HG22 ' H ' ' A' ' 36' ' ' ASN . 4.3 p 160.69 -147.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.064 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.1 t30 -144.98 23.58 1.52 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.783 HG21 ' HE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -10.59 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.134 -176.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER 172.65 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.502 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.626 HG22 ' HD2' ' A' ' 41' ' ' HIS . 11.6 p -113.04 -2.25 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 112.346 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 61.98 19.3 10.64 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.069 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HD2' HG22 ' A' ' 39' ' ' VAL . 78.1 m-70 -139.67 -25.9 0.81 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 146.78 -107.05 0.39 Allowed Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.765 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 118.44 59.71 0.28 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 117.31 1.684 . . . . 0.0 117.31 176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.103 HG22 HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -70.9 130.51 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.377 1.089 . . . . 0.0 111.77 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.9 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 83.3 m-85 -123.37 140.76 52.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.629 176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.922 HG13 ' N ' ' A' ' 48' ' ' ALA . 3.2 p -164.04 -170.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -172.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.102 ' HB3' HG21 ' A' ' 28' ' ' VAL . 22.8 pttt -92.64 -19.07 22.25 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.922 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.53 -141.35 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.891 0 CA-C-N 111.952 -2.386 . . . . 0.0 112.52 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.9 m -77.81 138.2 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.19 161.78 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 CA-C-N 111.015 -2.811 . . . . 0.0 110.984 177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.35 -25.93 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.387 2.058 . . . . 0.0 112.51 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' N ' HG23 ' A' ' 50' ' ' ILE . 15.1 pt20 -91.87 17.46 9.13 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.744 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.93 -95.48 1.57 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.46 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 39.86 -109.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.915 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.78 -35.86 61.78 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.318 1.056 . . . . 0.0 108.663 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.5 tt0 -56.28 -31.42 63.61 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 113.405 -1.725 . . . . 0.0 109.14 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.32 -40.71 35.85 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.75 ' HA ' HD23 ' A' ' 15' ' ' LEU . 6.7 t0 -60.94 -22.98 64.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 74.98 53.66 6.15 Favored Glycine 0 CA--C 1.493 -1.339 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.645 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.794 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -115.07 47.86 1.23 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.662 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -84.8 142.34 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.204 0 CA-C-N 114.406 -1.27 . . . . 0.0 114.15 -177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' CB ' ' O ' ' A' ' 61' ' ' ILE . 26.4 m-70 128.01 104.1 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.814 -1.994 . . . . 0.0 109.943 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -82.98 109.99 17.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.667 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 78.51 107.51 0.2 Allowed Glycine 0 CA--C 1.502 -0.743 0 C-N-CA 118.262 -1.923 . . . . 0.0 111.343 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.18 -169.89 0.41 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.553 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.765 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.92 108.54 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.103 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.91 142.26 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 C-N-CA 126.322 1.849 . . . . 0.0 115.922 177.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -82.91 -48.31 10.86 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.069 -1.878 . . . . 0.0 107.246 174.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 152.17 51.72 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.005 HG23 HD11 ' A' ' 96' ' ' LEU . 14.5 p -123.84 143.88 35.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 29.9 t-20 44.14 17.86 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.017 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 105.88 -25.68 23.25 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.942 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 82' ' ' GLN . 99.2 t -86.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -78.71 118.39 20.75 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.89 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -96.82 77.45 2.82 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.473 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -92.78 35.69 1.04 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.692 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.624 ' CA ' ' HB2' ' A' ' 36' ' ' ASN . . . 106.25 10.79 28.99 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.584 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -79.14 -53.6 6.83 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.963 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 20.82 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.128 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.504 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.677 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.7 t60 17.18 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 125.231 1.582 . . . . 0.0 108.49 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.801 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.1 tttp -83.41 -62.08 1.68 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.849 ' O ' ' HB ' ' A' ' 86' ' ' THR . 11.2 mt-30 -71.45 -55.89 7.02 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.963 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.48 -49.88 15.44 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 117.719 -1.592 . . . . 0.0 114.28 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.819 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -63.15 -45.62 98.07 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.759 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.801 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 21.6 tt0 -63.96 -33.59 76.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.059 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.849 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -74.45 -38.39 62.98 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.107 -175.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 84' ' ' VAL . 1.2 mt -60.57 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -76.46 -30.93 57.51 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.695 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.2 m120 -97.95 -3.91 37.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.857 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.8 p -45.4 174.76 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.953 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.622 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.47 -67.13 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.423 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' C ' ' O ' ' A' ' 91' ' ' GLY . 12.7 pt20 -31.98 -43.08 0.07 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.703 0.763 . . . . 0.0 109.856 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.99 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.377 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.857 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.65 136.71 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 CA-C-O 122.917 1.341 . . . . 0.0 113.78 -174.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.775 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 63.3 m80 -134.23 114.71 13.34 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 112.111 -2.313 . . . . 0.0 110.295 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.005 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -123.33 137.09 54.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.694 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.9 mt -112.54 113.23 25.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.047 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.948 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.73 153.62 23.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.621 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -129.77 119.04 22.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.751 178.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.711 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -65.99 112.06 3.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.063 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.55 33.26 0.83 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.969 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.6 OUTLIER -77.38 81.76 3.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.292 -0.454 . . . . 0.0 111.196 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -125.48 75.58 69.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.982 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -56.1 170.83 0.97 Allowed 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.661 2.241 . . . . 0.0 112.711 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 m -56.28 -49.72 73.42 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.58 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -166.85 38.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.13 31.35 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.919 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.57 -69.27 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 m -178.2 80.11 0.23 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.11 110.75 2.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.614 2.209 . . . . 0.0 112.275 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.37 -169.88 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.496 2.131 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.06 146.99 93.46 Favored Pre-proline 0 CA--C 1.503 -0.833 0 CA-C-O 121.637 0.732 . . . . 0.0 111.211 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.41 171.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.763 2.309 . . . . 0.0 112.838 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 105.84 26.12 6.23 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.701 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 175.26 -138.48 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.02 100.92 4.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 122.12 0.962 . . . . 0.0 109.356 179.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 13' ' ' VAL . 10.9 t80 -118.63 140.2 50.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.038 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -113.28 151.07 31.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.993 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.5 m -124.98 110.05 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.016 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.784 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 12.6 pt-20 -116.03 126.85 54.35 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -144.56 148.01 33.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.764 175.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.005 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -108.71 124.03 49.91 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.3 tmtp? -41.79 91.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.293 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 16' ' ' ALA . 45.0 t-20 -136.3 -57.59 0.75 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.002 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.97 -36.8 2.81 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.116 0.96 . . . . 0.0 108.436 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 71.9 m-80 -165.7 155.84 12.89 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 113.295 -1.775 . . . . 0.0 107.885 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 6.6 t -168.02 36.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.824 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 166.0 179.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.177 -177.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.831 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 145.61 37.33 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -118.64 150.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -101.51 114.29 28.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.448 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG11 HD13 ' A' ' 87' ' ' LEU . 14.0 p -99.83 157.75 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.563 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.906 HG22 ' HA ' ' A' ' 32' ' ' LYS . 1.3 p 79.52 0.31 2.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.47 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.059 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.2 m -75.08 -41.91 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.343 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.24 -13.59 13.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.05 0.928 . . . . 0.0 108.667 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.721 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -125.25 -165.0 1.35 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.374 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -99.29 -20.41 16.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.904 0.383 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.906 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -173.93 35.84 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.656 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 55.93 -100.35 0.1 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.542 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.765 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -54.89 159.11 6.0 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.318 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.018 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.2 p 157.17 -162.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.018 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -142.09 25.05 1.95 Allowed 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 175.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.515 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.8 t -5.47 -53.89 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 111.972 -2.376 . . . . 0.0 114.137 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.624 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.8 m -159.38 37.97 0.2 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -141.25 -155.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 39' ' ' VAL . 22.9 ttt85 -126.64 -16.48 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -89.88 -26.91 20.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 110.522 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 129.83 -108.51 0.87 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.435 -178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.844 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 112.72 84.78 1.39 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 116.978 1.551 . . . . 0.0 116.978 176.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.999 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -79.46 132.95 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.413 0.625 . . . . 0.0 112.171 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.721 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -123.86 138.0 54.56 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.58 175.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -163.23 -172.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -172.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.059 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.2 ptmt -90.49 -17.4 27.17 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.996 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 79.76 -141.49 0.01 OUTLIER 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 112.13 -2.305 . . . . 0.0 112.444 176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.9 m -77.42 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 -174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.9 162.09 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 111.045 -2.798 . . . . 0.0 110.901 177.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.14 -26.06 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.337 2.025 . . . . 0.0 112.584 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' N ' HG23 ' A' ' 50' ' ' ILE . 11.6 pt20 -91.78 17.54 8.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.736 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.02 -94.28 1.41 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.469 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.05 -109.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.54 -35.77 61.1 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.54 1.162 . . . . 0.0 108.618 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -56.55 -31.34 64.08 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.045 179.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.4 t -78.35 -40.15 37.3 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.713 ' HA ' ' CG ' ' A' ' 15' ' ' LEU . 6.6 t0 -59.75 -23.06 62.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 72.68 50.26 15.27 Favored Glycine 0 CA--C 1.493 -1.287 0 CA-C-N 114.405 -1.27 . . . . 0.0 110.538 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.993 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -117.49 55.58 0.85 Allowed 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.24 141.47 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.378 -1.283 . . . . 0.0 114.271 -176.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.9 m80 133.07 106.84 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.825 -1.989 . . . . 0.0 109.865 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.4 pttt -83.88 110.02 18.04 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 79.68 108.72 0.25 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.179 -1.962 . . . . 0.0 110.878 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.595 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.67 -171.14 0.45 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.211 -0.495 . . . . 0.0 110.733 -178.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.844 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.13 108.37 10.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -79.68 142.62 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 177.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.8 pp -85.65 -48.04 9.25 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 112.825 -1.989 . . . . 0.0 107.277 174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.94 151.12 51.36 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.98 HG23 HD11 ' A' ' 96' ' ' LEU . 13.1 p -123.57 143.84 35.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.657 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 t30 45.17 16.33 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.36 -24.5 25.89 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.738 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.644 HG11 ' HB3' ' A' ' 82' ' ' GLN . 79.4 t -86.79 142.7 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.75 115.73 18.64 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -96.71 77.91 2.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -93.64 29.6 1.98 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.985 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 111.21 22.45 6.18 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -90.72 -52.31 4.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.994 -0.603 . . . . 0.0 110.224 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.942 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.85 -99.21 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.041 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.487 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.54 -79.56 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 125.255 1.597 . . . . 0.0 108.534 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.803 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 9.4 ttpt -83.53 -61.98 1.7 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.821 ' O ' ' HB ' ' A' ' 86' ' ' THR . 9.7 mt-30 -71.63 -55.75 7.15 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.588 2.81 . . . . 0.0 118.588 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.942 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.51 -49.71 15.81 Favored 'General case' 0 CA--C 1.488 -1.426 0 C-N-CA 117.806 -1.558 . . . . 0.0 114.216 -174.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.76 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.13 -44.88 97.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.956 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.803 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.7 tt0 -64.94 -32.97 74.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.948 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.821 ' HB ' ' O ' ' A' ' 82' ' ' GLN . 0.6 OUTLIER -79.05 -42.61 26.02 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.315 -175.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 88' ' ' ARG . 3.8 pp -58.66 -37.58 76.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.876 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.3 tpt180 -77.02 -31.11 56.14 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.786 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.3 m120 -97.1 -2.56 42.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.832 HG22 ' CG2' ' A' ' 94' ' ' VAL . 4.0 p -44.23 175.43 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.096 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 105.07 -64.69 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.268 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' GLY . 6.1 pt20 -34.15 -41.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 0.0 109.708 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.005 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 173.64 109.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.373 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.832 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.7 136.67 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 123.018 1.389 . . . . 0.0 113.878 -174.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.784 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 62.8 m80 -134.14 114.88 13.59 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 111.937 -2.392 . . . . 0.0 110.391 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.038 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.88 137.03 54.71 Favored 'General case' 0 N--CA 1.409 -2.489 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -177.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.709 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.5 mt -110.87 113.82 26.69 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.546 174.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.864 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.02 153.18 28.5 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.018 -178.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.568 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 -126.47 110.52 13.39 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.036 0.922 . . . . 0.0 111.509 178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.747 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.64 111.3 3.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.876 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.15 36.96 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.831 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -80.08 -49.41 11.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.333 -0.433 . . . . 0.0 111.217 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.413 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -59.96 -52.17 75.43 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.65 ' O ' HG23 ' A' ' 105' ' ' THR . 35.5 Cg_exo -41.9 95.69 0.02 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.347 0 C-N-CA 123.109 2.54 . . . . 0.0 113.548 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.74 HG21 ' CD ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER 176.63 -174.24 0.11 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.052 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -88.92 53.69 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mttt 59.7 32.82 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.74 ' CD ' HG21 ' A' ' 105' ' ' THR . 21.1 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -49.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -178.36 -61.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 60.1 Cg_endo -72.41 169.74 20.98 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.93 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.595 2.196 . . . . 0.0 112.205 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -179.23 139.99 0.35 Allowed Pre-proline 0 CA--C 1.504 -0.809 0 CA-C-O 121.542 0.687 . . . . 0.0 111.065 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.47 168.62 0.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.209 1.939 . . . . 0.0 112.49 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 104.91 28.2 5.69 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER 177.41 -139.65 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.51 100.23 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.149 0.976 . . . . 0.0 109.765 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 12' ' ' GLU . 9.7 t80 -119.21 140.32 50.39 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -115.14 151.22 34.75 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.901 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.945 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -124.16 110.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.306 -178.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.799 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.4 OUTLIER -116.48 128.58 55.59 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.73 150.38 37.17 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 124.142 0.977 . . . . 0.0 109.467 175.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.955 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.82 120.67 43.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -40.27 92.03 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.455 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.6 t-20 -137.56 -56.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.067 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -124.03 -35.94 2.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 108.619 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 25.6 m120 -165.5 154.66 12.18 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.357 -1.747 . . . . 0.0 108.014 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.594 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 5.9 t -168.0 36.17 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.828 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.47 179.73 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 113.317 -1.765 . . . . 0.0 108.195 -177.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.838 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.3 36.93 0.06 OUTLIER Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.987 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.41 149.56 20.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.612 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.7 m -101.46 115.17 29.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.853 HG11 HD13 ' A' ' 87' ' ' LEU . 7.9 p -99.82 157.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.066 -177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 26' ' ' VAL . 6.3 m 81.07 -2.06 1.76 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.561 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HB3' ' A' ' 47' ' ' LYS . 26.8 m -72.34 -43.07 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.164 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.3 mt -111.67 -14.09 13.67 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.964 0.888 . . . . 0.0 108.762 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.67 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -124.0 -168.66 1.83 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.466 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.75 -10.65 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' N ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER 179.11 36.69 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.696 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 52.15 -97.78 0.02 OUTLIER Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.085 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.62 161.64 7.26 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.729 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.4 p 156.65 -161.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.005 ' H ' HG22 ' A' ' 35' ' ' VAL . 16.1 t-20 -142.33 25.23 1.89 Allowed 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.737 HG21 ' OH ' ' A' ' 45' ' ' TYR . 1.7 t -4.86 -56.05 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.11 -2.314 . . . . 0.0 113.315 -176.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 36' ' ' ASN . 18.1 m -171.19 66.6 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.096 0 CA-C-O 121.164 0.506 . . . . 0.0 111.828 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.835 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.4 p -156.61 -155.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.026 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 39' ' ' VAL . 17.0 ttt180 -131.09 30.07 4.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.795 ' H ' HG13 ' A' ' 39' ' ' VAL . 38.3 m-70 -147.42 -31.03 0.32 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.428 0.633 . . . . 0.0 111.587 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 140.75 -108.31 0.55 Allowed Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.839 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 116.43 68.72 0.41 Allowed Glycine 0 CA--C 1.524 0.597 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.058 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.4 133.07 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.478 0.656 . . . . 0.0 112.44 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.737 ' OH ' HG21 ' A' ' 37' ' ' THR . 2.0 m-30 -121.77 144.84 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.071 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.954 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.5 p -170.6 -173.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.028 ' HB3' HG21 ' A' ' 28' ' ' VAL . 4.1 ptmt -90.02 -19.03 24.91 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.954 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 80.99 -141.84 0.01 OUTLIER 'General case' 0 N--CA 1.403 -2.812 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.167 176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.987 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.73 138.09 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 117.781 2.511 . . . . 0.0 117.781 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -41.56 161.56 0.14 Allowed Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.977 177.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.0 Cg_exo -79.25 -25.93 5.46 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.324 2.016 . . . . 0.0 112.562 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.56 ' N ' HG23 ' A' ' 50' ' ' ILE . 6.1 pt20 -91.77 17.58 8.84 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.753 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 99.5 -95.43 1.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.424 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.31 -110.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.917 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.75 -35.82 61.66 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 122.323 1.059 . . . . 0.0 108.585 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.9 tt0 -56.46 -31.13 63.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.354 -1.748 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -78.06 -40.85 37.32 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.735 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.18 -22.92 63.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.16 52.11 9.26 Favored Glycine 0 CA--C 1.494 -1.224 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.519 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.945 ' HA ' HG11 ' A' ' 13' ' ' VAL . 9.2 ttt180 -115.84 49.65 1.09 Allowed 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -83.25 142.76 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.226 0 CA-C-N 114.418 -1.265 . . . . 0.0 113.997 -177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.667 ' CG ' ' O ' ' A' ' 61' ' ' ILE . 27.0 m170 130.41 105.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.406 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.95 110.01 18.07 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.56 106.96 0.17 Allowed Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 118.162 -1.971 . . . . 0.0 110.785 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -173.46 -171.47 0.69 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.168 -0.516 . . . . 0.0 111.227 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.839 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -129.14 108.91 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.058 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -84.06 142.12 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 C-N-CA 126.477 1.911 . . . . 0.0 116.057 177.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.616 HD21 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.42 -47.63 10.48 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.055 -1.884 . . . . 0.0 107.348 174.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.816 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.85 152.39 51.85 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.979 HG23 HD11 ' A' ' 96' ' ' LEU . 14.3 p -123.29 143.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.685 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 24.7 t-20 43.03 18.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.281 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 106.75 -26.09 20.67 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.085 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 82' ' ' GLN . 86.4 t -86.81 142.72 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.2 m -78.35 118.45 20.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.905 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.39 77.57 3.0 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 0.2 OUTLIER -93.36 34.71 1.13 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.949 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.587 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.84 16.12 20.35 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.565 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -83.54 -52.9 6.09 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.415 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.934 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.52 -98.96 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.057 0 CA-C-O 119.162 -0.447 . . . . 0.0 111.574 -179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.6 t60 17.38 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 125.198 1.561 . . . . 0.0 108.589 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.6 tttp -83.48 -61.96 1.71 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.676 ' HB3' HG11 ' A' ' 73' ' ' VAL . 9.5 mt-30 -71.69 -55.8 7.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 118.579 2.807 . . . . 0.0 118.579 -173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.68 -49.61 15.7 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.221 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.766 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -63.41 -45.37 98.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.904 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.785 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 24.4 tt0 -65.56 -33.62 76.33 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.129 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.769 HG21 HG13 ' A' ' 70' ' ' VAL . 1.9 t -79.38 -38.78 34.13 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.608 -175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 88' ' ' ARG . 3.9 pp -61.84 -37.26 83.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.882 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -76.94 -31.02 56.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.695 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -96.64 -2.54 44.51 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.848 HG22 ' CG2' ' A' ' 94' ' ' VAL . 2.7 p -43.84 173.86 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.031 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.594 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 106.86 -65.82 0.25 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.413 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' GLY . 15.8 pt20 -33.15 -41.7 0.08 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.753 0.787 . . . . 0.0 109.854 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.955 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.93 109.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.36 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.848 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.27 136.56 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.362 0 CA-C-O 122.98 1.371 . . . . 0.0 113.818 -174.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.799 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.3 m80 -134.1 115.04 13.81 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 111.989 -2.369 . . . . 0.0 110.616 175.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.063 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -123.9 135.22 53.56 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -177.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 12' ' ' GLU . 19.9 mt -108.39 113.85 27.23 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.231 -1.35 . . . . 0.0 108.78 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.875 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -114.49 153.56 29.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -132.94 121.86 23.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 122.135 0.969 . . . . 0.0 112.063 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.713 ' HB2' ' N ' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -66.02 119.87 12.14 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.548 -1.205 . . . . 0.0 112.704 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 66' ' ' ARG . . . -158.05 34.8 0.52 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.598 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.0 mm-40 -90.18 -27.58 19.46 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.356 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.4 -53.95 50.74 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.206 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.07 133.19 14.83 Favored 'Trans proline' 0 CA--C 1.493 -1.529 0 C-N-CA 122.792 2.328 . . . . 0.0 113.308 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 108' ' ' GLU . 1.6 t -107.81 56.63 0.63 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.338 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m 63.23 49.44 3.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.37 70.62 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' CG ' ' CG2' ' A' ' 105' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -95.0 169.91 9.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 145.21 49.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.37 170.13 20.92 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.571 2.181 . . . . 0.0 112.307 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -167.94 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.646 2.23 . . . . 0.0 112.305 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -103.49 142.1 23.88 Favored Pre-proline 0 CA--C 1.504 -0.804 0 CA-C-O 121.643 0.735 . . . . 0.0 111.268 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.33 173.14 0.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.284 1.989 . . . . 0.0 112.758 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 109.84 24.04 5.95 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.653 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER 172.63 -137.31 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.729 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -79.47 100.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-O 122.048 0.928 . . . . 0.0 110.061 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE2' HG12 ' A' ' 13' ' ' VAL . 11.7 t80 -118.77 138.77 52.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.326 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.994 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -111.68 151.42 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.509 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.002 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.4 m -126.35 109.58 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.608 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.814 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 15.9 pt-20 -116.31 128.23 55.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -144.77 147.17 32.61 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 124.036 0.934 . . . . 0.0 109.734 175.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.967 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.21 123.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HB2' ' C ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -41.05 91.59 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.491 -178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 16' ' ' ALA . 13.9 t-20 -136.53 -58.41 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.786 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.21 -35.89 2.74 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.105 0.955 . . . . 0.0 108.427 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.782 ' O ' HD12 ' A' ' 15' ' ' LEU . 75.8 m-20 -165.7 154.25 11.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 113.347 -1.751 . . . . 0.0 107.918 177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.671 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 9.7 t -166.72 34.05 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 122.274 1.035 . . . . 0.0 108.436 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.855 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 167.16 -179.05 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.243 -1.799 . . . . 0.0 108.014 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.808 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.08 37.73 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.992 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.2 pp -118.01 152.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.482 0.658 . . . . 0.0 112.705 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.3 t -103.6 114.88 29.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.358 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.013 HG21 HD22 ' A' ' 87' ' ' LEU . 11.5 p -99.89 157.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.311 -177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 26' ' ' VAL . 11.8 m 81.7 -3.27 1.59 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.469 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.066 HG21 ' HB3' ' A' ' 47' ' ' LYS . 21.7 m -71.88 -40.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.016 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.7 mt -112.64 -13.25 13.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 122.001 0.905 . . . . 0.0 108.763 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.713 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -126.42 -162.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.25 179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' C ' ' HG3' ' A' ' 32' ' ' LYS . 4.6 m-20 -107.3 -14.74 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 110.397 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HG3' ' C ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -175.31 35.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.65 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . . . 51.61 -100.08 0.04 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.77 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 160.82 7.89 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.743 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.016 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.5 p 156.56 -161.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.016 ' H ' HG22 ' A' ' 35' ' ' VAL . 12.2 t30 -143.06 25.8 1.73 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 175.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -8.94 -53.3 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 111.817 -2.447 . . . . 0.0 114.149 -175.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 36' ' ' ASN . 4.5 m -165.12 44.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.808 HG22 ' H ' ' A' ' 40' ' ' ARG . 7.9 p -141.25 -151.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.808 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -129.81 -3.97 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.598 ' H ' HG13 ' A' ' 39' ' ' VAL . 49.6 m-70 -109.19 -26.87 9.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.43 0.633 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.722 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 138.19 -108.41 0.62 Allowed Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 121.74 66.09 0.24 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 176.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 tt -69.83 129.04 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 117.942 0.871 . . . . 0.0 112.378 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.713 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 66.1 m-85 -123.69 133.71 53.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.033 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.938 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -159.11 -171.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -173.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.066 ' HB3' HG21 ' A' ' 28' ' ' VAL . 6.2 ptpt -92.56 -18.84 22.59 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.7 -141.25 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 111.935 -2.393 . . . . 0.0 112.949 176.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.992 ' HA ' HG22 ' A' ' 24' ' ' ILE . 8.1 m -77.74 138.12 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -40.71 162.24 0.1 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 111.007 -2.815 . . . . 0.0 110.922 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 50' ' ' ILE . 3.8 Cg_exo -80.73 -26.06 3.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.396 2.064 . . . . 0.0 112.913 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -94.3 18.74 10.51 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.111 -178.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 103.81 -98.47 1.59 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.876 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.72 -112.03 0.14 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.944 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.69 -35.88 61.58 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.296 1.046 . . . . 0.0 108.62 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.2 tt0 -56.47 -31.2 63.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.489 -1.687 . . . . 0.0 108.935 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -78.23 -40.02 38.61 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.806 ' HA ' HD23 ' A' ' 15' ' ' LEU . 23.6 t0 -59.81 -23.01 62.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 52.54 8.76 Favored Glycine 0 CA--C 1.492 -1.362 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.447 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 1.002 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -118.15 54.26 0.93 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.682 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -88.41 141.81 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.241 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -177.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.64 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 31.3 m-70 128.94 104.91 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 112.842 -1.981 . . . . 0.0 110.125 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 5.2 ptpp? -82.04 111.07 17.86 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.065 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 79.97 107.54 0.26 Allowed Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 118.204 -1.95 . . . . 0.0 111.074 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -175.32 -170.35 0.43 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.69 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.34 108.11 9.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.049 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.26 142.24 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 126.364 1.866 . . . . 0.0 116.002 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 69' ' ' ALA . 3.7 pp -84.43 -48.55 9.52 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.148 -1.842 . . . . 0.0 107.55 174.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.887 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.13 149.27 51.07 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.011 HG23 HD11 ' A' ' 96' ' ' LEU . 10.5 p -123.08 143.6 35.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.713 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 45.2 t30 48.5 16.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.611 -177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 103.1 -22.06 37.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.067 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' CD ' ' A' ' 82' ' ' GLN . 70.0 t -86.71 142.75 12.62 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 5.8 m -78.77 116.16 18.94 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.39 3.72 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.458 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 25.1 pt-20 -93.63 35.94 1.11 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.734 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.602 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 105.39 20.45 9.61 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -85.67 -53.73 4.97 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.971 -0.614 . . . . 0.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.96 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 23.19 -100.34 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.112 0 CA-C-O 119.2 -0.428 . . . . 0.0 111.48 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.661 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.3 t60 18.37 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 125.096 1.497 . . . . 0.0 108.507 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.118 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 5.8 tptm -83.73 -61.9 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.073 ' O ' HG22 ' A' ' 86' ' ' THR . 7.3 mt-30 -71.58 -55.44 7.78 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.758 2.873 . . . . 0.0 118.758 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.96 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.08 -47.71 23.57 Favored 'General case' 0 CA--C 1.49 -1.338 0 C-N-CA 118.638 -1.225 . . . . 0.0 114.218 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.02 -39.36 85.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.457 179.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.118 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 18.9 tt0 -61.59 -36.33 80.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.044 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.073 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -70.02 -39.79 75.58 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 119.729 -0.788 . . . . 0.0 112.214 -176.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.013 HD22 HG21 ' A' ' 26' ' ' VAL . 3.6 pp -64.0 -36.23 83.3 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.938 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.33 -31.31 54.47 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.276 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.7 m-20 -104.64 -9.38 18.27 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.021 HG22 HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -34.66 151.55 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 112.94 -58.37 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.639 -1.267 . . . . 0.0 113.124 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.506 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 6.8 pt20 -37.22 -38.17 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.691 0.758 . . . . 0.0 109.46 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 16' ' ' ALA . 4.5 p 166.41 104.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.021 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -115.85 137.23 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 123.073 1.416 . . . . 0.0 113.678 -174.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.814 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.4 m80 -133.15 115.95 15.67 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 111.49 -2.595 . . . . 0.0 110.115 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.011 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -126.75 140.04 52.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -176.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 12' ' ' GLU . 22.0 mt -113.32 114.05 26.12 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.947 -1.478 . . . . 0.0 108.666 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.931 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -109.29 153.51 23.78 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.709 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 66' ' ' ARG . 70.4 mt-10 -128.71 116.43 19.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.989 0.9 . . . . 0.0 111.522 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.653 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.42 111.25 3.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.671 -1.149 . . . . 0.0 112.256 -179.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.78 34.78 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.741 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 1.4 mm-40 -88.28 -31.98 18.72 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.187 -0.507 . . . . 0.0 111.228 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.406 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -57.97 -51.82 78.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.372 -179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 103' ' ' SER . 27.5 Cg_exo -60.65 158.35 32.96 Favored 'Trans proline' 0 CA--C 1.501 -1.167 0 C-N-CA 122.635 2.223 . . . . 0.0 112.725 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -42.8 65.66 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.325 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.0 m 66.09 20.45 11.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.178 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 pttt 176.69 -48.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.889 0.376 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.96 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -176.68 134.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.65 142.78 91.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.807 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.63 110.17 2.9 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.582 2.188 . . . . 0.0 112.443 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.27 179.8 5.12 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.407 2.071 . . . . 0.0 112.285 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -121.61 150.31 54.79 Favored Pre-proline 0 CA--C 1.501 -0.94 0 CA-C-O 121.513 0.673 . . . . 0.0 111.324 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 70.7 Cg_endo -87.87 148.06 7.0 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 C-N-CA 121.886 1.724 . . . . 0.0 113.018 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.63 12.07 3.85 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.65 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.581 ' CA ' ' HB2' ' A' ' 100' ' ' LYS . 4.2 m-20 -174.03 -102.09 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.8 tp -100.28 99.71 9.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.435 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 59' ' ' GLY . 18.9 t80 -118.85 154.33 33.07 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.711 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.012 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -132.84 150.89 52.11 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.911 HG11 ' HA ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -123.31 109.32 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.273 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.849 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -117.38 126.05 52.01 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -144.94 148.82 34.26 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.919 0.888 . . . . 0.0 109.616 175.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.95 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.18 120.13 41.59 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 2.7 tmtm? -39.2 91.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.455 -178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 16' ' ' ALA . 29.3 t30 -137.34 -57.47 0.7 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.042 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -125.07 -35.56 2.64 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.097 0.951 . . . . 0.0 108.673 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.672 ' O ' HD12 ' A' ' 15' ' ' LEU . 27.0 m120 -165.03 152.84 11.42 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 113.392 -1.731 . . . . 0.0 108.149 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.631 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.2 t -166.96 34.69 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.833 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.98 -179.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.277 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.842 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.96 36.84 0.05 OUTLIER Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 176.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.984 HG22 ' HA ' ' A' ' 49' ' ' VAL . 2.1 pp -119.85 147.7 23.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 m -98.97 114.52 27.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.42 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.017 HG11 HD13 ' A' ' 87' ' ' LEU . 4.2 p -99.74 157.58 3.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.359 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 26' ' ' VAL . 8.5 m 80.66 1.13 1.84 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.438 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.3 m -77.46 -39.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.206 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 28' ' ' VAL . 6.0 mt -113.21 -13.38 12.98 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.058 0.933 . . . . 0.0 108.905 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.51 -165.51 1.39 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.791 -1.55 . . . . 0.0 109.891 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 27' ' ' THR . 3.7 m-20 -104.39 -10.52 17.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.386 . . . . 0.0 110.342 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HZ2' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 179.5 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.03 -102.17 0.05 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.175 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.793 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -56.68 156.53 12.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.04 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.9 p 158.13 -161.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 -178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.04 ' H ' HG22 ' A' ' 35' ' ' VAL . 14.3 t30 -144.11 26.34 1.51 Allowed 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.487 ' N ' HG22 ' A' ' 35' ' ' VAL . 7.4 t -10.25 -54.24 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 112.141 -2.3 . . . . 0.0 113.361 -175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASN . 24.1 m -169.63 64.64 0.05 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.798 HG22 ' H ' ' A' ' 40' ' ' ARG . 4.6 p -154.09 -155.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.947 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.798 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -130.17 29.82 4.86 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 122.096 -0.377 . . . . 0.0 111.512 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.784 ' H ' HG13 ' A' ' 39' ' ' VAL . 33.1 m-70 -148.97 -28.41 0.28 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.62 -108.85 0.66 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.818 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 117.75 69.34 0.38 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -69.98 131.37 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.546 0.688 . . . . 0.0 112.086 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.666 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 52.9 m-85 -123.72 142.93 50.61 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.441 176.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.93 HG23 ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -168.13 -173.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -173.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' HG21 ' A' ' 28' ' ' VAL . 13.2 pttt -89.62 -20.56 23.55 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.928 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.51 -142.04 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.73 0 CA-C-N 111.835 -2.438 . . . . 0.0 112.417 176.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.58 137.9 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -174.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -41.8 162.29 0.14 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 110.852 -2.885 . . . . 0.0 110.884 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.8 Cg_exo -79.33 -25.98 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.336 2.024 . . . . 0.0 112.55 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.569 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.6 pt20 -91.85 17.48 9.08 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.686 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.7 -94.49 1.46 Allowed Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.457 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.833 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.18 -108.96 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.6 -35.82 61.28 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.349 1.071 . . . . 0.0 108.709 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.707 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -56.6 -31.41 64.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.024 179.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 t -78.47 -40.72 34.68 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.751 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.4 t0 -60.02 -23.0 63.34 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' VAL . . . 74.0 54.89 6.11 Favored Glycine 0 CA--C 1.494 -1.245 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.36 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.911 ' HA ' HG11 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -120.92 54.8 1.07 Allowed 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' CG2' HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -90.27 141.69 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.131 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 12.5 m80 130.35 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.865 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -83.21 110.23 17.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.445 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 78.83 109.39 0.21 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 118.161 -1.971 . . . . 0.0 110.985 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -176.17 -170.38 0.36 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.978 -178.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.818 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.09 108.72 10.29 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.73 142.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 177.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -84.43 -48.05 10.04 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.186 -1.825 . . . . 0.0 107.586 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.63 149.17 51.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.053 HG23 HD11 ' A' ' 96' ' ' LEU . 11.9 p -123.04 143.68 35.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.8 t30 47.71 17.24 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.936 0.398 . . . . 0.0 110.826 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.21 -21.0 44.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.001 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 82' ' ' GLN . 77.4 t -86.69 142.89 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 28.1 p -78.82 117.39 19.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.912 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -96.66 77.68 2.89 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' C ' ' HB2' ' A' ' 36' ' ' ASN . 6.3 mt-10 -94.94 35.84 1.24 Allowed 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.675 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.619 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 103.85 24.01 7.93 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -88.87 -51.74 5.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 21.88 -100.4 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.082 0 CA-C-O 119.128 -0.463 . . . . 0.0 111.453 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.666 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.6 t60 18.28 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 125.152 1.532 . . . . 0.0 108.477 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.106 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 13.5 tptm -83.67 -61.72 1.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.022 ' O ' HG22 ' A' ' 86' ' ' THR . 31.4 mt-30 -71.65 -55.47 7.66 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -173.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.962 ' HB3' HG23 ' A' ' 79' ' ' THR . . . -76.28 -47.81 22.42 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 118.608 -1.237 . . . . 0.0 114.242 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.97 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.106 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 20.5 tt0 -60.94 -36.27 78.91 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.993 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.022 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -68.3 -38.85 82.05 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.605 -176.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.017 HD13 HG11 ' A' ' 26' ' ' VAL . 1.4 pp -59.33 -43.19 92.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.511 0.672 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.63 ' N ' HD12 ' A' ' 87' ' ' LEU . 3.6 ttt180 -76.55 -31.11 57.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.595 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 1.9 m-20 -100.44 -11.48 20.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.047 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.19 155.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.775 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.3 -62.36 0.29 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.056 -1.068 . . . . 0.0 113.017 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 91' ' ' GLY . 28.8 pt20 -35.0 -41.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.775 0.798 . . . . 0.0 109.626 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.8 p 172.01 108.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.047 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.53 136.63 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 CA-C-O 122.961 1.362 . . . . 0.0 113.537 -174.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.849 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 64.5 m80 -133.87 115.63 14.68 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.643 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.053 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -127.97 138.59 52.67 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD23 ' CB ' ' A' ' 12' ' ' GLU . 21.1 mt -113.62 113.28 24.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.049 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.62 153.39 23.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.499 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -127.26 114.4 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.63 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HB2' ' CA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -66.46 112.17 3.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.766 -179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.27 36.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.067 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 0.2 OUTLIER -72.48 -174.7 1.42 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.399 . . . . 0.0 111.27 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.2 m -156.43 117.01 2.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.79 169.88 9.49 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.536 2.157 . . . . 0.0 112.857 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.83 -28.78 66.38 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.05 30.94 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mttp -145.96 -52.04 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.883 -179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.94 76.63 1.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m 61.78 152.31 0.11 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.21 121.25 7.63 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.66 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.396 2.064 . . . . 0.0 112.268 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -113.83 140.12 24.35 Favored Pre-proline 0 CA--C 1.504 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.0 111.201 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.91 -169.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.364 2.042 . . . . 0.0 112.851 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 103.78 26.18 6.89 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.732 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 173.18 -141.36 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.864 HD11 HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -80.22 101.03 4.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 122.254 1.026 . . . . 0.0 109.394 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.672 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.9 t80 -119.14 145.98 45.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.14 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -112.8 150.71 31.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.316 0.507 . . . . 0.0 110.369 178.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 60' ' ' ARG . 2.2 m -121.73 109.41 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.349 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.757 ' HB2' ' NE2' ' A' ' 95' ' ' HIS . 11.1 pt-20 -116.32 129.47 56.28 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -144.74 147.75 33.33 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 109.445 175.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.87 120.57 42.65 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 3.2 tmtm? -40.78 91.55 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.483 -178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 16' ' ' ALA . 12.7 t-20 -137.63 -57.17 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.022 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.57 -36.22 2.8 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 122.105 0.955 . . . . 0.0 108.425 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.8 ' O ' HD12 ' A' ' 15' ' ' LEU . 31.5 m120 -164.61 155.08 14.45 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.351 -1.749 . . . . 0.0 107.982 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 7.6 t -167.84 36.14 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.812 ' O ' ' N ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER 167.27 179.55 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.862 -177.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.827 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 147.24 37.54 0.05 OUTLIER Glycine 0 CA--C 1.492 -1.39 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.298 176.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.998 HG22 ' HA ' ' A' ' 49' ' ' VAL . 26.4 pt -120.53 150.58 23.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -100.62 114.27 27.82 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.47 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 87' ' ' LEU . 13.0 p -99.84 158.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 32' ' ' LYS . 2.9 p 78.77 2.18 2.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.472 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.09 HG21 ' HB3' ' A' ' 47' ' ' LYS . 20.5 m -76.29 -42.43 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.581 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.6 mt -110.76 -14.02 14.08 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.124 0.964 . . . . 0.0 108.446 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -124.6 -165.58 1.4 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.651 -1.613 . . . . 0.0 109.773 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' CB ' ' HE2' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -101.89 -23.35 14.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.956 0.408 . . . . 0.0 110.034 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.845 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -166.83 38.9 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.81 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 49.48 -102.23 0.06 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.039 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -55.27 156.69 8.44 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.093 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.044 HG22 ' H ' ' A' ' 36' ' ' ASN . 6.2 p 156.59 -162.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.044 ' H ' HG22 ' A' ' 35' ' ' VAL . 11.9 t30 -145.46 26.98 1.27 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 35' ' ' VAL . 8.0 t -9.77 -54.79 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 112.247 -2.251 . . . . 0.0 113.215 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 16.9 m -165.57 72.66 0.18 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.125 0.488 . . . . 0.0 112.006 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.901 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.7 p -163.79 -156.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.938 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.901 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.2 tpt180 -130.2 25.26 5.21 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.162 -0.336 . . . . 0.0 111.505 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.744 ' H ' HG13 ' A' ' 39' ' ' VAL . 31.6 m-70 -143.0 -22.85 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.053 0.454 . . . . 0.0 111.976 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.718 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 125.64 -110.73 1.36 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -177.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 108.94 85.49 1.7 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 175.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.13 HG22 HG22 ' A' ' 67' ' ' VAL . 1.5 tt -77.19 132.19 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.332 0.587 . . . . 0.0 111.716 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 1.3 m-85 -123.78 136.1 54.21 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.004 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.945 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.8 p -160.75 -171.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -91.25 -19.37 23.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 105.296 -2.112 . . . . 0.0 105.296 174.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.945 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 81.83 -143.05 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.49 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 24' ' ' ILE . 5.5 m -77.93 138.16 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -43.61 162.57 0.18 Allowed Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 110.906 -2.861 . . . . 0.0 110.786 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' HG23 ' A' ' 50' ' ' ILE . 3.5 Cg_exo -80.53 -28.57 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.406 2.071 . . . . 0.0 113.226 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.781 ' H ' HG23 ' A' ' 50' ' ' ILE . 8.1 pt20 -92.09 23.88 3.56 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.552 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.19 -103.8 2.86 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.296 -0.954 . . . . 0.0 114.165 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 46.54 -114.74 0.53 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.965 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -54.88 -34.86 63.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.074 0.94 . . . . 0.0 108.587 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.0 tt0 -55.62 -30.83 61.61 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.049 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 54' ' ' ALA . 3.5 t -78.42 -41.22 33.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.741 ' HA ' HD23 ' A' ' 15' ' ' LEU . 8.3 t0 -59.8 -22.8 62.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.02 53.04 8.21 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.7 tpt180 -117.68 56.17 0.85 Allowed 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.659 ' CG2' HG21 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -90.41 141.79 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.9 m-70 130.48 106.84 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 112.659 -2.064 . . . . 0.0 109.935 177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -82.62 110.45 17.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.56 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.9 103.24 0.18 Allowed Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 118.269 -1.92 . . . . 0.0 110.948 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -167.07 -170.77 1.6 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.438 -178.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.789 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.15 107.95 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.13 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -78.27 142.08 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 177.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.864 HD23 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -84.55 -49.18 8.82 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.189 174.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.795 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.69 152.35 51.86 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 96' ' ' LEU . 14.1 p -123.23 143.53 35.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.675 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 14.4 t-20 42.28 19.42 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.205 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 104.66 -24.41 28.65 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.806 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.622 HG11 ' CD ' ' A' ' 82' ' ' GLN . 88.3 t -86.59 142.53 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -78.98 117.74 20.33 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 70' ' ' VAL . 1.1 pt? -98.63 78.26 2.35 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.64 27.38 2.34 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.408 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 36' ' ' ASN . . . 112.39 27.02 4.04 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . -94.08 -61.36 1.54 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.36 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.921 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER 38.98 -98.56 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.695 ' O ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 10.52 -76.12 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.868 1.355 . . . . 0.0 109.971 -173.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.8 ' O ' ' CB ' ' A' ' 85' ' ' GLU . 2.6 tptm -82.74 -62.07 1.7 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.684 ' O ' ' HB ' ' A' ' 86' ' ' THR . 8.9 mt-30 -72.32 -55.42 7.17 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -77.1 -50.12 13.75 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 117.533 -1.667 . . . . 0.0 114.532 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.739 HG12 ' C ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -64.95 -44.91 96.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.081 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.8 ' CB ' ' O ' ' A' ' 81' ' ' LYS . 29.1 tt0 -65.22 -32.33 73.96 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.158 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.787 HG21 HG13 ' A' ' 70' ' ' VAL . 2.0 t -79.28 -37.93 36.64 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.585 -175.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 26' ' ' VAL . 3.7 pp -63.71 -36.37 83.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.884 ' N ' HD12 ' A' ' 87' ' ' LEU . 3.4 mtt-85 -76.91 -31.27 56.58 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.968 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -99.81 -3.9 31.66 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.902 HG22 ' CG2' ' A' ' 94' ' ' VAL . 1.5 p -40.38 166.44 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.925 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 114.87 -65.64 0.29 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.76 -1.21 . . . . 0.0 113.533 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' GLY . 3.4 pt20 -32.08 -43.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.709 0.766 . . . . 0.0 109.859 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.988 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.4 p 174.09 109.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.382 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.902 ' CG2' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.82 136.81 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 0 CA-C-O 122.879 1.323 . . . . 0.0 113.999 -173.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.757 ' NE2' ' HB2' ' A' ' 14' ' ' GLU . 65.5 m80 -133.75 115.09 14.14 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.063 -2.335 . . . . 0.0 110.508 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.14 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -125.86 132.29 52.22 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 67' ' ' VAL . 17.7 mt -106.44 113.34 26.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.029 174.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.978 HD11 ' HD3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -110.47 145.74 37.15 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.132 -179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.572 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -110.77 110.49 21.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.087 0.946 . . . . 0.0 110.048 177.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.978 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.77 116.71 7.96 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.534 -178.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.54 34.23 0.5 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.958 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 1.6 mm100 -50.0 92.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.741 -0.729 . . . . 0.0 111.413 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 t -176.82 65.3 0.21 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.78 170.93 0.82 Allowed 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 122.642 2.228 . . . . 0.0 112.754 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -72.18 60.26 0.42 Allowed 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.795 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m 44.84 29.88 0.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.628 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.39 52.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.18 117.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -64.79 -60.83 7.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 71.5 Cg_endo -74.52 111.24 3.27 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.598 2.199 . . . . 0.0 112.302 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.61 54.04 4.93 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.528 2.152 . . . . 0.0 112.637 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 15.1 mtpp -153.44 154.75 30.98 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 121.303 0.573 . . . . 0.0 111.462 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 11' ' ' PHE . 10.5 Cg_exo -70.74 160.62 48.82 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 121.988 1.792 . . . . 0.0 113.014 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.84 5.02 3.65 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.87 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -179.85 -101.33 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -100.9 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.593 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 13' ' ' VAL . 7.2 t80 -118.95 140.87 49.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.205 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 1.082 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -117.34 150.11 39.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.3 m -125.48 109.87 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 118.831 -1.148 . . . . 0.0 110.702 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.779 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 14.1 pt-20 -116.44 127.56 54.7 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -144.37 147.34 33.29 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 123.912 0.885 . . . . 0.0 109.525 175.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -107.86 121.0 43.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -39.79 91.2 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.426 -178.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -135.65 -57.2 0.78 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.916 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -122.72 -36.9 2.83 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.142 0.972 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 26.5 m120 -166.68 154.3 9.6 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.876 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.619 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.3 t -166.68 34.27 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.166 0.984 . . . . 0.0 108.424 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 166.95 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.307 -177.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.855 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.46 37.16 0.05 OUTLIER Glycine 0 CA--C 1.495 -1.204 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.014 HG22 ' HA ' ' A' ' 49' ' ' VAL . 29.6 pt -118.69 148.3 21.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.5 t -98.87 114.18 26.66 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 87' ' ' LEU . 7.9 p -99.86 157.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.408 -177.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 31' ' ' ASP . 6.2 m 78.75 1.79 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.089 HG21 ' HB3' ' A' ' 47' ' ' LYS . 24.5 m -74.29 -41.44 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.964 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 28' ' ' VAL . 6.2 mt -111.29 -13.22 13.98 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 122.089 0.947 . . . . 0.0 108.489 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CE2' HG11 ' A' ' 35' ' ' VAL . 2.5 t80 -129.11 -172.44 2.73 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.758 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 27' ' ' THR . 2.1 m-20 -90.36 -21.08 22.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.781 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -174.68 38.28 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.132 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.642 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 58.91 -103.2 0.35 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.901 -1.142 . . . . 0.0 111.107 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -52.79 167.44 1.06 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-O 119.754 -0.47 . . . . 0.0 112.572 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.003 HG22 ' H ' ' A' ' 36' ' ' ASN . 3.3 p 158.5 -148.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.003 ' H ' HG22 ' A' ' 35' ' ' VAL . 8.4 p-10 -144.09 23.81 1.67 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.66 ' H ' HG13 ' A' ' 35' ' ' VAL . 3.6 t -3.22 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.667 -175.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.0 m 178.66 62.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.374 0.607 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.795 HG22 ' H ' ' A' ' 40' ' ' ARG . 9.8 p -160.4 -176.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.444 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.795 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -109.48 29.48 7.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.735 0.302 . . . . 0.0 111.737 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.747 ' H ' HG13 ' A' ' 39' ' ' VAL . 57.7 m-70 -139.58 -29.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 111.603 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 137.58 -107.34 0.58 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 114.14 85.25 1.33 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.012 HG22 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -82.8 133.11 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.203 0.525 . . . . 0.0 111.577 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.855 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 19.8 m-85 -123.57 135.07 53.78 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.423 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.943 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.6 p -158.68 -171.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -173.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.089 ' HB3' HG21 ' A' ' 28' ' ' VAL . 5.4 ptpt -92.15 -20.26 21.41 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.943 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 83.69 -140.86 0.01 OUTLIER 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.046 -2.343 . . . . 0.0 112.932 176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.014 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.3 m -77.21 138.49 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -42.45 163.14 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 110.811 -2.904 . . . . 0.0 110.756 177.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.458 ' HD3' HG13 ' A' ' 50' ' ' ILE . 5.1 Cg_exo -78.88 -26.12 5.7 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.304 2.003 . . . . 0.0 112.513 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 50' ' ' ILE . 7.1 pt20 -92.62 18.13 9.17 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.716 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 96.96 -93.28 1.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.522 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.56 -107.23 0.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.35 -35.67 60.51 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.469 1.128 . . . . 0.0 108.625 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 2.7 tm-20 -56.53 -31.14 63.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.167 -1.833 . . . . 0.0 109.011 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -78.02 -40.87 37.54 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.699 ' HA ' HD23 ' A' ' 15' ' ' LEU . 3.9 t0 -59.93 -23.12 63.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.601 ' O ' ' CG1' ' A' ' 13' ' ' VAL . . . 73.25 50.9 10.91 Favored Glycine 0 CA--C 1.495 -1.192 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.507 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.893 ' HA ' HG11 ' A' ' 13' ' ' VAL . 11.7 tpt85 -117.12 55.57 0.84 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 HG22 ' CG2' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.28 141.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.222 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.062 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 11.3 m80 131.2 107.13 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.025 -1.898 . . . . 0.0 110.37 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -83.15 110.21 17.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.758 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.754 ' H ' ' H ' ' A' ' 46' ' ' VAL . . . 77.37 104.01 0.17 Allowed Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 118.428 -1.844 . . . . 0.0 111.084 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -169.08 -170.14 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.351 -0.424 . . . . 0.0 110.323 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.854 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -130.43 108.03 9.67 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.012 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.14 142.43 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 176.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -86.4 -47.8 9.01 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.047 -1.888 . . . . 0.0 107.826 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -134.07 146.86 50.71 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.062 HG23 HD11 ' A' ' 96' ' ' LEU . 9.8 p -122.93 143.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.77 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 48.1 t30 48.88 16.2 0.11 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.355 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 101.85 -21.22 42.93 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.122 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.709 HG11 ' CD ' ' A' ' 82' ' ' GLN . 69.0 t -86.62 142.52 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 11.4 p -79.05 114.62 18.14 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.909 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -95.8 77.67 3.24 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -92.58 35.3 1.03 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.778 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.513 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 109.79 12.16 19.27 Favored Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -77.42 -55.69 5.18 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.175 -0.512 . . . . 0.0 110.532 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.955 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 24.21 -99.99 0.01 OUTLIER 'General case' 0 CA--C 1.47 -2.125 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.427 -179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.664 ' C ' ' O ' ' A' ' 79' ' ' THR . 6.4 t60 18.31 -80.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 125.209 1.568 . . . . 0.0 108.481 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.079 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 85.0 tttt -83.71 -62.03 1.68 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.053 ' O ' HG22 ' A' ' 86' ' ' THR . 9.0 mt-30 -71.56 -55.33 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 -173.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.955 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.18 -48.23 21.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 118.488 -1.285 . . . . 0.0 114.385 -174.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -63.1 -40.68 89.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.451 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.079 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.4 tt0 -61.58 -36.84 81.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.625 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.053 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER -67.55 -39.2 84.98 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.461 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.921 HD13 HG21 ' A' ' 26' ' ' VAL . 1.7 mt -62.6 -37.61 86.91 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -76.95 -30.99 56.29 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.957 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -103.79 -8.45 19.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.038 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -38.06 157.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.784 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 110.94 -63.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.138 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 91' ' ' GLY . 1.4 pp0? -34.02 -42.13 0.12 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.708 0.766 . . . . 0.0 109.582 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.949 HG23 ' HA ' ' A' ' 16' ' ' ALA . 1.5 p 173.04 108.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.038 HG21 HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -116.92 136.68 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 122.864 1.316 . . . . 0.0 113.653 -174.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.779 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 65.8 m80 -133.9 116.23 15.37 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 112.03 -2.35 . . . . 0.0 110.682 176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.082 ' O ' ' HA ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -129.32 137.79 51.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -177.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.3 mt -111.42 113.77 26.44 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.882 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.901 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -108.85 153.38 23.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.298 -178.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.589 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.9 OUTLIER -128.01 119.21 24.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.075 177.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -65.77 129.09 38.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.631 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.23 35.48 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.797 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 64' ' ' GLY . 20.2 mt-30 -54.66 -82.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.838 -0.681 . . . . 0.0 111.518 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.3 OUTLIER -83.75 -64.1 0.24 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.441 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 103' ' ' SER . 36.2 Cg_endo -64.6 166.38 17.9 Favored 'Trans proline' 0 CA--C 1.5 -1.201 0 C-N-CA 122.502 2.135 . . . . 0.0 112.923 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -61.33 -168.31 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.347 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 105' ' ' THR . 34.6 t -104.48 30.32 5.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.48 -58.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 61.73 115.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -175.4 -56.7 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.972 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 3' ' ' SER . 76.2 Cg_exo -50.52 147.67 16.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.084 . . . . 0.0 112.333 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.01 153.77 41.98 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -78.5 163.8 59.47 Favored Pre-proline 0 CA--C 1.503 -0.827 0 CA-C-O 121.372 0.605 . . . . 0.0 111.262 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.72 179.47 0.36 Allowed 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 121.799 1.666 . . . . 0.0 112.529 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 100' ' ' LYS . . . 107.55 25.45 6.0 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.678 ' N ' ' HB2' ' A' ' 100' ' ' LYS . 0.6 OUTLIER 174.3 -138.09 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -79.46 100.54 4.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.222 1.01 . . . . 0.0 109.552 179.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' A' ' 13' ' ' VAL . 9.0 t80 -119.06 141.42 48.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.413 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.972 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -116.28 150.79 37.03 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 119.165 -0.445 . . . . 0.0 110.081 178.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 60' ' ' ARG . 1.1 m -126.21 109.86 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 C-N-CA 119.044 -1.063 . . . . 0.0 110.335 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 95' ' ' HIS . 0.0 OUTLIER -116.75 127.37 54.3 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -144.59 147.7 33.47 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 123.874 0.87 . . . . 0.0 109.533 175.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.921 ' HA ' HG23 ' A' ' 93' ' ' VAL . . . -109.42 122.12 46.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 16' ' ' ALA . 5.2 tmtt? -39.21 91.38 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.444 -178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.4 t30 -135.49 -58.25 0.78 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.864 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.35 -36.55 2.79 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 122.163 0.982 . . . . 0.0 108.537 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.625 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 69.2 m-80 -166.55 154.41 9.94 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.245 -1.798 . . . . 0.0 107.846 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.678 ' HB3' ' HA2' ' A' ' 91' ' ' GLY . 8.7 t -167.22 34.37 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.236 1.017 . . . . 0.0 108.408 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.831 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.01 179.27 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.291 -177.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.86 ' N ' ' HB2' ' A' ' 55' ' ' ALA . . . 146.01 38.42 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.995 HG22 ' HA ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -119.83 148.29 22.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.7 t -98.91 114.53 27.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.447 178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.991 HG21 HD22 ' A' ' 87' ' ' LEU . 13.8 p -100.0 157.93 3.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.411 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.961 HG22 ' HA ' ' A' ' 32' ' ' LYS . 3.0 p 79.79 0.19 2.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.531 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.051 HG21 ' HB3' ' A' ' 47' ' ' LYS . 17.4 m -75.76 -39.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 28' ' ' VAL . 5.8 mt -113.51 -12.96 12.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.994 0.902 . . . . 0.0 108.876 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -126.43 -163.94 1.28 Allowed 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.99 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HB3' ' CE ' ' A' ' 32' ' ' LYS . 29.1 t0 -101.87 -16.58 16.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.864 0.364 . . . . 0.0 110.214 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.961 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -177.22 36.01 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 45' ' ' TYR . . . 54.12 -101.09 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.657 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -53.26 156.03 5.62 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.199 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.941 HG22 ' H ' ' A' ' 36' ' ' ASN . 7.2 p 153.73 -167.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.941 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -140.52 25.66 2.19 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 175.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 35' ' ' VAL . 11.1 t -6.46 -52.52 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.425 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.608 ' N ' ' O ' ' A' ' 36' ' ' ASN . 3.9 m -154.44 36.76 0.42 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.849 HG22 ' H ' ' A' ' 40' ' ' ARG . 5.8 p -142.5 -156.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.849 ' H ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.83 -12.76 5.92 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -95.04 -25.13 16.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.494 0.664 . . . . 0.0 110.719 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 75' ' ' LEU . . . 126.23 -108.71 1.05 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 66' ' ' ARG . . . 107.13 77.39 1.06 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 117.291 1.677 . . . . 0.0 117.291 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.04 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -70.18 134.97 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.349 0.595 . . . . 0.0 112.233 177.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.633 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 2.0 m-85 -123.9 143.63 50.25 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.925 HG13 ' N ' ' A' ' 48' ' ' ALA . 2.3 p -167.8 -173.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.051 ' HB3' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.92 -19.71 24.23 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.286 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.925 ' N ' HG13 ' A' ' 46' ' ' VAL . . . 82.47 -142.38 0.01 OUTLIER 'General case' 0 N--CA 1.404 -2.761 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.48 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.995 ' HA ' HG22 ' A' ' 24' ' ' ILE . 6.1 m -77.5 137.98 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 117.977 2.584 . . . . 0.0 117.977 -174.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.675 ' HB ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -42.12 162.24 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 110.915 -2.857 . . . . 0.0 110.928 177.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HD3' HG13 ' A' ' 50' ' ' ILE . 4.9 Cg_exo -79.34 -26.07 5.28 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.368 2.045 . . . . 0.0 112.604 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' HG23 ' A' ' 50' ' ' ILE . 15.5 pt20 -91.69 17.43 8.92 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.721 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 56' ' ' GLU . . . 98.62 -94.74 1.5 Allowed Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.499 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 22' ' ' LEU . . . 40.34 -109.02 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 49' ' ' VAL . . . -53.49 -35.78 60.98 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 122.454 1.121 . . . . 0.0 108.537 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -56.29 -31.05 63.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.015 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -78.01 -41.01 37.15 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' HD23 ' A' ' 15' ' ' LEU . 5.1 t0 -60.0 -23.1 63.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . 73.12 53.28 7.93 Favored Glycine 0 CA--C 1.494 -1.248 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.199 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.898 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 tpt180 -115.83 53.28 0.86 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.662 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -89.72 141.49 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.183 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -176.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.662 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 3.0 m-70 130.02 106.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.691 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -83.31 110.27 17.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.457 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 45' ' ' TYR . . . 77.74 105.35 0.17 Allowed Glycine 0 CA--C 1.503 -0.681 0 C-N-CA 118.241 -1.933 . . . . 0.0 110.965 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -171.5 -170.82 0.85 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.212 -0.494 . . . . 0.0 110.462 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.772 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -130.04 108.63 10.23 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.04 HG22 HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -80.27 142.19 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 C-N-CA 126.41 1.884 . . . . 0.0 115.91 177.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 69' ' ' ALA . 4.2 pp -85.0 -48.5 9.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.775 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.876 ' O ' HD23 ' A' ' 96' ' ' LEU . . . -133.78 148.08 51.33 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG23 HD11 ' A' ' 96' ' ' LEU . 8.7 p -123.01 143.74 34.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.684 ' HB2' ' OG1' ' A' ' 86' ' ' THR . 46.3 t30 49.8 16.28 0.2 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.059 0.457 . . . . 0.0 110.477 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' HIS . . . 100.89 -20.31 48.43 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.823 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.604 HG11 ' CD ' ' A' ' 82' ' ' GLN . 68.9 t -87.0 142.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -78.99 114.98 18.38 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.952 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -94.7 77.86 3.72 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.48 31.4 1.76 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.949 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.51 ' CA ' ' HB3' ' A' ' 36' ' ' ASN . . . 108.64 21.19 7.67 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.574 ' O ' ' C ' ' A' ' 79' ' ' THR . . . -86.4 -51.86 5.96 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.351 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.964 ' CG2' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER 22.98 -100.19 0.01 OUTLIER 'General case' 0 CA--C 1.471 -2.089 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.49 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' C ' ' O ' ' A' ' 79' ' ' THR . 5.8 t60 18.43 -79.94 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 125.168 1.543 . . . . 0.0 108.57 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.119 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 2.4 tptt -83.61 -61.93 1.71 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 1.044 ' O ' HG22 ' A' ' 86' ' ' THR . 31.4 mt-30 -71.5 -55.58 7.58 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 118.788 2.885 . . . . 0.0 118.788 -173.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 79' ' ' THR . . . -76.34 -47.9 21.87 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 118.65 -1.22 . . . . 0.0 114.247 -174.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG12 ' C ' ' A' ' 79' ' ' THR . 0.1 OUTLIER -64.09 -39.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.42 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 1.119 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 16.1 tt0 -61.55 -36.31 80.25 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.081 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.044 HG22 ' O ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -70.64 -39.98 73.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.458 -0.897 . . . . 0.0 112.226 -176.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.991 HD22 HG21 ' A' ' 26' ' ' VAL . 3.6 pp -63.1 -35.9 81.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.929 ' N ' HD12 ' A' ' 87' ' ' LEU . 4.8 ttp180 -77.37 -31.12 54.11 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.182 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 2.6 m-20 -104.71 -7.2 19.72 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.044 HG22 HG21 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -36.91 155.93 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.689 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.678 ' HA2' ' HB3' ' A' ' 21' ' ' SER . . . 107.23 -59.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.517 -1.325 . . . . 0.0 112.806 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 10.3 pt20 -37.76 -38.86 0.31 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.607 0.718 . . . . 0.0 109.195 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.921 HG23 ' HA ' ' A' ' 16' ' ' ALA . 3.7 p 168.63 105.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.393 -3.316 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -114.51 136.78 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-O 123.02 1.391 . . . . 0.0 113.565 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 14' ' ' GLU . 61.2 m80 -133.81 116.01 15.18 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 111.619 -2.537 . . . . 0.0 110.758 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.033 HD11 HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -128.96 138.84 52.21 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.721 HD23 ' CB ' ' A' ' 12' ' ' GLU . 20.2 mt -112.34 114.05 26.58 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.805 -1.543 . . . . 0.0 108.266 174.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.895 ' HA ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -113.05 153.08 28.71 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.357 -178.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.558 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.4 mt-10 -125.53 109.32 12.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.075 0.941 . . . . 0.0 111.162 177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.843 ' HD3' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -66.7 112.16 4.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.943 -179.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.82 31.54 2.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.703 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 12.9 mm100 -89.14 -52.94 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.08 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.47 165.85 33.59 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.634 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.41 171.51 3.27 Favored 'Trans proline' 0 CA--C 1.501 -1.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.695 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 t -58.43 -29.37 66.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.444 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.1 t 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -140.83 -53.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.944 179.956 . . . . . . . . 0 0 . 1 stop_ save_